Dystonia in complex regional pain syndrome  :  clinical, pathophysiological and therapeutic aspects by Rijn, M.A. van
Dystonia in Complex Regional Pain Syndrome
Clinical, pathophysiological and therapeutic aspects
Monique A. van Rijn
Monica Adriana van Rijn
Dystonia in Complex Regional Pain Syndrome
Clinical, pathophysiological and therapeutic aspects
PhD Thesis, Leiden University Medical Center, Leiden 2010
ISBN: 978-90-5335-303-5
© 2010, M. A. van Rijn, except (parts of ) the following chapters:
Chapter 3, 7, 8: Elsevier Science
Chapter 4: John Wiley & Sons, Ltd.
Chapter 5: BMJ Journals
Chapter 6: Springer
No part of this book may be reproduced, stored in a retrieval system of any nature, 
or transmitted in any form or by any means, electronic, mechanical, photocopying, 
recording or otherwise, without prior permission in writing of the copyright owner.
Cover: Monique van Rijn en Ridderprint bv
Lay-out and printed by: Ridderprint bv, Ridderkerk
Dystonia in Complex Regional Pain Syndrome
Clinical, pathophysiological and therapeutic aspects
Proefschrift
ter verkrijging van
de graad van Doctor aan de Universiteit Leiden,
op gezag van Rector Magnificus prof.mr. P.F. van der Heijden,
volgens besluit van het College voor Promoties
te verdedigen op dinsdag 12 oktober 2010
klokke 15.00 uur
door










Prof.Dr. F.J.P.M Huygen (Erasmus Medisch Centrum Rotterdam)
Dr. R.S.G.M. Perez (VU Medisch Centrum Amsterdam) 
 
This PhD project was performed within TREND (Trauma RElated Neuronal 
Dysfunction), a Dutch consortium that integrates research on epidemiology, 
assessment technology, pharmacotherapeutics, biomarkers and genetics on Complex 
Regional Pain Syndrome. The consortium aims to develop concepts on disease 
mechanisms that occur in response to tissue injury, its assessment and treatment. 
TREND is supported by a government grant (BSIK03016). 
Financial support for this thesis has been provided by Pfizer, Allergan, Nederlandse 
Vereniging van Posttraumatische Dystrofie Patiënten, van Alkemade-Keuls 
Foundation, and the J.E. Jurriaanse Stichting.
Aan alles, aan alles, komt een begin
(Herman van Veen)
Voor Milcar en Barbara

Contents 
1.  Introduction    9
       
2.     Spreading of Complex Regional Pain Syndrome: not a random process 23
  
3.     Onset and progression of dystonia in Complex Regional Pain Syndrome.  41
  
4.     Psychological features of patients with Complex Regional Pain Syndrome  57
  related dystonia.      
 
5.  Hyperacusis in patients with Complex Regional Pain Syndrome related dystonia     75
  
6.  Spatiotemporal integration of sensory stimuli in patients with Complex 87
  Regional Pain Syndrome and dystonia.   
  
7.  Cerebral activation during motor imagery in Complex Regional Pain  103
  Syndrome with dystonia.     
 
8.  Intrathecal baclofen for dystonia of Complex Regional Pain Syndrome  119
  
9.    Summary, conclusions and future plans    139
10.  Samenvatting,  conclusies en toekomstig onderzoek  153
  Acknowledgement      167
  List of Abbreviations     169
  List of publications     171






Complex Regional Pain Syndrome
 
The first description of what nowadays is known as Complex Regional Pain Syndrome 
(CRPS) originates from 1864 when Weir Mitchell, an American neurologist, reported 
a syndrome in casualties of the American Civil War that was accompanied by partial 
nerve lesions. He named the associated pain “causalgia”1,2. In 1900, Sudeck described a 
similar syndrome which he named “acute reflektorische knochenatrophie”, characterized 
by bone changes that occurred after an injury without obvious nerve damage3. In 
the following decades, several comparable syndromes were described using terms 
including algodystrophy, post-traumatic dystrophy and Sudeck atrophy. The supposed 
pathophysiological mechanism for these syndromes was an exaggerated reflex to an 
injury caused by dysregulation of the sympathetic nervous system. Therefore, around 
1940, the term Reflex Sympathetic Dystrophy (RSD) was introduced to specify all 
syndromes characterized by the combination of autonomic and trophic changes4. As it 
became increasingly clear that the clinical features of the syndrome were insufficiently 
explained by dysfunction of the autonomic nervous system, a consensus meeting was 
held in 1994 which resulted in a new set of diagnostic criteria and the introduction 
of the terms “complex regional pain syndrome (CRPS)” type I and type II. These 
terms were meant to substitute for RSD (type I) and causalgia (type II) (table 1)5,6. The 
difference between the two types of CRPS is based on the absence (CRPS-type I) or 
presence (CRPS-type II) of an overt nerve lesion. 
Table 1. Diagnostic criteria for CRPS type 1 of the International Association for the Study of Pain 
(IASP) 5.
1) the presence of an initiating noxious event or a cause of immobilization
2) continuing pain, allodynia or hyperalgesia with which the pain is disproportionate to any 
inciting event
3) evidence at some time of edema, changes in skin blood flow or abnormal sudomotor activity 
in the region of the pain 
4) absence of a condition that would otherwise account for the degree of pain and dysfunction 
Criteria 2-4 are necessary for a diagnosis of CRPS.
CRPS generally affects distal extremities and is preceded by a trauma in a majority of 
patients7,8. A spontaneous onset has been described in 3–11% of cases8-13. CRPS occurs 
more frequently in women and may occur at all ages although the highest incidence is 
found between 50 and 70 years. The reported incidence ranges from 5.5 to 26.2 per 
100,000 person-years7,14. 
CRPS is characterized by pain with various combinations of sensory disturbances 
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such as allodynia and hyperalgesia, and autonomic features like changes in skin blood 
flow, transpiration and abnormal hair and nail growth5,8. Occasionally, symptoms may 
spread to other extremities and body parts13,15. Furthermore, patients with CRPS may 
suffer from movement disorders (MDs), like tremor, myoclonia and dystonia16-19. 
Pathophysiology of CRPS 
CRPS is regarded a multifactorial disorder where both environmental and genetic 
factors contribute to the development of the disease. The role of environmental factors 
is evident as in ninety percent of the patients symptoms are preceded by a traumatic 
injury8. However, as some patients develop CRPS spontaneously, other factors must 
contribute20. The role of genetic factors is supported by the fact that CRPS may occur 
in a familial form and that these patients develop the disease at a younger age and have a 
more severe phenotype than sporadic cases21 which suggests an increased susceptibility 
to develop the disease22,23. A genetic predisposition for CRPS is also apparent from 
genetic associations that were found with different human leukocyte antigen (HLA) 
factors24-27. However, so far the role of HLA factors in CRPS has remained illusive. 
The pathophysiology of CRPS has been increasingly studied over the past decades. 
Hitherto several different pathophysiological mechanisms underpinning CRPS or 
parts of its clinical spectrum have been forwarded. 
Autonomic dysfunction 
For long, impairment of the sympathetic nervous system was held responsible 
for maintaining pain (“sympathetically maintained pain”, SMP) and autonomic 
dysfunctions in CRPS. In SMP, spontaneous and evoked pain is elicited by sympathetic 
hyperactivity through sympathetic afferent coupling, in which adrenergic receptors 
are expressed on primary sensory afferent fibres28,29. However, there are several 
reasons that argue against the sympathetic nervous system as the key player in the 
generation and maintenance of CRPS: for example, sweating and trophic disturbances 
are not the most predominant features of CRPS8,30 and can also be induced by the 
neuropeptides calcitonin-gene-related peptide (CGRP) and substance P (SP)31. 
Additionally, vasoconstriction does not always reflect sympathetic activity32 and 
alternative mechanisms like endothelial dysfunction may account for the vasomotor 
impairments33,34. Finally, although sympatholytic strategies have been recommended 
for decades, in many patients they are not beneficial35. Compelling evidence therefore 
suggests that SMP and sympathetic dysregulation may play a role in CRPS, but the 
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pathophysiology of the syndrome cannot be reduced to a sole dysfunction of the 
sympathetic nervous system. 
Vasomotor dysfunction
Decreased skin temperature and skin discoloration both suggest that mechanisms 
underpinning vasomotor dysfunction are involved in CRPS. Skin capillary hemoglobin 
oxygenation (HbO2) is lower36 and skin lactate is increased, reflecting enhanced 
anaerobic glycolysis16,36,37 in muscles of limbs affected by CRPS. Muscle tissue obtained 
from amputated limbs of CRPS patients showed evidence of oxidative stress and 
ischemic conditions resulting from microangiopathy in muscle tissue38. Collectively, 
this information underscores that vasomotor dysfunction is an important component 
of CRPS. Both sympathetic dysfunction and endothelial dysfunction have emerged as 
mechanisms of disease that potentially may contribute to vasomotor dysfunction in 
CRPS39.
Aberrant inflammation 
Similarities between the classical symptoms of inflammation and the clinical features 
of CRPS have led several investigators to suggest that the disease is caused by an 
exaggerated inflammatory response. This view is supported by research in blister 
fluid of CRPS patients which showed high levels of pro-inflammatory cytokines40,41. 
Some researchers found evidence for an increased level of inflammatory mediators 
in cerebrospinal fluid42, although others could not confirm this43. Additionally, an 
enhanced migration of injected radiolabelled autologous leukocytes or non-specific 
immunoglobulines towards the CRPS affected location has been described44,45 and 
open label studies with immunomodulating drugs like infliximab46,47 and thalidomide48 
report beneficial effects. Collectively, this led to the assumption that CRPS I is 
induced by an exaggerated inflammatory response to tissue injury, mediated by an 
excessive production of toxic oxygen radicals49. Support for the role of free radicals in 
CRPS I was found in randomized clinical trials in human CRPS with scavengers like 
dimethylsulfoxide, N-acetylcysteine and vitamin C in early treatment50,51.
Finally, involvement of the immune system may be supported by reports on an 
increased prevalence of antecedent viral infections in CRPS patients and the presence 
of autoantibodies against a surface epitope of autonomic neurons52. 
Alterations in the somatic nervous system  
Several studies have reported axonal degeneration in small distal nerve fibers of patients 
with CRPS38,53,54, but there is debate among researchers whether this is a cause or a 
consequence of the syndrome. Increasing evidence hints towards a perturbed function 
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of both non-myelinated C and myelinated Aδ fibres of sensory nerves, resulting in the 
increased secretion of neuropeptides such as SP and CGRP, a process called  neurogenic 
inflammation55,56. Animal studies in neuropathic pain syndromes have shown that these 
neuropeptides are also released spinally (by central nerve endings of primary afferents) 
which, in turn, may lead to central sensitization57. Central sensitization is induced in 
dorsal horn neurons and involves a reduction in pain threshold, amplification of pain 
responses and spread of pain sensitivity to adjacent, non-injured areas58. It is associated 
with neurochemical changes, functional alterations of excitatory and inhibitory 
connections, cell death of neurons and interneurons, and sprouting of new connections 
in the spinal cord59. 
In addition to spinal alterations, supraspinal sensorimotor neural networks are likely 
to contribute to the pathophysiology of CRPS. Which level of the CNS is the primary 
site where pathological alterations originate, remains unsolved. Referred sensations, 
changes in the size and organization of the somatosensory map, and changes in motor 
cortex representation are strongly suggestive of cortical involvement in CRPS60. For 
example, in CRPS patients watching the mirror-image of the unaffected limb elicits 
pain on the affected side61 and referred sensations of a tactile or painful stimulus were 
experienced outside its expected somatic territory62. A fMRI study in CRPS focusing 
on mechanical hyperalgesia, reported alterations in nociceptive, cognitive and motor 
processing63. Schwenkreis et al.64 studied patients with unilateral CRPS I involving the 
hand by means of transcranial magnetic stimulation using a paired-pulse paradigm. The 
authors found a significant bilateral reduction of intracortical inhibition in patients 
with CRPS compared with control subjects. Recently, regional grey matter atrophy and 
abnormal gray-white matter interactions, including decreased connectivity between 
the ventromedial cortex and basal ganglion have been observed65. 
Psychological factors
In the absence of a clear somatic cause, CRPS has often been considered as a psychogenic 
disorder66. Non-organic factors are often advanced as potential predisposing factors and 
some authors argue that the symptoms can be interpreted as a conversion reaction67,68or 
malingering69. However, much research on this topic is of poor methodologic quality 
and only a few prospective, well controlled studies have been performed. A recent 
population-based study by De Mos et al.70 compared the medical history of patients 
who developed CRPS with age and sex matched patients who did not develop CRPS 
after a similar trauma and found that psychological factors were not associated with 
an increased probability to develop CRPS. Another prospective study comprising 596 
patients with a single fracture found that there were no baseline differences in any of 
the psychological factors as measured by the SCL-90 between the 42 patients who 
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developed CRPS versus those who did not71. Three other prospective studies compared 
baseline data between patients who did and did not develop CRPS after surgery. None 
of these found a unique psychological profile in patients who developed CRPS72-74.  
There are no indications that childhood trauma plays a unique role in the onset of 
CRPS, as evidenced by a study from Ciccone 75 who found that child hood trauma and 
abuse were evenly distributed among patients with CRPS, local neuropathic pain and 
low back pain (LBP). Reports for the role of stressful life events are contradictory76,77. 
The majority of studies on psychological factors in CRPS involve cross-sectional 
studies, in which psychological and personality traits are compared between CRPS 
patients and patients with other pain syndromes. This approach does not permit 
conclusions regarding potential predisposing factors, since the present health status 
will inevitably reflect changes that occurred as a consequence of the condition. Three 
studies cross-sectionally compared patients with CRPS with patients with other pain 
conditions, using the Symptom Checklist (SCL-90) or its short version, the Brief 
Symptom Inventory. DeGood et al. found that, in comparison with patients with 
headache or low back pain (LBP), patients with CRPS had lower scores on 6 of the 
10 scales despite experiencing the highest level of pain intensity; differences on the 
other scales were not significant78. No differences in psychological profile were found 
in a study comparing CRPS patients with patients waiting for hand surgery76. Bruehl 
et al. reported that CRPS patients exhibited some elevations on the somatisation and 
phobic anxiety subscales compared to patients with LBP or limb pain; differences on 
the other scales were not significant79. In contrast with Bruehl79, van der Laan80 found 
that CRPS patients with dystonia exhibited lower scores on the somatisation subscale 
than a control population of rehabilitation patients. Together the results of these 
prospective and cross-sectional studies do not support a unique psychological profile 
that characterizes patients with CRPS.
Movement disorders in CRPS 
Motor abnormalities in war casualties with causalgia were first reported by Mitchell in 
the 19th century. This is illustrated by his description of case 28 from Injuries of Nerves 
and their Consequences: D.H., a girl of thirteen accidentally ran a small penknife blade 
into her right hand and developed burning pain, swelling, livid discoloration and a 
low temperature of the hand. A few months after the accident “the fingers became 
contracted, and the hand flexed, the palm continuing to suffer with burning pain. 
These conditions existed ……up to March 1869.……and the flexions became extreme”2. 
A more extensive description of the movement disorders (MDs) in CRPS followed in 
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the last two decades of the 20th century by Marsden and Schwartzman18,81. These MDs 
are not infrequent, as data from studies where selection bias towards MDs was unlikely 
indicate that 9-49% of the CRPS patients may develop MDs with dystonia being the 
most prevalent (14-25%)8,18,82,83. The increasing awareness that CRPS patients may 
suffer MDs has resulted in a proposal to add this clinical category to the new diagnostic 
criteria set84.
Dystonia in CRPS is predominantly characterized by fixed flexion postures (figure 1), 
frequently has a delayed onset and may spread to other extremities18,19. Several small 
studies found that the interval between the onset of CRPS and that of MDs can be up 
to 3 years81,85,86. In Veldman’s study, the prevalence of MDs increased with the duration 
of CRPS8. 
Figure 1. Flexion postures in dystonia of CRPS. 
Dystonia is defined as abnormal involuntary muscle contractions that cause twisting or 
repetitive movements or sustained postures87. In primary dystonia, no other abnormality 
than dystonia is present and the cause is genetic or unknown. However, dystonia may 
also be brought on by a large and diverse group of disorders (secondary dystonia), 
such as an exogenous insult (exposure to certain drugs) or may be the result of 
heredodegenerative and metabolic disorders. One of the potential causes of secondary 
dystonia is trauma. Although there is general agreement that traumatic brain injury can 
cause dystonia, the question whether peripheral trauma can cause dystonia has since 
long been a subject of debate88-90. 
Traditionally, dystonia is associated with basal ganglia dysfunction, but recent 
developments have led to further maturing of the concept of dystonia. First, the influence 
of sensory tricks in reducing dystonia severity and evidence from neurophysiological 
studies highlighted the role of faulty sensory-motor processing in dystonia91-93. Second, 
recent studies have reported the occurrence of dystonia in cerebellar disease and thereby 
expanded the anatomical territory of dystonia to include the cerebellum94-96. Finally, 
two interventional studies on DYT1 dystonia and levodopa-responsive dystonia 
have shown that both disorders are associated with neurophysiological abnormalities 
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along the whole neuraxis that improved after deep brain stimulation or after levodopa 
challenge97,98. These findings have positioned dystonia as a manifestation of aberrant 
neural networks that are involved in sensory-motor processing required for the 
control and execution of voluntary movement99. In line with this new concept, several 
neurophysiological studies in CRPS-related dystonia have found evidence of impaired 
inhibition at the spinal cord and motor cortex64,100,101. 
The treatment of movement disorders of CRPS is a field still in its infancy. Randomized 
controlled studies of physical therapy, occupational therapy or pharmacotherapy are 
lacking. In Schwartzman and Kerrigan’s report18, some CRPS patients with dystonia 
benefited from oral baclofen and benzodiazepines. Splints and plaster casts have been 
used for the treatment of dystonic postures but are often ineffective or may even worsen 
the dystonia85.  Although in some cases favorable responses have been reported following 
sympathetic blocks102, no solid evidence is available to support this treatment mode for 
MDs in CRPS. Continuous intrathecal baclofen administration was evaluated in six 
CRPS patients with multifocal or generalized dystonia103. During prolonged therapy, 
three patients regained normal hand function, and two patients regained the ability to 
walk. In one woman the pain and violent jerks disappeared and the dystonic posturing 
of the arm decreased. In two women the spasms or restlessness of the legs decreased 
without any change in dystonia. 
Prognosis of CRPS
Contradicting reports have been published regarding the outcome of CRPS. Sandroni 
et al performed a population-based study7 and mentioned complete symptom resolution 
in 74% of the patients within one year after CRPS onset, on the basis of the medical 
chart review. In contrast, Veldman et al.8 and Galer 104 et al. objectively assessed patients 
and found persistent disturbances in most of them after one or more years follow-up. 
In addition, Geertzen et al.105 reported impairments and disability in 62% of patients 
5.5 years after CRPS onset. In a population based retrospective comparative cohort 
study, de Mos et al106 found that a majority of patients had persistent impairments at 2 
or more years since the onset of CRPS.  Sixty-four percent of the patients still fulfilled 
IASP criteria at an average of 5.8 years after the initial injury. The impact of the disease 
on the ability to work was high: 31% had become permanently incapable of work, 
whereas another 28% had to make working adjustments. Population based studies on 
the prognosis of CRPS patients with movement disorders are lacking but observational 
studies report a poor prognosis after several years of follow-up107. 
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MDs occur frequently in patients with CRPS, have a poor prognosis and form a major 
challenge in the clinical management of patients with CRPS. A better delineation of 
clinical, pathophysiological and therapeutic aspects of MDs in CRPS may potentially 
contribute to better management strategies for this disabling component of the 
syndrome. 
Aim of this thesis
1. To study the clinical characteristics and disease course of patients with CRPS in 
multiple extremities and of CRPS patients with movement disorders, in particular 
dystonia. 
2. To study the neurophysiologic and neuroradiological characteristics of dystonia in 
CRPS. 
3. To evaluate the efficacy and safety of intrathecal baclofen treatment for dystonia 
of CRPS. 
These three aims will be addressed in studies described in chapter 2 to 8 of this thesis. 
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Background: Complex Regional Pain Syndrome (CRPS) generally remains restricted 
to one limb  but occasionally may spread to other limbs. Knowledge of the spreading 
pattern of CRPS may lead to hypotheses about underlying mechanisms but to date 
little is known about this process.  
Objective: To study patterns of spread of CRPS from a first to a second limb and the 
factors associated with this process. 
Methods: One hundred-eighty-five CRPS patients were retrospectively evaluated. 
Cox’s proportional hazards model was used to evaluate factors that influenced spread 
of CRPS symptoms. 
Results: Eighty-nine patients exhibited CRPS in multiple limbs. In 72 patients spread 
from a first to a second limb occurred showing a contralateral pattern in 49%, ipsilateral 
pattern in 30% and diagonal pattern in 14%. A trauma preceded the onset in the second 
limb in 37, 44 and 91%, respectively. The hazard of spread of CRPS increased with 
the number of limbs affected. Compared to patients with CRPS in one limb, patients 
with CRPS in multiple limbs were on average 7 years younger and more often had 
movement disorders. 
Conclusions: In patients with CRPS in multiple limbs, spontaneous spread of symptoms 
generally follows a contralateral or ipsilateral pattern whereas diagonal spread is rare 
and generally preceded by a new trauma. Spread is associated with a younger age at 
onset and a more severely affected phenotype. We argue that both spinal and supra-
spinal processes may play a role in the spontaneous spread in CRPS.
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Introduction
Complex regional pain syndrome (CRPS) is characterized by various combinations 
of sensory, autonomic and motor disturbances, and is usually preceded by a minor to 
severe trauma affecting a limb.1-3 CRPS usually remains restricted to one limb, but it 
can spread to other body parts.4,5 Although several small studies have reported spread 
of specific sensory, autonomic or motor features of the syndrome, the overall picture 
remains unclear.4-7 CRPS in one limb may extend to another limb either as result 
of a new trauma to a previously unaffected limb, or because the syndrome spreads 
spontaneously. Although different causes of spontaneous spread have been proposed, 
including genetic predisposition, aberrant regulation of neurogenic inflammation 
and maladaptive neuronal plasticity, the underlying mechanisms have not been 
elucidated.4,5,8 
We were able to characterize a large sample of patients in whom CRPS in one limb 
spread to involve another limb. We were particularly interested in patients in whom 
spreading occurred spontaneously, because this may reflect true spread of the disorder, 
which might provide important information about the mechanisms behind this process. 
For example, if systemic factors underpin spontaneous spread, then one would expect 
an indiscriminate pattern of spread; if cortical mechanisms underpin spontaneous 
spread, then one would expect an ipsilateral pattern, and if spinal mechanisms underpin 
spontaneous spread, then one would expect a contralateral pattern.
The present study aims to evaluate patterns of spread of CRPS from one to a second 
limb and consider potential mechanisms that could explain this process. In addition, 
factors that are associated with the occurrence of spread are studied. 
Methods 
Patients
All patients who visited the outpatient movement disorders clinic of the department of 
Neurology of the Leiden University Medical Center in the period from January 1998 
to April 2004 were considered for inclusion in the study. Patients were eligible if they 
met the CRPS criteria of the International Association for the Study of Pain (IASP), 
either at the time of disease onset or at the time of presentation at the clinic. The IASP 
criteria include the combination of: 1) the presence of an initiating noxious event or 
a cause of immobilization, 2) continuing pain, allodynia or hyperalgesia with which 
the pain is disproportionate to any inciting event, 3) evidence at some time of edema, 
changes in skin blood flow or abnormal sudomotor activity in the region of the pain 
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and 4) absence of a condition that would otherwise account for the degree of pain and 
dysfunction. Although only criteria 2-4 have to be satisfied3, we only included patients 
who identified an initiating noxious event in the first affected limb. Patients consent 
was obtained according to the Declaration of Helsinki and the study was approved by 
the Ethical Committee of the Leiden University Medical Center
Data Collection
Dates of onset of CRPS signs or symptoms for every involved limb were obtained from 
the patient’s history. Medical records were reviewed to verify data wherever possible. 
Recorded sensory features included pain, hypoalgesia, hyperalgesia and allodynia. 
Recorded autonomic features involved oedema, temperature changes, colour changes, 
hyper- or hypohidrosis, and changes in nail and hair growth. Recorded movement 
disorders included dystonia, tremor and myoclonus. For all affected limbs we evaluated 
if the symptoms and signs fulfilled the IASP criteria for CRPS. Age at onset in the first 
limb and length of interval to onset of symptoms in subsequent limbs were calculated. 
The presence and type of traumas (soft tissue injury, fracture, surgery) preceding CRPS 
was registered. We categorized patients according to three criteria. First, if CRPS was 
present in one limb, patients were categorized as ‘Single-CRPS’. If CRPS was present 
in more than one limb, they were categorized as ‘Multiple-CRPS’. Second, Multiple-
CRPS cases were categorized according to whether or not spread was associated with a 
separate trauma to the limb. If not, patients were categorized as ‘Spontaneous spread’. 
If so, they were categorized as ‘Separate trauma’.   Third, Multiple-CRPS cases were 
categorized according to which limb was subsequently affected: ‘Contralateral’ (e.g. 
left hand to right hand), ‘Ipsilateral’ (e.g. left hand to left leg) or ‘Diagonal’ (e.g. left 
hand to right leg). 
Statistical analysis
The independent-samples t-test was used to assess differences between groups in normally 
distributed continuous data, while non-parametric tests were used to assess differences 
in non-normally distributed continuous or categorical data. Baseline differences in 
disease duration were taken into account and analyzed with analysis of covariance. The 
time from onset of initial symptoms to extension to other limbs was calculated for each 
limb, where time to spread was censored at the time of last assessment. In patients who 
showed spontaneous spread of symptoms to subsequent limbs, a multivariate analysis 
of factors associated with spread of symptoms was carried out with Cox’s proportional 
hazards model. At any point in time, an individual has an instantaneous risk (“hazard”) 
to reach the endpoint (here: “spread to a second limb”). The Hazard ratio presents the 
increased or decreased risk on reaching the endpoint at any point in time (compared 
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to a reference value), adjusted for other potentially confounding variables in the 
model. Patients with simultaneous onset of symptoms in more than one limb or with 
simultaneous spread from one affected limb to more than one subsequent limb were 
excluded from this analysis. The hazard of spread was estimated while several variables 
were accounted for, including trauma characteristics, location of initial symptoms, 
presence of movement disorders and patient characteristics. The probabilities of spread 
to other limbs were calculated as cumulative incidences (competing risks).9 For the 
analysis of rate of spread comparing the presence of one, two or three affected limbs, 
the variance of the estimated coefficients was adjusted by using a sandwich estimator, 
accounting for possible correlations of event times within patients.10 P values £0.05 
were considered significant. All statistical analyses were performed with SPSS (version 
14.0), except for the survival analyses, which were performed with ‘R’ (version 2.0.1). 
Results
 
One-hundred-eighty-five patients were included in the study (table 1, figure 1). 
At assessment, 96 patients (52%) had a single affected limb, whereas 89 (48%) had 
multiple affected limbs. Signs and symptoms are presented in Table 2. In the Multiple-
CRPS group, the syndrome started in one limb in 78 patients (i.e. 88%), a simultaneous 
start in two limbs occurred in 10 patients (11%) and a simultaneous start in four limbs 
occurred in one patient (1%). 
Spread of CRPS from one to two limbs
CRPS had spread to another limb in 78 patients. Spread occurred simultaneously from 
one to three limbs in 5 patients and from one to four limbs in one (figure 1). CRPS 
spread from one to two limbs in 72 patients according to the following patterns (table 
3): contralateral pattern in 38 patients (53%; 22 arm to arm, 16 leg to leg); ipsilateral 
pattern in 23 patients (32%; 12 arm to leg, 11 leg to arm) and diagonal pattern in 11 
patients (15%). New trauma preceded the onset of CRPS in the second limb in 37 % of 
the patients with contralateral spread, in 44% of the patients with ipsilateral spread and 
in 91 % of the patients with diagonal spread, which indicates that diagonal spreading 
is almost always associated with a new trauma. Patient characteristics did not differ 
between the three types of spread. 
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Table 1. Demographics of 185 patients with CRPS.
Characteristic Value
females - no (%)      160 (86.5)
disease duration, mean (SD) - years 6.0 (6.0)
age at assessment, mean (SD) - years 43.5 (15.4)
age at onset of CRPS, mean (SD) - years 37.5 (15.4)
preceding trauma - no (%)
       soft tissue injury
       fracture 




CRPS involvement - no (%)
 -  single limb
          -  multiple limbs
                         affected limbs at initial CRPS onset - no (%)                                                     
                                 1
                                 2
                                 3
                                 4
                          affected limbs at assessment - no (%)
                                 2
                                 3
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Figure 1. Flow diagram of patients included in the study. 
Section A shows the included patients in which CRPS symptoms spread from one to 
two limbs and who were evaluated for different patterns of spread. Section B shows 
the included patients with multiple and single affected limbs that were compared for 




78 onset in 1 limb 
185 CRPS patients  
89 multiple affected limbs 
72 spread from 1 to 2 limbs 
38 without trauma of 2nd limb 
96 single affected limb 
11 onset ≥ 2 limbs 
6 spread from 1 to 3 or 4 limbs 
34 separate trauma of 2nd limb 
B 
A 
Pattern of spread: 
14 contralateral 
10 ipsilateral 
10 diagonal  
Pattern of spread: 
24 contralateral 
13 ipsilateral 
  1 diagonal  
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Present/absent/unknown, no. 185/0/0 89/0/0 44/0/0 26/0/0
Hyperalgesia/allodynia
Present/absent/unknown, no. 101/78/6 40/48/1 19/24/1 10/16/0
Hypoalgesia
Present/absent/unknown, no. 152/30/3 72/17/0 39/5/0 23/3/0
Edema 
Present/absent/unknown, no. 168/9/8 67/20/2 27/13/4 17/8/1
Temperature changes
Present/absent/unknown, no. 165/9/11 73/9/7 41/2/1 21/4/1
Color changes
Present/absent/unknown, no. 176/3/6 82/5/2 33/7/4 24/2/0
Hyper/hypohidrosis
Present/absent/unknown, no. 122/44/19 59/27/3 26/15/3 13/12/1
Hair and nail growth changes
Present/absent/unknown, no. 134/42/9/ 52/32/5 27/13/4 18/7/1
Movement disorders*
Present/absent/unknown, no. 115/70/0 67/22/0 36/8/0 25/1/0
Variables were deemed to be present if a symptom, a sign or both were reported or observed. 
* Recorded movement disorders were dystonia, tremor and myoclonus.
Table 3. Patterns of spread in 72  patients who spread from one to two limbs spontaneously or after 
a separate trauma of the second extremity






Contralateral - no.(%) 38 (53) 24 (63) 14 (41)
Ipsilateral        - no.(%) 23 (32) 13 (34) 10 (29)
Diagonal         - no.(%) 11 (15)   1   (3)  10 (29)
* Patterns of spread were significantly different between patients with spontaneous spread 
and spread after a separate trauma; χ2(2) = 10.2; p=0.006.
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Spontaneous spread versus spread after separate trauma 
In thirty-eight patients who showed spontaneous spread of CRPS from a first to a 
second limb, contralateral spread occurred in 24 (63%, 11 arm to arm and 13 leg to 
leg) (table 3). Ipsilateral spread occurred in 13 patients (34%, 8 arm to leg and 5 leg to 
arm) and diagonal spread in 1 (3%). In 34 patients who showed spread after a separate 
trauma of the second limb, contralateral spread occurred in 14 (41%, 11 arm to arm 
and 3 leg to leg). Ipsilateral spread occurred in 10 patients (29%, 4 arm to leg and 6 leg 
to arm) and diagonal spread also occurred in 10 (29%, 4 arm to leg and 6 leg to arm). 
Patterns of spread differed significantly between patients with spontaneous spread and 
spread after a separate trauma (χ2(2) = 10.2; p=0.006). Patient characteristics did not 
differ significantly between patients who spread spontaneously and those who spread 
after a separate trauma. Patients in whom spreading occurred spontaneously showed a 
non-random pattern of spread, so further analysis were performed on data from this 
subgroup.
Characteristics of spontaneous spread 
The median interval between occurrence in the first and second limb was 21 months 
(n=24, range 2-95) for contralateral spread, 19 months (n=13, range 3-58) for 
ipsilateral spread and 10 months (n=1) for diagonal spread. The difference in intervals 
between contralateral and ipsilateral pattern was not significant (Mann-Whitney U 
test; p =0.16). 
Next, the hazard of the different types of spontaneous spread was calculated (table 4). 
Compared to patients with contralateral pattern (reference value of 1.00) the hazard of 
ipsilateral spread was 0.44 (95% CI: 0.22-0.89), whereas the hazard of diagonal spread 
was 0.04 (CI 0.005-0.30) (figure 2). Age at onset, sex,  onset of symptoms in arm or 
leg, or in left or right sided limbs, did not affect the hazard. Compared to presence of 
CRPS in one limb, the presence in two limbs increased the hazard of spread of CRPS to 
a third limb with 2.19 (95% CI: 1.35-3.57). CRPS in three limbs increased the hazard 
of spread to a fourth limb to 3.75 (95% CI: 1.92-7.32). The hazard of spread in patients 
with onset of CRPS on the left side was 1.46 (95% CI: 1.00-2.11, P=0.047) compared 
to patients with right-sided onset, indicating a somewhat higher risk of spread in 
patients with left sided onset. 
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Table 4. Hazard on spread of CRPS - Multivariate Cox regression model
Variable Hazard ratio 95%-CI
Pattern of spread to second affected limb
        Mirror-image
        Ipsilateral







        Right sided 
        Left sided     
1
1.46 1.00- 2.11
Number of limbs already affected by CRPS
        1        2






* Regression coefficient with 95%-CI
Comparison of Single and Multiple CRPS patients
Ninety-six patients with Single-CRPS were compared with 89 patients with Multiple-
CRPS (figure 1, section B). Patients with Multiple-CRPS had longer disease duration, 
and were significantly younger at onset, than patients with Single-CRPS (table 5). 
Additional analyses with adjustment for differences in disease duration showed that 
patients with Multiple-CRPS were 6.7 years younger (95% CI: 6.3-7.1). There was 
no significant difference in type of trauma (χ2(2) = 5.67; p=0.06) between groups. 
Movement disorder was more common in those with Multiple-CRPS than it was in 
those with Single-CRPS (78% versus 54%, mean (95% CI) difference = 23% (10-37)). 
No difference between groups was found in the type of sensory symptoms (χ2(2) = 
0.73; p=0.69). Patients with spontaneous spread had a shorter disease duration than 
those with secondary trauma-related spread (6.4 versus 9.6 years, mean difference 3.2 
years, 95% CI: 0.4-5.8) but there were no other differences between these two groups. 
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Figure 2. The probability of spread of CRPS.
The probability on the occurrence of different types of spread in CRPS patients since 
the onset of  symptoms in the first limb. In this multivariate model differences in patient 
characteristics were accounted for.



















































Female - no. (%)  160 (86.5) 84 (87.5) 76 (85.4) 2.1 (-10.6;14.8)
First aff. limb arm - no. (%) n=174     91 (52.3) 50 (52.1) 41 (52.6) 0.5 (-14.4;15.4)
Disease duration - mean (SD) yr        6.0 (6.0) 4.1(4.7) 8.1 (6.6) 4.0 (2.3;5.7)
Age at onset CRPS - mean (SD) yr 37.5 (15.4) 40.7 (14.7) 34.0 (14.7) 6.7 (6.3;7.1)
Kind of trauma - no. (%) 
     soft tissue injury
     fracture limb/other










χ2 (df=2) = 5.67
P= 0.06
Movement disorders - no. (%) 121 (65.4) 52 (54.2) 69 (77.5) 23.3 (10.1;36.5) а
Type sensory symptoms - no. (%)   
n=165
     hypaesthesia/hypalgesia
     hyperaesthesia/hyperalgesia/                   
     allodynia










χ2 (df=2) = 0.73
P= 0.69
а Adjusted for disease duration
Discussion
We set out to determine patterns of spread of CRPS and the factors that are associated 
with spread.  Our results show that CRPS usually affects one limb but in some cases it 
spreads to another limb, most often in a contralateral (53%) or ipsilateral (32%) pattern 
and usually without secondary trauma.  A diagonal pattern of spread was nearly always 
triggered by a new trauma. Spontaneous spread and spread after a separate trauma 
followed different patterns.
The mechanism underlying spontaneous spread of CRPS to other limbs is unclear. 
Common patterns of spontaneous spread of CRPS may hint at the origin of the 
pattern. Spread after a separate trauma followed no particular pattern, which strongly 
suggests that CRPS in one limb does not specifically predispose a particular other limb 
to CRPS and supports the idea that these patients have multiple CRPS rather than 
CRPS of multiple limbs. In contrast, spontaneous spread to the contralateral limb was 
2.3 times more likely than spread to the ipsilateral limb and 25 times more likely than 
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diagonal spread.  This result casts light on previous reports of similar rates of ipsilateral 
and diagonal spread5 because that work did not differentiate between spontaneous and 
second trauma-related spread. 
Patients with a spontaneous onset or who have a familial form of CRPS develop the 
syndrome at a younger age and are more likely to have a more severe phenotype.11 
Additionally, CRPS patients younger than 50 have an increased risk of having siblings 
with CRPS.12  In line with these studies, patients with Multiple-CRPS more often 
exhibited movement disorders and also had a significantly younger age at onset of 
CRPS than patients with Single-CRPS. Collectively, these findings indicate that in 
patients with a younger onset of CRPS, genetic factors may play a role in the onset or 
chronicity of the syndrome. A genetic predisposition is also suggested by  associations 
that were found with different human leukocyte antigen (HLA) class I and II 
factors.13-16 Interestingly, HLA class I molecules have been implicated in non-immune 
roles including neuroplasticity.17,18
The dominant patterns of spontaneous spread observed here strongly suggest that 
CRPS does not spread according to some systemic vulnerability, but is more likely to 
spread via spinal or cortically mediated mechanisms. 
Pain that spreads contralaterally has been reported in CRPS and other chronic 
pain conditions, such as atypical facial pain19, phantom limb pain20 and repetitive 
strain injury.21 Several animal models of neuropathic pain and CRPS have reported 
contralateral spread of symptoms after nerve lesions or inflammation.22-24 In a recent 
rat model of CRPS, 57% of the animals exhibited contralateral hindpaw mechanical 
hypersensitivity after unilateral needle stick distal nerve injury.25 Following an 
intradermal injection of capsaicin, human subjects developed contralateral hyperalgesia 
and allodynia.26 The etiology behind the contralateral spread of pain is largely unknown; 
however, increasing evidence from experimental studies on neuropathic pain suggests 
that contralateral changes arise via altered spinal processing of incoming sensory 
information.22,27 This may be mediated by growth factors via commissural interneurons 
in the spinal cord and brainstem. In addition, spinal glia cells and pro-inflammatory 
cytokines have been documented as important factors behind the contralateral spread 
of symptoms.28,29
In contrast to the number of studies on contralateral spread, data on mechanisms 
underlying spread of symptoms to the ipsilateral limb are scarce. Axial spread of disease 
along the spinal cord is well documented for degenerative diseases such as amyotrophic 
lateral sclerosis and infectious agents such as the poliovirus.30 It is conceivable that 
glial mediated changes at one segment of the spinal cord can reach remote segments 
by axonal transport via descending or ascending fibre tracts. This is also suggested by a 
recent autopsy paper on a patient with longstanding CRPS that started in the left leg, 
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but eventually spread to all limbs.31 The researchers demonstrated a significant loss of 
posterior horn cells and activation of both microglia and astrocytes not only at the 
site of the initial injury, but extending throughout the entire length of the spinal cord. 
These diffuse alterations may support the hypothesis that segmental changes in the 
spinal cord induced by CRPS in one limb, may not only spread to the contralateral 
side but can extend more rostrally and caudally from the initially affected segment. 
Interestingly, this latter study31 also reported that the greatest degree of microglial cell 
activation in the spinal cord was seen in the left lumbar segments and the least in the 
right cervical cord, which suggests that ispilateral changes are induced more easily than 
diagonal changes. 
Another explanation for spread of symptoms may be found at the supraspinal level. 
Rommel et al32 showed hemisensory impairment in CRPS patients with only one 
affected limb, and that this was more commonly found in those with left-sided CRPS. 
They proposed that the results may reflect functional alterations in the thalamus. 
Relevant to this is the recent discovery of space-based, but not arm-based shift in 
tactile processing in people with CRPS of one arm.33  Of further relevance here is the 
observation that left-sided CRPS is associated with a higher hazard of spontaneous 
spread – space-based tactile neglect after stroke commonly involves the left side of the 
body, consequent to right sided brain damage.34 
Contralateral spread probably involves different supraspinal mechanisms.  Noxious 
stimuli activate bilateral regions of the brain associated with descending control 
pathways including the thalamus and rostral ventral medulla, which suggests one 
putative mechanism for mediating altered spinal gating contralaterally.35,36 Additionally, 
the growing body of data implicating cortical changes in CRPS (see37 for review), offers 
potential mechanisms.  For example, watching the mirror-image of the unaffected limb 
being touched elicits pain on the affected side38 and referred sensations of a tactile 
or painful stimulus were also experienced outside its expected somatic territory.39 
Forss et al.40 describe a patient with chronic CRPS type-1 in whom pain and motor 
symptoms spread to the contralateral arm, and whole-head-magnetoencephalography 
demonstrated abnormal bilateral activation in the primary somatosensory cortices 
to unilateral tactile stimuli, which suggests that interhemispheric spread of cortical 
activation may contribute to contralateral spread. Furthermore, supraspinal glia and 
glial-derived proinflammatory cytokines may play a role in spread of symptoms as well 
as their major influence on pain modulation.27 Whether these supraspinal changes 
can initiate spread of CRPS symptoms or if they are secondary to peripheral or spinal 
processes remains to be elucidated. 
Our study demonstrates that if CRPS develops spontaneously in more than one limb, 
there is a greater risk of spread to subsequent limbs without the requirement of a new 
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trauma. This accelerated occurrence has been documented for clinical manifestations 
of other diseases and probably reflect changes in the central nervous system, perhaps in 
an attempt to adapt to the altered condition by remodelling of neuronal contacts and 
circuits, a process also known as neuronal plasticity.41-44 
Interpretation of our results should consider some methodological issues. A 
retrospective design is less accurate than prospective designs and may result in 
incomplete data, although such issues would seem unlikely to bias the results in one 
direction over another. Furthermore, follow-up data were not available and Single-
CRPS patients had shorter disease duration than patients with Multiple-CRPS, which 
raises the possibility that some Single-CRPS patients would have ultimately developed 
Multiple-CRPS if we left it longer to find out. We addressed this issue by controlling 
for disease duration in the analysis. 
In conclusion, this study shows that spread of CRPS symptoms often occurs 
spontaneously and contralateral spread is twice as likely as ipsilateral spread, but 
diagonal spread is rare. We contend that these patterns of spread implicate spinal cord 
and/or supraspinal mechanisms rather than systemic mechanisms, although further 
work is required to elucidate them in detail. 
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Complex Regional Pain Syndrome (CRPS) may lead to movement disorders (MDs) in 
some patients. Reliable information on the nature, chronology and clinical determinants 
of MDs in CRPS patients is lacking but could provide better insight in the underlying 
pathophysiological mechanism. We retrospectively evaluated the clinical and temporal 
characteristics of MDs in patients with CRPS. Cox’s proportional hazards model was 
used to evaluate factors influencing the onset of MDs. One-hundred-and eighty-five 
patients suffered CRPS in one or more extremities. MDs occurred in 121 patients, with 
dystonia (91%) being the most prevalent. Sixty-two percent of these patients displayed 
dystonia in multiple extremities. Patients with dystonia were on average eleven years 
younger and more often had CRPS in multiple extremities. The interval between the 
onset of CRPS and dystonia in the first affected extremity varied from less than one 
week in 26% of the patients to more than one year in 27%. The hazard of developing 
dystonia in subsequent extremities increased with the number of extremities affected 
by dystonia. We conclude that dystonia in CRPS shows highly variable onset latency 
and is associated with younger age at onset and increased risk of developing dystonia 
in other extremities. The delayed onset and progression of dystonia in CRPS may 
indicate the involvement of a different underlying mechanism, possibly associated with 
maladaptive neuroplasticity. 
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Introduction
Complex Regional Pain Syndrome (CRPS) is commonly known as a disorder that 
follows a minor to severe trauma to an extremity and occurs more frequently in women.1,2 
In the acute phase, CRPS is characterized by pain, changes in skin blood flow, sweating 
and swelling.3,4 Occasionally, CRPS may spread to other extremities and body parts.5,6 
Patients with CRPS may also suffer from movement disorders (MDs), like tremor, 
myoclonia and dystonia.7-10 These MDs are not infrequent, as data from studies where 
selection bias towards MDs was unlikely indicate that 9-49% of the CRPS patients may 
develop MDs, 14-25% of which involve dystonia.11-14 The increasing awareness that 
CRPS patients may suffer MDs has resulted in a proposal to add this clinical category 
to the new criteria set.15 
Little is known about the interval between the onset of CRPS and MDs in the same 
extremity and the determinants of spread of MDs to other extremities. Available infor-
mation shows that the interval may vary considerably between patients.16,17 Obviously, 
the longer the interval between CRPS and the onset of MDs, the less certain one is 
about the causal relation. Some investigators consider a cause-effect relation between 
trauma and MD for peripherally induced MDs unlikely if the interval is more than one 
year18, but others have accepted intervals as long as several years.19 Reliable information 
on the distribution of the interval duration between CRPS and the onset of MDs is 
important, because the presence of an interval may indicate that different mechanisms 
underlie the initial (sensory and autonomic) and late (motor) features of CRPS. Simi-
larly, accurate data on the temporal characteristics of spread to other extremities may 
provide insight in the nature of mechanisms that play a role in MDs in CRPS. 
Our clinic’s special interest in MDs and CRPS provided a unique opportunity to col-
lect and study a large sample of patients over the years. Since the phenomenology of the 
MDs in CRPS has been described in detail elsewhere8,20-22, the objective of the current 
study was to describe the temporal characteristics of MDs in CRPS, and to evaluate 
factors associated with their onset and progression. 
Methods
Patients 
All patients who visited the Movement Disorders Clinic of the department of Neurolo-
gy, Leiden University Medical Center with a diagnosis of CRPS between January 1998 
and April 2004 were considered for inclusion in the study. Patient with a possible or 
definitive diagnosis of CRPS were referred by general practitioners, anesthesiologists, 
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rehabilitation physicians and other neurologists throughout the Netherlands. Patients 
were eligible if the first affected extremity met the CRPS criteria of the International 
Association for the Study of Pain (IASP), either at the time of disease onset or at the 
time of presentation at the clinic. The IASP criteria include the combination of 1) the 
presence of an initiating noxious event or a cause of immobilization, 2) continuing pain, 
allodynia or hyperalgesia with which the pain is disproportionate to any inciting event, 
3) evidence at some time of edema, changes in skin blood flow or abnormal sudomotor 
activity in the region of the pain and 4) absence of a condition that would otherwise 
account for the degree of pain and dysfunction.3 To increase the homogeneity of the 
population, we only included patients in whom a noxious event triggered the onset of 
CRPS in the first affected extremity.  For similar reasons, we also excluded patients in 
whom a MD developed before the onset of other symptoms and signs of CRPS. Blood 
tests, and nerve conduction and imaging studies (computed tomography, magnetic 
resonance imaging) of the spinal cord and brain were used to rule out other causes of 
MDs. Patient consent was obtained according to the Declaration of Helsinki and the 
study was approved by the ethical committee of the Leiden University Medical Center.
Data collection
Data from physical examination and patient’s history were collected in a standardized 
way during the first visit with respect to the current diagnosis, after which historic in-
formation was verified by reviewing medical records. Dates of onset of CRPS and MDs 
were recorded for every affected extremity. Age at onset and the time interval between 
onset of CRPS and MDs in the same extremity were subsequently determined. The 
type (soft tissue injury, fracture, surgery) of the trauma preceding CRPS and MDs was 
registered. The evaluated MDs included dystonia, tremor and myoclonus, and were 
considered present if observed at assessment. We did not consider muscle weakness a 
MD as this could result from pain or oedema. Sensitivity to light touch (hypaesthesia, 
hyperaesthesia and allodynia) and pinprick (hyperalgesia, hypalgesia) were assessed. 
Statistical analysis 
We compared the characteristics of CRPS patients with MDs in any extremity with 
those of CRPS patients without MDs. Continuous variables were compared with a 
t-test for independent samples or Mann-Whitney-U test as appropriate. Chi-square 
tests were used to compare categorical data. A multivariate analysis of factors associated 
with the onset of MDs was carried out with Cox’s proportional hazards model. The 
hazard of developing MDs was estimated for several variables, including the number 
of extremities with initial sensory and autonomic symptoms but without MDs, the 
number of extremities previously affected by MD (both as time-dependent covariates) 
Onset and progression of dystonia in Complex Regional Pain Syndrome
45
and patient characteristics. We used time from onset of initial symptoms to development 
of MDs for each extremity, where time to MD of an extremity was censored at the 
time of assessment. Robust standard errors of the estimated coefficients were used to 
account for correlation of event times of extremities within patients. P values ≤ 0.05 
were considered significant. All statistical analyses were performed with SPSS (version 
10.0), except for the Cox analysis, which was performed with the statistical program R 
(version 2.0.1, R Development Core Team). 
Results
One-hundred-eighty-five patients fulfilled IASP criteria 1-4 for CRPS-1 in the first 
affected extremity and were included in the study (table 1). Included patients were 
mainly female (86.5%). At assessment, 96 (51.9%) patients had more than one af-
fected extremity. We noted a simultaneous onset of CRPS in multiple extremities in 
13 patients (7.0%). In general, treatments with benzodiazepines, oral baclofen, ami-
triptyline, antiepileptics, analgetics including morfine, and mannitol infusions proved 
unrewarding with respect to the MDs or were stopped because of side-effects. One-
hundred-twenty-one patients (65.4%) suffered from at least one type of MD (table 1). 
Dystonia was present in 110 (90.9%) patients with MDs, whether or not combined 
with other types of MDs. 
Dystonia was predominantly characterized by tonic flexion postures. In the majority 
of patients dystonia was limited to the distal extremity and mostly involved flexion of 
digits and wrists in the arms, and inversion and flexion postures in the feet. In a minor-
ity of patients, dystonia extended proximally to either elbows or shoulders, and knees 
or hips. In patients with bilateral arm or leg involvement, characteristics of dystonia 
were generally very similar. We encountered combinations of (intermittent) dystonia, 
myoclonus or tremor in 24.8% of the patients with MDs. Fifty-six patients (30.3%) had 
a MD in one extremity, whereas 32 patients (17.3%) had two, 13 patients (7.0%) had 
three and 21 patients (11.4%) had four affected extremities. In patients with multiple 
subsequently extremities affected by MDs, 81.2% of the extremities with MDs fulfilled 
both IASP criterion 2 (continuing pain, or allodynia, or hyperalgesie; present in 91.4% 
of the patients) and criterion 3 (evidence at some time of edema, changes in skin blood 




Table 1. Characteristics of patients and movement disorders (MDs)
Number of patients 185
Number (%) of females 160  (86.5)
Mean (SD) disease duration - yrs 6.0    (6.0)
Mean (SD) age at assessment - yrs 43.5 (15.4)
Mean (SD) age at onset of CRPS - yrs 37.5 (15.4)
Preceding trauma – n (%)
       soft tissue injury
       fracture 
       surgery 
  92  (49.7)
  48  (25.9)
  45  (24.3)
Extremities affected by CRPS at assessment - n (%)
        one
        more than one
   89 (48.1)
   96 (51.9) 
Extremities affected by CRPS at initial onset of symptoms - n (%)                                                     
        one
        arm
        leg
       more than one 
 172 (93.0)
   91 (49.2)
   81 (43.8)
  13  (7.0) 
Number of patients with MDs (%)  121 (65.4)
Extremities affected by MDs- n (% of total number of patients)
     1
     2
     3
     4
  56  (30.3)
  32  (17.3)
  13   (7.0)
  21  (11.4)
Type of MD - n (% of patients with MDs) 
     tonic dystonia
     intermittent dystonia
     myoclonus    
     tremor
    combination of (intermittent) dystonia and myoclonus
    combination of (intermittent) dystonia and tremor
    combination of tremor and myclonus
    combination of  (intermittent) dystonia, myoclonus and tremor
   75 (62.0)
     9  (7.4)
     6  (5.0)
     1  (0.8)
   13 (10.7)
    2   (1.7)
    4   (3.3)
 11    (9.1)
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As dystonia was by far the most common MD, we focussed our further analyses on 
comparing CRPS patients with and without dystonia. 
Compared to patients without dystonia, patients with dystonia had longer disease 
duration (7.4  versus 4.0 years respectively) and more frequently displayed CRPS in 
multiple extremities (table 2). Differences in disease duration were therefore taken into 
account in subsequent analyses. The presence of the various sensory signs was approxi-
mately equally distributed in both groups and not associated with disease duration. 
Patients with dystonia were on average 10.6 years (95% confidence interval (CI):7.6-
13.6) younger at disease onset than patients without dystonia (33.4 versus 44.0 years, 
respectively). Patients with CRPS in multiple extremities had a 6.5 (95% CI: 3.4-9.6) 
younger age at onset than those with CRPS in one extremity. 
We calculated the latency to onset of dystonia in patients in whom CRPS started in 
one extremity and dystonia developed in that same extremity simultaneously with or 
after CRPS onset (n=97). This latency showed a skewed distribution with a median 
of 61 days (figure 1). Dystonia developed simultaneously (i.e., within one week) with 
non-motor CRPS symptoms in 25.8% of the patients. Dystonias that did not develop 
simultaneously with non-motor symptoms of CRPS were preceded by a new trauma in 
only six patients (6.2%). Three patients (3.1%) developed dystonia more than five years 
after CRPS onset, but the dystonia characteristics of these patients were similar to those 
of patients with an earlier onset of dystonia. The duration of the interval between onset 
of CRPS and dystonia was not related to age at onset, gender, type of trauma, onset 
in upper or lower extremity, disease duration or the number of affected extremities at 
assessment.
The presence of dystonia in the first affected extremity increased the hazard of devel-
oping dystonia in a second extremity with 2.29 (CI: 1.67-3.14). Dystonia in two ex-
tremities increased the hazard of developing dystonia in a third extremity to 2.15 (CI: 
1.33-3.48). If dystonia was present in three extremities, the hazard of dystonia in the 
fourth affected extremity increased to 7.4 (CI: 3.74-14.65) (figure 2). In contrast, as 
the number of extremities with only non-motor CRPS symptoms (i.e. pain, sensory 
and autonomic symptoms) increased, the hazard of developing dystonia decreased (2 
affected extremities 0.91 (CI: 0.62-1.32); 3 affected extremities 0.67 (CI: 0.35-1.27); 4 
affected extremities 0.27 (CI 0.06-0.94)). Upper extremity involvement (HR 1.35 (CI 
1.06-1.72)) was associated with a higher risk of dystonia, whereas age at onset, gender 
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Figure 1. Latency between non-motor symptoms and dystonia in the first affected extremity
Latency to onset of dystonia assessed in the 97 patients who initially developed non-motor 
symptoms in one extremity
 
Table 3. Hazard of of dystonia - Multivariate Cox regression model
Variable Hazard ratio 95%-CI
Extremity
        Lower
        Upper
1
1.35 1.06; 1.72
Age at onset -0.009 * -0.021;0.002 *
Number of extremities already affected by dystonia
        0
        1
        2








Number of extremities with CRPS but without dystonia
        1
        2
        3








* Regression coefficient with 95%-CI
 
 








  (n=25)          (n=43)        (n=63)       (n=71)        (n=94)         (n=97) 
time to onset of dystonia 
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Figure 2. Probability of developing dystonia
The probability of developing dystonia expressed as a function of the number of ex-
tremities that are already affected by dystonia. For example, for patients with CRPS 
symptoms in one extremity, the probability of immediately developing dystonia is 20% 
and this increases to approximately 40% after one year. In this multivariate model dif-
ferences in patient characteristics were accounted for (see data in table 3).
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Discussion 
This study shows how CRPS may evolve into a disabling disorder with prominent mo-
tor involvement of multiple extremities. Sixty-five percent of the patients in our sample 
suffered some form of MD, with dystonia being the most prevalent. Compared to other 
studies the proportion of patients with MDs in our sample is high, which likely re-
flects referral bias, since especially CRPS patients with neurological symptoms will be 
referred to a neurology clinic. Nevertheless, the large number of CRPS patients with 
MDs seen at our department over a period of six years, as well as the data from studies 
where selection bias towards MDs was unlikely, underscores that this development is 
far from rare.23-26
Previous studies, which were based on small numbers, showed that the interval be-
tween the onset of CRPS and onset of dystonia may vary.27-29 Fifty-six percent of the 
patients in our study developed dystonia more than one month after onset of CRPS, 
27% beyond a year and three patients developed dystonia even more than 5 years fol-
lowing CRPS.  The clinical characteristics of patients with onset of dystonia before or 
after one year were similar, likely suggesting a common mechanism of dystonia in these 
patients. The delayed onset of dystonia encountered in many CRPS patients, may sug-
gest that mechanisms underlying the acute phase of CRPS and dystonia differ. In line 
with another study, we found that if dystonia developed in a later stage than the non-
motor symptoms of CRPS, the occurrence of a new trauma before the onset of dystonia 
was rare.30 
Till recently, dystonia was considered to reflect basal ganglia dysfunction.31 Mounting 
evidence, however, suggests that, opposed to a disorder of a single brain structure, dys-
tonia is a disorder of neural circuits with abnormalities at multiple levels of the central 
nervous system (CNS).32 Accordingly, in CRPS, disinhibition has been demonstrated 
on both a spinal and cortical level but the sequence of involvement remains unclear.8,33 
However, the initial (non-motor) symptoms of CRPS have been attributed to a per-
turbed function of C and Aδ-sensory nerve fibres. These fibres are capable of inducing 
inflammation by releasing the neuropeptides substance P (SP) and Calcitonin-Gene-
Related-Peptide (CGRP), a process called neurogenic inflammation.34,35  In case of tis-
sue or nerve injury, SP may also activate SP receptors on lamina I neurons in the dor-
sal horn of the spinal cord, thus enhancing synaptic transmission efficiency , i.e. long-
term potentiation (LTP), a form of neuronal plasticity.36 As a result, pain may become 
chronic and positive sensory signs, including allodynia and hyperalgesia, may develop, 
a process known as central sensitization.37,38 It seems unlikely that LTP only involves 
pathways that deal with perception of pain and not those that mediate the response 
to pain. C and Aδ sensory fibres, however, are also connected with spinal circuits that 
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mediate nociceptive withdrawal reflexes (NWRs), which serve to minimize or avoid 
potential tissue damage39 and exhibit LTP after intense nociceptive stimulation.40 Ani-
mal models of neurogenic inflammation have shown that SP released at the dorsal horn 
of the spinal cord, enhances NWRs.41 Flexor muscles play a prominent role in NWRs 
and, interestingly, there also is a conspicuous involvement of flexor postures in CRPS-
related dystonia.42,43 Neurophysiologic studies have shown a decreased presynaptic 
GABA-ergic inhibition in CRPS patients with dystonia.44 Both SP sensitized NWRs 
in animal models and dystonia in CRPS patients respond to the intrathecal administra-
tion of GABAB agonist baclofen, which enhances spinal GABA-ergic inhibition.
45,46 
In view of the sequence of events in CRPS, these findings may suggest disinhibition of 
spinal mediated NWRs as a primary causal mechanism of dystonia in CRPS. 
We found that once dystonia was present, the hazard of dystonia in subsequent ex-
tremities increased with the number of extremities already affected by dystonia.  Inter-
estingly, both the delayed onset and an accellerated disease course are characteristics 
of maladaptive neuronal plasticity and have been documented for clinical manifesta-
tions of other diseases.47-50 In those patients where the number of extremities with only 
non-motor CRPS symptoms increased, the hazard of dystonia decreased. Apparently, 
CRPS may evolve into two different chronic phenotypes, again suggesting a distinct 
underlying mechanism for dystonia, which, once set into motion, has the capacity to 
facilitate the occurrence of dystonia in other body parts. Additionally, a more severe 
phenotype with dystonia or multiple affected extremities was associated with a consid-
erable younger age at onset of CRPS.
Our findings suggest the existence of a subgroup that develops MDs, likely reflecting 
the involvement of a distinct biological pathway, which may be induced by the mecha-
nisms underlying CRPS. This raises the question whether the criteria should be broad-
ened to encompass the complete phenotype, or if mechanism-related criteria should be 
devised. An argument in favor of the latter is that homogenous CRPS subgroups may 
benefit research aiming to unravel the clinical, pathophysiological and genetic coher-
ence.
This study was not designed to address the question as to what extent psychogenic fac-
tors contribute to the onset of trauma-related MDs, as suggested by others.51 Although 
a role of psychogenic factors cannot be ruled out in the absence of an established patho-
physiological explanation, we consider a major role for psychological factors unlikely 
for several reasons. First, the phenotype has distinct characteristics, which are similar 
across populations of different cultural background.52 Second, neurophysiologic and 
pharmacotherapeutic data on CRPS-related dystonia show reduced central inhibition 
and are thus in line with the current concept of  dystonia as a central circuit disorder of 
impaired processing of afferent information.8,53
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As a consequence of the retrospective design, this study has some limitations. First, 
information on the exact dates of onset is less accurate than those that would have been 
obtained in a prospective design. However, the error associated with such inaccuracy 
is unlikely to bias the results in one direction.  Second, follow-up data were not avail-
able and patients without dystonia had shorter disease duration than patients with dys-
tonia. Therefore, the possibility that some patients ultimately would have developed 
dystonia cannot be ruled out. To minimize the effect of this confounder, we controlled 
for disease duration in the analyses. It is also possible that in some cases dystonia may 
have resolved. However, most patients had CRPS for several years and both our experi-
ence as well as evidence from the literature underscore a poor prognosis for dystonia in 
CRPS.54,55 
This study is the largest series of CRPS patients with dystonia and our findings sug-
gest that in a proportion of the patients, CRPS may trigger a new mechanism, which 
underlies the development of dystonia. The temporal characteristics of dystonia in our 
patients hint that maladaptive neuroplasticity which is associated with disinhibition of 
spinal mediated withdrawal reflexes may underlie this MD in CRPS.  
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The objective of this study was to evaluate psychological features in severely affected 
patients with Complex Regional Pain Syndrome (CRPS) related dystonia. Personality 
traits, psychopathology, dissociative experiences, the number of traumatic experiences, 
and quality of life were studied in 46 patients. Findings were compared to two historical 
psychiatric control groups (54 patients with conversion disorder (CD) and 50 patients 
with affective disorders (AD)) and normative population data. The CRPS patients 
showed elevated scores on the measures for somatoform dissociation, traumatic 
experiences, general psychopathology and lower scores on quality of life compared 
to general  population data, but had significantly lower total scores on the measures 
for personality traits, recent life events and general psychopathology compared to the 
CD and AD patients. Rates of early traumatic experiences were comparable to the CD 
and AD patients, and the level of somatoform dissociation was comparable to the CD 
patients but was elevated in comparison to the AD patients. Early traumatic experiences 
were reported in 87% of the CRPS patients and were found to be moderately related to 
somatoform dissociative experiences, indicating that early traumatic experiences might 
be a predisposing, though not necessary factor for the development of CRPS related 
dystonia. Although the psychological profile of the patients with CRPS related dystonia 
shows some elevations, there does not seem to be a unique disturbed psychological 
profile on a group level.  
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Introduction
Complex Regional Pain Syndrome (CRPS), formerly known as reflex sympathetic 
dystrophy (RSD) or Sudeck syndrome,1 is commonly preceded by a minor to severe 
trauma to an extremity and occurs more frequently in women.2 CRPS is characterized 
by various combinations of sensory, autonomic and trophic features, in absence of 
any evident nerve lesions.1,2 Compelling evidence indicates that patients with CRPS 
may develop movement disorders (MDs), which may occur early in the disease course 
but generally tend to occur with a variable delay.2-5 Fixed dystonia is among the most 
common MDs in CRPS and may spread to other extremities.6
Although compelling evidence suggests a role for disinhibition of spinal and 
supraspinal neuronal circuits in dystonia of CRPS,5,7,8 the nature of CRPS and its 
associated MDs has since long been subject of debate. While some consider CRPS 
a somatic disorder,9,10 others have suggested that the MDs and other features of the 
disorder are psychogenic.11,12 From the latter perspective the symptoms of CRPS 
could be interpreted as a conversion reaction13 or malingering.14 Affective and anxiety 
disorders are often noted among CRPS patients,15,16 and similarities between CRPS 
and conversion disorder (CD) have also been documented.17 Many clinicians who treat 
CRPS patients feel there is a psychological aspect to the syndrome, either primary, as 
predisposing personality traits and premorbid psychiatric disorders, or secondary, as a 
result of the pain and disabilities.13 A specific CRPS-personality has been suggested in 
the literature,12 but has not been confirmed.1,13 Studies of personality profiles and pre- 
and co-morbid psychiatric disorders in CRPS have primarily focused on patients with 
acute CRPS, and have yielded conflicting results.13,15,16
To obtain more insight in the psychological features of patients with CRPS related 
dystonia, we assessed a chronic group of severely affected patients and compared them 
to two historical psychiatric control groups. Personality traits, psychiatric co-morbidity, 
dissociative experiences, and the number of traumatic experiences were studied. In 
addition, the experienced quality of life was assessed.
Methods
Patients
The department of Neurology of the Leiden University Medical Center (LUMC) is 
a national referral center for patients with CRPS related movement disorders. CRPS 
patients that suffer dystonia in at least one extremity are offered to participate in a trial 
which aims to evaluate the efficacy and safety of intrathecal administration of baclofen, 
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which is a specific γ-amino butyric acid (GABA) receptor agonist. Baclofen inhibits 
sensory input to the spinal cord,18 reducing muscle tone and stiffness. A total of 46 
patients who participated in a screening for responsiveness to intrathecal baclofen 
between July 2003 and September 2005 were included in this study. All patients met 
the International Association for the Study of Pain (IASP) criteria of CRPS19 for their 
first affected extremity. Blood tests, nerve conduction and imaging studies of the spinal 
cord and brain were used to rule out other causes of dystonia. Dystonia generally 
affected the distal limb and was characterized by flexion postures. Medication used at 
the time of the screening falls into three categories: antidepressants (Selective Serotonin 
Re-uptake Inhibitors (used by 9% of the patients) and Tricyclic antidepressants (TCA) 
(15%), though the TCA’s were mainly used as pain medication), muscle relaxing agents 
(baclofen (35%) and benzodiazepines (41%)), and pain medication (anticonvulsant 
drugs (15%), acetaminophen or NSAIDs (24%) and opiods (30%)). This study was 
approved by the medical ethical committee of the LUMC, and the patients gave their 
informed consent. Psychological features of the CRPS patients were assessed by means 
of self-report instruments before they entered the baclofen trial.
Two historical control groups were used which included 54 patients with CD and 50 
patients with at least one affective disorder (AD). Both control groups were part of a 
previous study on the involvement of emotional traumas and dissociative features of 
CD.20 Data collection of this study took place from 1997 until 2000 and all patients 
were seen by a psychiatrist to determine whether the diagnosis of CD or AD as stated in 
the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV)21 was applicable. The physical examination in the CD patients was performed by a 
neurologist. All patients gave their informed consent (for more detail, see the study of 
Roelofs et al.20).  
Instruments
The Personality Diagnostic Questionnaire-Revised (PDQ-R)22 can be used for screening 
for DSM-III-R23 personality disorders. The PDQ-R consists of 133 true/false items. A 
high total score indicates severe personality pathology. 
The Traumatic Experiences Checklist (TEC)24 is a 25-item questionnaire that evaluates 
the presence or absence of emotional life events. Among these are emotional neglect, 
physical abuse, sexual harassment, sexual abuse, parentification and life threatening 
experiences.
The Dutch Recent Life Event Questionnaire (“Vragenlijst Recent Meegemaakte 
Gebeurtenissen”, VRMG)25 measures the perception of recent life events. The original 
instrument consists of 115 items, but in the current study a shortened version of the 
VRMG was used.26 The addressed categories include health, pregnancy/birth, work, 
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relationships, and “other”. For each event, patients had to indicate whether it had 
occurred in the twelve months preceding the symptom onset. 
The Dissociative Experiences Scale (DES)27 is a 28-item self-report questionnaire 
which assesses the frequency of various psychological or psychoform dissociative 
symptoms. The mean of all item scores ranges from 0 to 100 and is called the DES 
score. High DES scores indicate severe psychoform dissociative problems. The DES 
addresses disturbances in memory, awareness, identity and cognition, and feelings of 
depersonalization and derealisation.27 
To measure somatoform dissociation, the Somatoform Dissociation Questionnaire-20 
(SDQ-20) was used. The SDQ-20 consists of 20 items rated on a five-point scale 
with a total score range of 20-100. The items address medically unexplained analgesia, 
anesthesia, motor disturbances, alternating preferences for tastes and smells, pain, 
and loss of consciousness. A high total score is an indicator for many somatoform 
dissociative experiences.28 
To screen for the general level of psychopathology we used the Symptom Checklist-90-
Revised (SCL-90-R),29 consisting of 90 items rated on a five-point scale with a total 
score range of 90-450. High total scores indicate high levels of psychopathology. 
The Research and Development-36 (RAND-36)30 was administered to measure quality 
of life. The questionnaire consists of 36 items and assesses physical, psychological and 
social well-being on eight subscales. The maximum total score per subscale is 100. 
People with high scores view their health in a positive manner and report few psychical 
and emotional problems. The RAND-36 was not used in both control groups, yet was 
added to the current study to assess the quality of life of the CRPS patients.  
Dutch versions of all instruments were used. All questionnaires were completed by the 
patients themselves, with the exception of patients in whom the severity of the dystonia 
would not allow this. In those cases the questionnaires were orally administered by a 
trained research nurse. 
Statistics
SPSS for Windows, version 11.0, was used for data-analysis. As most of the data were 
not normally distributed, non-parametric test methods were used. The Mann Whitney 
U test was used when comparing two groups, whereas the Kruskall Wallis test was used 
for comparison of three groups. To compare the results with normative data available 
in the literature, mean scores and standard deviations were also calculated. To compare 
means of the CRPS group on the RAND-36 to norm data, an unpaired t-test was used. 




Characteristics of all patient groups are presented in table 1. There were no significant 
differences with respect to sex (χ2=4.64, df=2, p=0.10), marital status (χ2=7.68, df=6, 
p=0.26) and age (χ2=1.53, df=2, p=0.46). Table 2 reflects the characteristics and 
symptoms of the CRPS patients. In table 3 the results for PDQ-R, TEC, VRMG, DES, 
SDQ-20 and SCL-90-R for the three groups are presented.
 
Personality
No normative data for the PDQ-R were available in the literature. The total PDQ-R 
score of the CRPS patients is significantly lower than that of the CD patients (z=-
3.97, p<0.001) and the AD patients (z=-5.26, p<0.001). Among the CRPS patients, 
most personality traits were observed in the schizoid, obsessive-compulsive, borderline, 
paranoid and schizotypical personality clusters.  
Life events
No significant differences in the total number of traumatic experiences on the TEC 
were found between the CRPS patients and the CD patients (z=-1.34, p=0.18) or AD 
patients (z=-1.07, p=0.29). A total of 87% of the CRPS patients experienced at least 
one of the listed traumatic experiences. In specific they reported intense pain (67%); 
witnessing traumatic experiences of others (46%); emotional neglect (35%); emotional 
abuse (39%); physical abuse (28%); sexual traumas (35%); and incestuous acts (22%). 
A total of 52% of the CRPS patients reported at least one form of physical, emotional 
or sexual abuse.
The results on the VRMG showed that the CRPS patients experienced less life events 
in the year before the onset of their symptoms than both control groups (z=-4.72, 
p<0.001 compared to the CD patients; z=-5.02, p<0.001 compared to AD patients).
Dissociative experiences
The mean DES-score of the CRPS patients fell in the normal range (3.7-7.8), in contrast 
to both control groups. Fifteen CRPS patients (33%) obtained a score above 7.8. All 
three groups had lower scores than the mean scores of psychiatric patients (14.6-17.0), 
patients with dissociative identity disorder (49.5) and patients with other dissociative 
disorders (>25).27,31 The score of the CRPS group was significantly lower than the CD 
group score (z=-2.95, p=0.003), but did not differ significantly from the AD group 
score (z=-1.82, p=0.07).
For the SDQ-20 no normative data are available in the literature. Compared to the CD 
patients, no significant differences were found (z=-0.30, p=0.76), indicating that both 
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groups had similar levels of somatoform dissociation. In comparison to AD patients, 
CRPS patients had significantly higher scores (z=-4.96, p<0.001). 
Table 4 shows correlations between the total number of traumatic life events (TEC) 
on the one hand, and the DES and SDQ-20 scores on the other hand. The CD and 
AD groups showed moderate significant positive correlations between the number of 
traumatic life events and psychoform dissociative experiences. Only the CRPS patients 
demonstrated a moderate significant positive correlation between the number of 
traumatic life events and somatoform dissociative experiences1*. 
General psychopathology
Compared to normative data for the general population,29 the CRPS patients 
obtained a high total score on the SCL-90-R, indicating an increased general level of 
psychopathology. However, the CRPS group had a significantly lower score compared 
to both control groups (CD group: z=-4.51, p<0.001; AD group: z=-4.90, p<0.001). 
For the CPRS-I patients, scores on the somatic and depression subscales were elevated. 
However, compared to the normative data29 of chronic pain patients, no differences 
were found.
Quality of life
In comparison to normative data consisting of randomly chosen individuals from the 
general population,32 the quality of life of the CRPS patients was severely impaired, 
as measured by the RAND-36 (table 5). The patients reported severe limitations in 
physical activities, and indicated that this had a negative impact on work-related or 
other daily activities. Also, pain, fatigue and limitations in social functioning were 
reported more often by the CRPS patients. 
1* Previous investigations in the CD group using a structured trauma interview did show a 
significant correlation with SDQ-20 scores.20 Here we only found a trend. This discrepancy is 
presumably due to the use of a different trauma measure.
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Men/women (% female) 2/44 (96) 9/45 (83) 9/41 (82)
Median age in years (IQR) 41 (28-50) 36 (28-47) 36 (28-46)


















Mean disease duration in 
years (SD)
10.1 (6.5) 5.1 (7.1) not available








not applicable not applicable
IQR: interquartile range; SD: standard deviation
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#:  smaller sample size due to missing data
*: significantly different scores (p<0.05); only presented for medians, since non parametric tests 
were used to assess differences between groups
SD=standard deviation; IQR=interquartile range; PDQ-R=Personality Diagnostic 
Questionnaire-Revised; TEC=Traumatic Experiences Scale; VRMG=Recent Life Event 
Questionnaire (“Vragenlijst Recent Meegemaakte Gebeurtenissen”); DES=Dissociative 
Experiences Scale; SDQ-20=Somatoform Dissociation Questionnaire-20; SCL-90-
R=Symptom Checklist-90-Revised.
The CRPS patients had significantly lower total scores on the PDQ-R, VRMG and SCL-90-R, 
compared to the conversion patients and patients with affective disorders. On the TEC, no 
significant differences were found. On the DES, the CRPS patients had a significantly lower 
score than the conversion patients only, and on the SDQ-20, both the CRPS and conversion 
patients had a significantly higher score than the patients with affective disorders. 
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Table 4. Correlation values between life events (TEC) and psychoform dissociation (DES) on the 
one hand and somatoform dissociation (SDQ-20) on the other hand
Spearman’s rho DES Spearman’s rho SDQ-20
CRPS 0.22 (p=0.15) 0.30 (p=0.04)
Conversion disorder 0.28 (p=0.04) 0.25 (p=0.07)
Affective disorder 0.30 (p=0.03) 0.22 (p=0.13)
TEC=Traumatic Experiences Scale; DES=Dissociative Experiences Scale; 
SDQ-20=Somatoform Dissociation Questionnaire-20
Table 5. Mean (SD) RAND-36 scores
CRPS (N=40) General population (N=1063) significance
PF 15.6 (16.9) 81.9 (23.2) p<0.005
SF 55.3 (23.2) 86.9 (20.5) p<0.005
PR 20.0 (30.6) 79.4 (35.5) p<0.005
ER 69.2 (41.6) 81.1 (32.3) p<0.005
MH 72.9 (18.1) 76.8 (18.4) p=0.19
V 49.3 (17.5) 67.4 (19.9) p<0.005
BP 35.1 (17.7) 79.5 (25.6) p<0.005
GHP 46.6 (19.9) 72.7 (22.7) p<0.005
PHC 24.3 (26.0) 52.4 (19.4) p<0.005
RAND-36= Research and Development-36; SD=standard deviation; PF=physical 
functioning, SF=social functioning, PR=role limitations due to physical health problems, 
ER=role limitations due to emotional problems, MH=mental health, V=vitality, BP=bodily 
pain, GHP=general health perceptions, PHC=perceived health change
An unpaired t-test was used to compare means of the CRPS group to the norm group.
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Discussion
In accordance with other studies in CRPS patients15,16,33 and chronic CRPS patients 
with dystonia34 our study does not support the presence of a unique disturbed 
psychological profile. Compared to the general Dutch population, the general level of 
psychopathology was elevated in the CRPS patients in an extent similar to chronic pain 
patients29 but this level was significantly lower than both psychiatric control groups. 
The total level of psychopathology is slightly higher as compared to earlier studies.34,35 
However, these studies had smaller sample sizes and included patients with a shorter 
disease duration, and moreover these patients were less severely affected by CRPS. The 
relatively low scores with regard to affective, dissociative and anxiety features among 
patients with CRPS related dystonia contrast with the study of Schrag et al.,36 who 
found affective disorders in 85%, dissociative symptoms in 42% and anxiety disorders 
in 58% of a group of 26 patients with fixed dystonia. However, one should be cautious 
comparing these results as the focus of the study of Schrag et al.36 were patients with 
fixed dystonia of which a minority met the IASP-criteria of CRPS, while also different 
instruments were used.
CRPS patients reported only few relevant life events in the year preceding the symptom 
onset, but more than three quarters of the patients reported at least one traumatic 
experience in their early history. In more than half of the patients at least one form of 
physical, emotional or sexual abuse, or neglect had occurred. No official normative data 
of the TEC are available, but it has been administered in 73 Dutch students and in the 
general population (N=147).37 The total TEC scores of the CRPS, CD and AD groups 
we studied are much higher than those of the students and the general population. An 
interesting observation is that the total score of the CRPS patients is higher than the 
total score of the AD group and than the score of a group of various female psychiatric 
patients (eating disorders, substance abuse disorders and ADs, among others) in an 
earlier study.38 Possibly, this is caused by the fact that one of the included traumas is 
the experience of intense pain, which is inherent to CRPS. However, when the data 
are corrected for this type of trauma, the total mean score for the CRPS patients is 
3.89, which is still higher than the score of the AD patients of the current study. One 
may therefore conclude that in patients with CRPS related dystonia early traumatic 
experiences are more prevalent. 
An association between somatoform dissociation and lifetime traumatic experiences 
has been suggested earlier, both in clinical20,24,39 and non-clinical populations.37 In our 
study, we also found a significant, though moderate (r=0.30) association between 
the number of traumatic life events and levels of somatoform dissociation in CRPS 
patients. The elevated SDQ-20 scores that we found among the CRPS patients are 
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in the range of patients with somatoform disorders.40 These results suggest similarity 
to the conversion disorder patients and may indicate that in chronic CRPS patients 
dissociative phenomena may be present. Though the association between traumatic 
experiences and somatoform dissociation in this study is only moderate, these results 
generate interesting hypotheses for further research. Also, a 0.3 correlation is considered 
meaningful in the social sciences.41 A relationship between psychological trauma and 
physical complaints, such as lung diseases,42,43,44 peptic ulcer,43 diabetes,43,44 cardiac 
disease43,44 and headache44 has been found, yet also a relation between trauma and 
the severity of ‘medically unexplained symptoms’, as chronic pelvic pain,45,46 irritable 
bowel syndrome,47,48,49,50 pseudo-epileptic seizures,48 chronic fatigue51 and somatization 
disorder,52 has been found in previous studies. However, it should be noted that the 
SDQ-20 scores of CRPS patients are possibly inflated because some items of the SDQ-
20, such as voiding symptoms and feelings of numbness, are features known to be 
associated with CRPS.4,53 
The current study clearly shows that the CRPS patients experience less personality 
pathology than both psychiatric control groups. Personality traits of the schizoid, 
obsessive-compulsive, borderline, paranoid and schizotypical personality disorders 
were most prevalent among the CRPS patients, which partly corresponds to results 
found by Monti et al.54 
In contrast to our study, Shiri et al.,17 found no significant differences in the psychological 
profiles of CRPS patients and CD patients. Possible explanations for these conflicting 
results include the use of different instruments and the smaller sample size (17 CRPS 
patients and 20 CD patients). The predominance of male CRPS patients (94%) in the 
study of Shiri and colleagues17 is conspicuous, but the difference in gender distributions 
between these studies is an unlikely explanation for the differences in results in view of 
the fact that in general both CRPS-1 and CD are more frequent among women. 
The CRPS patients in our study reported poorer general health and quality of life as 
compared to the general population. The general health score of the CRPS patients in 
the current study, however, is similar to those reported for patients with other causes of 
chronic pain.55 
One of the strengths of this study is the applied extensive set of psychological 
instruments. Additionally, we were able to compare our patients with two psychiatric 
control groups. Some limitations of the present study should also be noted. Data was 
collected retrospectively and therefore no data on premorbid psychological symptoms 
and disorders are available. In this study self report instruments were used. Reported life 
events and other psychological symptoms were not confirmed by a clinical examination, 
and were not verified with third parties or authorities. Also, the mean disease duration 
of the CRPS patients was 10.1 years, much longer than in the conversion disorder 
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group, and it cannot be ruled out that some patients may have developed secondary 
psychological disorders during this period. Here recall bias could also have played a 
role since patients were asked about life events which occurred in the year preceding the 
first signs and symptoms. Also, the results of this study cannot be generalized to acute 
or milder forms of CRPS, as the CRPS group consisted of severely affected patients 
with a long mean disease duration. Next, due to the severity of their dystonia, some 
patients were not able to complete the questionnaires themselves. In these cases they 
were orally administered by a trained research nurse, which may have led to social 
desirable answers. Lastly, a normal control group was not used. 
In summary, CRPS is a multifactorial condition where, aside biological factors, 
psychological and social factors may play a role in the onset or development of chronicity 
of the condition. Although in this study patients with CRPS related dystonia showed 
elevated scores on some of the scales we used, there does not seem to be a unique 
psychological profile on a group level, and only few similarities between the profiles 
of patients with CRPS and CD were found. Early traumatic lifetime experiences were 
frequently reported and may be a possible, though not necessary, predisposing factor 
for CRPS-related dystonia.  
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Introduction: In Complex Regional Pain Syndrome (CRPS), patients may have 
manifestations of central involvement, including allodynia, hyperalgesia or dystonia. 
We noted that more severely affected patients may experience hyperacusis, which may 
also reflect central involvement. Aim of this study is to evaluate the occurrence and 
characteristics of hyperacusis in patients with CRPS related dystonia.
Methods: Presence of hyperacusis, speech reception thresholds (SRT), pure-tone 
thresholds (PTT) and uncomfortable loudness (UCL) were evaluated in 40 patients 
with CRPS-related dystonia. 
Results:  PTT and SRT were normal for all patients. Fifteen patients (38%) reported 
hyperacusis and this was associated with allodynia/hyperalgesia and with more affected 
extremities. UCLs of patients with hyperacusis were significantly lower than UCLs of 
patients without hyperacusis.  
Conclusion: Hyperacusis is common among severely affected patients with CRPS 
related dystonia and may indicate that the disease spreads beyond those circuits related 
to sensory-motor processing of extremities. 
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Introduction
Complex Regional Pain Syndrome (CRPS) is frequently preceded by a trauma (70-
90%). In the acute phase, the clinical presentation is dominated by various combinations 
of sensory and autonomic symptoms and signs.1,2 Some patients with chronic CRPS 
may also develop movement disorders (MDs) like tremor, myoclonia and dystonia.3  
Because of our clinic’s special interest in MDs and CRPS, we had the opportunity to 
evaluate the more severely affected patients in whom CRPS evolved into a disabling 
disorder with prominent dystonia of multiple extremities. In the course of these 
evaluations, we noted that some patients reported hyperacusis,4 that is, an intolerance 
of ordinary sound levels. Hyperacusis is primarily associated with painful sensations to 
sound, which eventually may result in avoidance-like behavior, whereas phonophobia 
is an anxious sensitivity towards specific sound, largely independent of its volume.5 
Contrary to phonophobia, hyperacusis is not directly related to fear to sound.6 
Hyperacusis can arise from damage to the inner ear and 8th nerve, but has also been 
associated with central nervous system involvement as may occur in migraine.7,8 
In CRPS, patients may experience an increased response to a painful stimulus 
(hyperalgesia) or even pain when the skin is gently touched (allodynia).  Both sensory 
features have been associated with abnormal excitability of nociceptive neurons within 
the central nervous system, a process known as central sensitization.9 Pathophysiological 
studies in CRPS have provided evidence of functional changes at different levels of the 
central nervous system changes.10,11 
Taken together, the increased sensitivity to ordinary sound levels in patients with 
CRPS may suggest that this is yet another manifestation of central involvement in this 
disorder. Against this background we evaluated the occurrence and characteristics of 
hyperacusis in patients with CRPS related dystonia.
Methods
Patients
Patients with a diagnosis of CRPS and dystonia in one or more extremities who were 
referred to our department for treatment of dystonia between January 2000 and May 
2006, were included in this study. Patients were generally referred from pain clinics and 
from departments of anaesthesiology, rehabilitation medicine and surgery. Patients had 
to meet the CRPS diagnostic criteria of the International Association for the Study 
of Pain (IASP).12 According to these criteria patients must have (1) continuing pain, 
allodynia or hyperalgesia, in which the pain is disproportionate to any inciting event, (2) 
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evidence at some time of oedema, changes in skin blood flow or abnormal sudomotor 
activity in the region of the pain, and (3) no condition that would otherwise account 
for the degree of pain and dysfunction. Exclusion criteria were other disorders that 
could cause auditory impairment. The study protocol was approved by the hospital 
ethics committee and all patients gave informed consent.
Audiogram
Pure-tone audiogram thresholds (PTT), uncomfortable loudness (UCL) and speech 
reception thresholds (SRT) were assessed with an ENT audiometer by a certified 
audiologist using a standard method.13,14 Briefly, for the determination of PTT, patients 
wearing a headphone had to press a button when they heard a tone in the frequency 
range of 250-8000 Hz that was presented at 5 dB increments (within the range of 0 dB 
to 120 dB). To establish the patient’s UCL, tones were presented in similar manner as 
for determination of the PTT and patients had to indicate when they considered the 
sound level as uncomfortably loud. The speech reception threshold was determined 
with the standard CVC (Consonant-Vowel-Consonant) word list on CD (prerecorded 
female speaker) of the Dutch Society of Audiology.15 All words were balanced on a 
rms level, sub-lists were homogeneous with regard to speech reception scores and 
normative values were available. Each list consisted of equivalent sub-list of 11 Dutch 
three-phoneme monosyllables. Based on the individual pure tone threshold, tests were 
done at a fixed presentation level around the pure tone threshold. The first list of words 
is always presented at a level of +20 dB above the threshold. For most subjects this 
will result in a 100% phoneme score. Afterwards, lists are presented at levels in steps 
of 10 dB down until the subject can hardly understand the tokens and reaches a score 
below 50%. The threshold is then determined by simple linear interpolation of the 
percentages found for the levels just above and below 50%.
For the PTTs and UCLs a low Fletcher Index (FI-low: mean over the frequency range 
500 Hz-2000 Hz) and a high Fletcher Index (FI-high: mean over frequency range 1000 
Hz-4000 Hz) were calculated. In general, normal values for the SRT and PTT do not 
exceed 20dB.16  An UCL threshold of 100 dB is considered normal and values below 
100 dB indicate the presence of hyperacusis.17          
Clinical characteristics
Demographic and clinical information was collected and included pain intensity, 
number of affected extremities, type of motor impairments, presence of allodynia 
or hyperalgesia, and presence of hyperacusis. Additionally, the Pain Coping and 
Cognition List (PCCL) was administered.18 The PCCL includes a subscale on pain 
catastrophizing (12 items), which was used as an approximate to assess the potential 
relation between a more focused attention to external stimuli and hyperacusis.
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Data analysis and statistics
Data were analyzed with SPSS 12.01 (SPSS Inc., 2003), using parametric tests for 
normally distributed continuous data and non-parametric tests for other data. Pearson’s 
correlation coefficient was used to compare SRT, PTT, and UCL between both ears of 
each patient. The significance threshold was set at p<0.05.
Results
Demographic information and CRPS characteristics of the forty included patients 
are presented in table 1, whereas table 2 enlists the differences in CRPS characteristics 
between patients with and without hyperacusis. 
Since the correlations of SRTs, PTTs, and UCLs (both for FI-low and FI-high) between 
the right and left ear of each patient were high (all > 0.7; p< 0.001), we used the mean 
thresholds of both ears in the subsequent analyses. The SRT and the PTT (FI-low and 
FI-high) for all patients were within the normal range (Table 3). The mean UCL for 
both FI-low and FI-high were significantly lower (p <0.001 for both thresholds) in our 
patient group compared to the normal population value of 100 dB. 
Patients with hyperacusis had significantly lower UCLs at all the indicated frequencies 
compared to patients without hyperacusis (Figure 1).  Disease duration did not differ 
significantly between patients with hyperacusis (13.1 years) compared to patients 
without hyperacusis (10.4 years; p = 0.365). Seven of the 15 patients with hyperacusis 
reported tinnitus.
Thirty-one patients had 3 or 4 affected extremities of which 15 reported hyperacusis. 
Interestingly, none of the nine patients with 1 or 2 affected extremities reported 
hyperacusis (Fisher’s exact test, p =0.015).  However, patients with 1 or 2 affected 
extremities did not differ significantly in UCL thresholds (FI-high nor FI-low) from 
patients with 3 or 4 affected extremities.
Patients without hyperalgesia and/or allodynia less frequently reported hyperacusis 
compared to patients with these sensory symptoms (Chi-square; p =0.026). The odds 
ratio on hyperacusis in patients with hyperalgesia / allodynia was 7.0 (95% CI: 1.7-
12.4). The UCLs did not differ significantly for both FI-low and Fl-high between 
patients with hyperalgesia/allodynia and patients without these symptoms.  
Patients with hyperacusis had lower scores on the pain catastrophizing subscale of the 
PCCL (2.5 vs 3.2; p < 0.05). 
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Table 1. Demographic data and CRPS characteristics of patients.
Number of patients 40
Female/Male 38/2
Mean (SD) age in years 41.9 (10.2)
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Table 2. Differences between patients with and without hyperacusis
No Hyperacusis Hyperacusis P-value
Number of patients 25 15
Female / Male* 25 / 0 13 / 2 0.061
Mean (SD) age in years** 42.7 (9.6) 40.6 (11.3) 0.538
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* Chi-square ** T-test for independent samples
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Table 3. Values of thresholds
Measurement Mean value (dB) 95% CI
PTT FI-Low 12.1 8.9;15.4
PTT FI-High 15.5 11.4;19.5
SRT 10.3 7.7;12.9
UCL FI-Low 79.9 71.4;88.3
UCL FI-High 78.9 70.4;87.5
The means and 95% confidence interval (CI) of the thresholds for all 40 patients. PTT: pure 
one threshold; SRT: speech reception threshold; UCL: uncomfortable loudness; FI-low/high: 
low/high fletcher index.
Figure 1. UCL levels of patients with and without hyperacusis
Figure 1:  Uncomfortable loudness levels with 95% confidence interval in CPRS patients with 
(N=15) and without hyperacusis (N=25); ** p < 0.001, * p< 0.05, compared to patients without 
hyperacusis. High and low fletcher index for patients with hyperacusis (52.6 dB and 53.8 dB, 
respectively) were significantly lower (p<0.001) compared to the high and low fletcher Index of 
patients without hyperacusis (91.0 dB and 91.7 dB, respectively).
Discussion
Although our findings are limited to an extreme phenotype, to the best of our knowledge 
this is the first study to evaluate hyperacusis in CRPS. Thirty-eight percent of the patients 
with CRPS related dystonia in our study reported hyperacusis, whereas the prevalence 
of hyperacusis in the general population is less than 2%.19 Auditory function, evaluated 
by means of the PTT and SRT, showed no differences between the patients and general 
population data. UCLs of CRPS patients not experiencing hyperacusis were normal. 
In contrast, UCLs of patients with hyperacusis were significantly lower than UCLs of 
patients without hyperacusis. It is unlikely that the presence of hyperacusis is explained 
through a more focussed attention to external stimuli, since then also higher scores on 
pain catastrophizing would have been expected in patients with hyperacusis compared 
to patients without hyperacusis, but, surprisingly, the opposite was found.  
Interestingly, patients with hyperacusis more often experienced allodynia and/or 
hyperalgesia, which are manifestations of central sensitization. This phenomenon 
concerns the increased sensitivity of spinal neurons, despite a lack of change of afferent 
input.20  Patients with hyperacusis also had more extremities with dystonia, which is 
associated with central disinhibition.21,22  The degree of spread of dystonia, therefore 
likely reflects a marker of severity of central involvement. Although the difference was 
not significant, patients with hyperacusis had a mean duration of disease of 2.7 years 
longer than those without hyperacusis, which may hint at the possibility that with 
further progression of the disease, some of the patients without hyperacusis in this study 
ultimately would develop hyperacusis. Together, the sensory and motor features of this 
phenotype provide circumstantial evidence that hyperacusis in these patients initiates 
centrally. The high correlations of SRTs, PTTs, and UCLs between both ears in each 
patient make an unilateral peripheral cause unlikely and further support the central 
involvement in hyperacusis. However, the question remains how the pathophysiology 
of hyperacusis and the central features of CRPS intersect.
Key to central sensitization is the disturbed inhibitory-excitatory balance, which is as-
sociated with multiple biological changes in the central nervous system. These biologi-
cal changes may include increased activity in excitatory pathways where substance P, 
excitatory neurotransmitters and adenosine triphosphate act via voltage-gated calcium 
channels and/or diminished activity in inhibitory pathways via gamma-aminobutyric 
acid (GABA) and glycine.23 Interestingly, these neurotransmitters and neuropeptides 
not only play a role in synaptic transmission of the auditory system, but also act as trop-
ic agents that modulate auditory signal processing as a results of sensory experience.24,25 
By altering auditory type I neural excitability to glutamate, these neuropeptides, for 
example, could induce hyperacusis and contribute to the induction, maintenance, or 
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Discussion
Although our findings are limited to an extreme phenotype, to the best of our knowledge 
this is the first study to evaluate hyperacusis in CRPS. Thirty-eight percent of the patients 
with CRPS related dystonia in our study reported hyperacusis, whereas the prevalence 
of hyperacusis in the general population is less than 2%.19 Auditory function, evaluated 
by means of the PTT and SRT, showed no differences between the patients and general 
population data. UCLs of CRPS patients not experiencing hyperacusis were normal. 
In contrast, UCLs of patients with hyperacusis were significantly lower than UCLs of 
patients without hyperacusis. It is unlikely that the presence of hyperacusis is explained 
through a more focussed attention to external stimuli, since then also higher scores on 
pain catastrophizing would have been expected in patients with hyperacusis compared 
to patients without hyperacusis, but, surprisingly, the opposite was found.  
Interestingly, patients with hyperacusis more often experienced allodynia and/or 
hyperalgesia, which are manifestations of central sensitization. This phenomenon 
concerns the increased sensitivity of spinal neurons, despite a lack of change of afferent 
input.20  Patients with hyperacusis also had more extremities with dystonia, which is 
associated with central disinhibition.21,22  The degree of spread of dystonia, therefore 
likely reflects a marker of severity of central involvement. Although the difference was 
not significant, patients with hyperacusis had a mean duration of disease of 2.7 years 
longer than those without hyperacusis, which may hint at the possibility that with 
further progression of the disease, some of the patients without hyperacusis in this study 
ultimately would develop hyperacusis. Together, the sensory and motor features of this 
phenotype provide circumstantial evidence that hyperacusis in these patients initiates 
centrally. The high correlations of SRTs, PTTs, and UCLs between both ears in each 
patient make an unilateral peripheral cause unlikely and further support the central 
involvement in hyperacusis. However, the question remains how the pathophysiology 
of hyperacusis and the central features of CRPS intersect.
Key to central sensitization is the disturbed inhibitory-excitatory balance, which is as-
sociated with multiple biological changes in the central nervous system. These biologi-
cal changes may include increased activity in excitatory pathways where substance P, 
excitatory neurotransmitters and adenosine triphosphate act via voltage-gated calcium 
channels and/or diminished activity in inhibitory pathways via gamma-aminobutyric 
acid (GABA) and glycine.23 Interestingly, these neurotransmitters and neuropeptides 
not only play a role in synaptic transmission of the auditory system, but also act as trop-
ic agents that modulate auditory signal processing as a results of sensory experience.24,25 
By altering auditory type I neural excitability to glutamate, these neuropeptides, for 
example, could induce hyperacusis and contribute to the induction, maintenance, or 
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exacerbation of tinnitus in the auditory periphery.26 
In CRPS, central sensitization may spread in an ipsilateral somatotopic  distribution 
up the neuraxis to involve nociceptive processing at the level of the thalamus or higher 
cortical centers.27 Because different sensory inputs converge at the level of the thalamus, 
central sensitization may affect auditory circuitry. On the other hand, hyperacusis in our 
patients was related to the perception of discomfort, and not to the sound perception 
threshold. Hence, the “annoyance factor” of hyperacusis may hint at a role of the 
limbic activation as has been implicated for other features of CRPS and tinnitus.28-31 
A potential limitation of this study is that the included patients reflect an extreme 
phenotype of CRPS, limiting any conclusion regarding the prevalence of hyperacusis in 
CRPS patients in general. The association between hyperacusis and dystonia could be 
more thoroughly evaluated if data regarding the occurrence of hyperacusis in severely 
affected patients without dystonia would have been available. It is also important to 
realize that the assessment technique of evaluating UCL thresholds relies on patient-
provided information, rendering the findings sensitive to subjective influences. Our 
findings may stimulate the development of objective assessment techniques that aim to 
evaluate manifestations of central sensitisation in the auditory system.
In conclusion, we found that hyperacusis is common among severely affected patients 
with CRPS related dystonia. Hyperacusis in these patients may reflect the spreading of 
central sensitization to auditory circuitry. 
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Objective: The aetiology of dystonia in Complex Regional Pain Syndrome (CRPS) 
is incompletely understood. In primary dystonia, somatosensory evoked potentials 
(SSEP) after spatially or temporally separated stimulation revealed impaired central 
sensory integration. Information on somatosensory processing in dystonia in CRPS 
patients may provide better insight in the underlying pathophysiological mechanism. 
Methods: We studied SSEPs in 33 patients with CRPS and dystonia and 19 healthy 
controls. N9, N14, N20 and N35 amplitudes were recorded after paired stimulation 
of median and ulnar nerves (‘spatial’) and after stimulation of both nerves with single 
stimuli and with interstimulus intervals of 20 and 40 ms (‘temporal’ stimulation). 
Finally, both methods were integrated resulting in spatiotemporal stimulation. 
Statistical testing was performed using linear mixed model analysis of variance.
Results: SSEP amplitudes were significantly suppressed after spatial and temporal 
stimulation. No difference was observed between patients and healthy controls. 
Spatiotemporal stimulation did not show an additional suppressive effect in any group.
Conclusions: Central sensory integration of proprioceptive afferent input is normal in 
patients with CPRS-related dystonia. Other mechanisms may underlie the development 
of dystonia in this disorder.
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Introduction
Complex Regional Pain Syndrome (CRPS) is commonly known as a disorder that is 
preceded by  a minor to severe trauma to an extremity in the absence of an obvious 
nerve lesion and occurs more frequently in women.1-3 
There is compelling evidence indicating that aberrant inflammation plays an important 
role in the acute phase of CRPS.4,5 In some patients, the acute phase of CRPS may lead to 
a new phase called central sensitisation which is associated with neurochemical changes, 
functional alterations of excitatory and inhibitory connections, cell death of neurons 
and interneurons, and sprouting of new connections in the spinal cord.6 Such changes 
may have important influences on sensory processing and movement control. Indeed, 
central sensitization is typically associated with chronic pain, allodynia, hyperalgesia 
and about 20% of the CRPS patients develop dystonia which may spread to multiple 
extremities.6-8 Traditionally, dystonia is associated with basal ganglia dysfunction, but 
recent studies have broadened  the concept of dystonia by defining it as a disorder of 
neural circuits that mediate sensory-motor integration as opposed to a disorder of a 
single brain structure.9-11 In line with this new concept, several neurophysiological 
studies in CRPS-related dystonia have found evidence of impaired inhibition at the 
spinal cord and motor cortex.12-14
The recording of somatosensory evoked potentials (SSEP) in a spatially or temporally 
separated stimuli design is another method to evaluate cortical disinhibition. In 
primary segmental or generalized dystonia, this approach has revealed evidence of 
impaired cortical inhibition.15,16 In one study, SSEPs were recorded after stimulating 
the median and ulnar nerves both separately and simultaneously.15 In normal subjects, 
adding SSEPs obtained separately for the two nerves resulted in amplitudes that were 
higher than when the two nerves were stimulated simultaneously, showing that there is 
a cortical ‘competition’. In dystonia patients this effect was less pronounced, which was 
explained as a defect of surrounding inhibition. In another study, SSEPs were recorded 
after single shocks and after pairs of shocks.16 The response to the second of the two 
shocks is normally lower in amplitude than that to the first one, but this effect was less 
pronounced in patients with dystonia, supporting the concept of cortical disinhibition. 
It is not known whether such changes also occur in secondary forms of dystonia such 
as dystonia associated with CPRS. The current study therefore applied SSEP’s with 
temporal and spatial separated stimuli and their interactions in CRPS-related dystonia 





We studied SSEPs in 33 consecutive CRPS patients (table 1, 32 women, one men, 
age  range 18-60, mean age 39.7 years ) in whom dystonia progressed to a multifocal 
or generalized distribution and 19 healthy controls (19 women, age range 23-55, 
mean age 40.2 years). All patients fulfilled the criteria for CPRS of the International 
Association for the Study of Pain (IASP).17 All patients had tonic dystonia of at least 
two extremities including one upper extremity.  In the majority of patients dystonia was 
limited to the distal extremity and mostly involved flexion of digits and wrists in the 
arms, and inversion and flexion postures in the feet. In a minority of patients, dystonia 
extended proximally to either elbows or shoulders, and knees or hips.
None of the patients had a history of birth trauma or abnormal development. Other 
causes of dystonia had been excluded using appropriate blood and imaging studies 
(computed tomography, magnetic resonance imaging) of the spinal cord and brain. 
Patients were allowed to continue current medication. Informed consent was obtained 
according to the Declaration of Helsinki and the study was approved by the ethical 
committee of the Leiden University Medical Center.
SSEP acquisition 
SSEPs were recorded using a Nicolet Viking III P (Nicolet Biomedical, Madison, USA). 
Patients were instructed to lie supine on an examination couch.  Electrical stimuli of 0.2 
ms duration were given to the median and ulnar nerves at the wrist of the affected arm 
in the patient group and the right arm in the control group. The sampling rate was 
10.000 per second. Stimulus intensity was adjusted to result in a small twitch of the 
hand muscles innervated by the nerve in question. Stimulation frequency was 4.7 Hz. 
Each SSEP consisted of a four-channel recording (30-1000 Hz bandpass filter): Erb’s 
point; a cervical lead aimed at the N14 peak, and the other two recorded ipsilateral and 
contralateral cortical activity. For all leads a 100 ms period was recorded. 
SSEPs were acquired with two sessions of 350 stimuli which allowed reproducibility to 
be judged visually before the automated analysis (see below). We used three ‘temporal’ 
settings, consisting of single shocks, paired shocks with an interstimulus interval (ISI) 
of 20 ms and paired shocks with an ISI of 40 ms. The single shocks will further be 
labeled as having an ISI of 0 ms. We used three spatial settings: stimulation of the 
median nerve, of the ulnar nerve, and of both nerves together. All combinations were 
studied with nonrandom intervals, resulting in 9 SSEPs.    
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Table 1. Demographics of 33 patients with CRPS and dystonia.
Characteristic Value
Females - no (%)      32 (97)
Disease duration, mean (SD) - years   9.0 (6.4)
Age at assessment, mean (SD) - years 39.7 (10.9)
Age at onset of CRPS, mean (SD) - years 30.7 (10.0)
Affected extremities with CRPS- no
        2 
        3




Affected extremities with dystonia- no
        2 
        3




Concomitant oral medication – no.(%)
    Antidepressants
    Baclofen
    Benzodiazepines
    Anticonvulsant drug
    Acetaminophen or NSAIDs








Responses to single stimuli were subtracted from those obtained following temporal 
paired stimuli (Figure 1). This procedure resulted in SSEPs that started at the onset 
of the second stimulus, and that represent neural activity resulting only from the 
second of the paired stimuli. Afterwards, SSEPs following median and ulnar nerve 
stimulation were summed separately per ISI (Figure 2). This resulted in four groups 
of SSEPs representing: 1. median nerve stimulation, 2. ulnar nerve stimulation, 3. 
simultaneous stimulation of median and ulnar nerves (labelled as ‘simultaneous’), and 
4. the mathematical sums of the SSEPs obtained separately for median and ulnar nerves 
(labelled ‘nonsimultaneous’). Grand averages were constructed to aid visualization of 
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responses. The result of these procedures was 12 SSEP’s per subject: for each of the three 
temporal conditions ISIs (0, 20 and 40 ms) there were four spatial variants (median, 
ulnar, simultaneous and nonsimultaneous). 
Peaks were analysed objectively using a computer programme (written in Matlab, 
The Mathworks, Natick, version 6.1.0.450, release 12.1). For example, Erb’s peak was 
identified as the point of maximum electrical potential in an 8-12.5 ms window in the 
appropriate channel. Beginnings and end of these windows were based on inspection 
of grand averages. A local miminum just following the identified maximum was located 
in a 10-17.5 ms window in the same channel, and Erb’s peak amplitude was defined 
as the difference in voltage between the two points.  The N14 peak was identified 
using a local maximum in a 10-17.5 ms window, compared to a local minimum in a 
12.5-22.5 ms window, similarly as for Erb’s peak. For the N20 peak, a 15-22.5 ms peak 
was used, and its amplitude was compared to the N25 local minimum, found with a 
20-27.5 ms window. Additional later potentials in the cortical leads were identified 
using a 22.5- 42.5 ms lead (N35) and a 32.5-50 ms window to help measure N35 
amplitude. This was done for ipsilateral as well as for contralateral cortical leads. Peaks 
were considered absent if there was no local maximum or minimum, i.e., if the point of 
maximum potential coincided with an edge of the search window. Interpeak latencies 
were calculated for the Erb-N14 latency and the N14-N20 latency.
Statistical analysis
As amplitudes and latencies showed a skewed distribution a logarithmic transformation 
was performed. Subsequently, the analysis was carried out in the following order:
1. Latencies and amplitudes obtained after stimulation with single shocks of the median 
and ulnar nerves separately were first descriptively evaluated. Differences between 
SSEPs of the median and ulnar nerves were investigated with the paired samples 
t-test. Differences between patients and controls were evaluated using the t-test for 
independent samples.
2. To evaluate temporal and spatial effects of stimulation, a linear mixed model analysis 
of variance was used. Amplitude of the N20 and N35 peaks were entered as the 
dependent variable. Spatial stimulation (simultaneous or nonsimultaneous), temporal 
stimulation (ISI of 0, 20 or 40 ms) and group (patient or control) were entered as fixed 
factors. The amplitude of the N9 peak was added as covariate to adjust for its possible 
effects on N14, N20 and N35 amplitudes.
Interactions were taken into account with all three factors (group x spatial x temporal), 
and when the factor group revealed a nonsignificant effect, the analysis was rerun 
without the three-way interaction of group, temporal stimulation and spatial 
stimulation. P-values of <0.05 were considered significant.  All statistical analyses were 
performed with SPSS (version 12.0).
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Figure 1. Scheme of SSEP analysis
Figure 1a shows temporal eff ects. Simulated cortical leads are shown to explain the subtraction 
procedure. Panel A shows a SSEP obtained aft er a stimulus at the beginning of the trace. Panel 
B shows the result aft er paired stimulation with an interstimulus interval of 20 ms (recognizable 
through the stimulus artifact): the recording contains the added response to both stimuli. Panel 
C shows the remainder aft er trace A is subtracted from trace B: the response to the fi rst stimulus 
is negated, leaving an isolated response to the second stimulus. For further analysis the fi rst 20 
ms were cut from the trace (not shown).  
Figure 1b shows spatial eff ects. Th e left -hand side of the fi gure shows simulated cortical 
SSEPs obtained for stimulation of the median nerve (top), the ulnar nerve (middle) as well of 
stimulation of both nerves stimulated simultaneously (bottom). Th e right-hand side shows the 






Figure 2. Grand averages of patients’ SSEPs
The six panels show grand averages for SSEPS obtained with temporal manipulation (ISI 0, 20 
and 40 ms) and spatial manipulation (‘M&U’: simultaneous stimulation of the median and 
ulnar nerves; ‘M+U’: mathematical sum of the SSEPs obtained with separate stimulation of the 
median and ulnar nerves). Horizontal scales denote ms. The four channels shown in each panel 
concern, from top to bottom, the ipsilateral cortical lead, the contralateral one, the N14 lead, 
and the lead showing Erb’s peak. 
Distances between ticks on the vertical axes denote 5 microVolt. The first 4 ms are set to zero to 
suppress the stimulus artefact.




In both patients and controls, the amplitudes of the N9, N14 and N20 peaks evoked 
after stimulation of the median nerve were significantly higher than those evoked after 
stimulation of the ulnar nerve (p < 0.001, table 2). The N35 amplitude did not differ 
significantly between median and ulnar nerve stimulation.  
Latencies of the N14 peak were shorter after median nerve stimulation than after 
ulnar nerve stimulation in patients and controls (both groups; p ≤ 0.001). This was 
also found for the N20 latency in controls (p <0.001). Compared to controls, patients 
had a significantly shorter N9 latency after median nerve stimulation (p=0.02) and a 
significantly shorter N20 latency after ulnar nerve stimulation (p=0.02). 
Spatiotemporal interaction
The temporal factor resulted in highly significant differences for all SSEP amplitudes 
after adjusting for the influence of the N9 amplitude (P<0.001 for N9, N14, N20 
and N35 amplitudes). Table 3 shows that this was due to lower amplitudes following 
the second of the two stimuli. The spatial factor also resulted in highly significant 
differences for all SSEP amplitudes (P<0.001 for N9, N14, N20 and N35 amplitudes). 
Simultaneous stimulation of median and ulnar nerve evoked amplitudes that were 
smaller than the arithmetic sum of separately obtained SSEPs of the median and ulnar 
nerves. 
The factor group did not show a significant interaction with either the spatial or temporal 
factor, meaning that patients and controls responded similarly to spatial and temporal 
effects. The three-way interaction did not result in significant differences for any peak, 
so the analysis was rerun without interactions with group. The interaction between the 
spatial and temporal factors did not show significant differences for SSEP amplitudes 
(p= 0.92, 0.27, 0.18 and 0.30 for N9, N14, N20 and N35 amplitudes respectively). The 
interaction between the factor group and the factor spatiotemporal stimulation was 
not significant either. Within patients, there was no significant interaction between the 
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Table 3. Median values and interquartile range of N20 and N35 SSEP amplitudes (µV) after 
spatiotemporal stimulation in controls and patients.
Temporal stimulation





of median and ulnar nerve
(spatial stimulation)
N20    controls 3.46 (3.38) 3.55 (4.20) 2.88 (3.20)
             patients     3.03 (2.81) 3.17 (2.62) 2.70 (2.35)
N35    controls 2.92 (1.78) 2.71 (1.96) 1.79 (1.49)
             patients 2.54 (1.67) 1.47 (2.17) 1.83 (1.54)
Mathemetical sum of 
individual stimulation of 
median and ulnar nerve
N20    controls 4.49 (3.76) 4.58 (2.89) 4.00 (1.23)
             patients 4.33 (4.05) 3.51 (2.92) 2.82 (1.66)
N35    controls 4.37 (2.44) 3.07 (2.85) 2.39 (2.29)
             patients 3.82 (3.63) 2.71 (2.20) 2.44 (2.90)
   
The temporal factor resulted in highly significant differences for the N20 and N35 
amplitudes after adjusting for the influence of the N9 amplitude (P<0.001). The spatial 
factor also resulted in highly significant differences for the N20 and N35 amplitudes 
(P<0.001).
Discussion
In patients with primary dystonia SSEPs after spatial or temporal separated stimuli 
have yielded evidence of  impaired cortical inhibition.15,16  Against this background 
we evaluated the presence of disinhibition in the sensory cortex by studying SSEPs 
obtained after spatiotemporal stimuli. 
Contrary to the reported findings in patients with primary dystonia, spatial and 
temporal SSEP stimulation did not reveal a difference between CRPS patients with 
dystonia and controls. The temporal factor proved highly significant, in that the second 
of two stimuli given with a short interval evoked a potential of lesser amplitude than 
the first one. As such, clear evidence of differential processing was obtained, involving 
habituation or inhibition of successive stimuli. Stimuli given simultaneously to two 
different nerves resulted in amplitudes that were smaller than the sum of two SSEP’s 
obtained separately, indicating ‘competition’ for cortical processing. However, both 
approaches did not differ between groups.  As the amount of sensory input with 
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spatiotemporal stimulation to the somatosensory system is larger than with temporal or 
spatial stimulation alone, one would expect additional suppression of SSEP’s. However, 
interactions of spatial and temporal effects did not reveal an additional suppression of 
amplitudes, in patients nor controls. Possibly, this is due to saturation or habituation of 
the gating capacity of the somatosensory system.
The current results thus indicate that sensory processing of proprioceptive input 
is normal in patients with CPRS and dystonia. One other study on CRPS patients 
measured EMG responses to TMS preceded by paired median nerve stimulation 
and found suppression similar to healthy controls suggesting a normal sensorimotor 
interaction.18 Since spatial and temporal stimulation in both our groups suppressed 
SSEP amplitudes, methodological issues are an unlikely explanation of our findings. 
It is also unlikely that medication was of influence, as we found no significant effects 
of the use of benzodiazepines or baclofen. We don’t think that that our results were 
influenced by ongoing dystonic contraction of the muscles in the affected arm. 
Gantchev et al. studied this issue in healthy subjects and found no difference between 
the “hold” condition (isometric contraction) and rest.19 
The failure to demonstrate abnormalities in our patients may be interpreted as evidence 
in favour of the notion that psychogenic factors contribute to the dystonia in many 
of these patients.20 However, seventy-three percent of the patients in our study also 
participated in a case-control study, in which their psychological characteristics were 
compared with those of patients with affective and conversion disorders.21 In line 
with another case-control study22,  this study found no evidence to support a distinct 
psychological profile in patients with CRPS-related dystonia.
To the best of our knowledge, SSEPs after spatial or temporal separated stimuli 
have not been applied to other secondary causes of dystonia and it may well be that 
disinhibition of the sensory cortex is an exclusive finding of primary dystonia. In line 
with the concept of dystonia as a disorder of neural circuits that mediate sensory-motor 
integration, several studies have documented physiologic abnormalities at multiple 
levels of the central nervous system in dystonia of varying etiology.9,11,23 This raises 
an interesting issue about the commonality of  neural circuits involved in dystonia of 
different aetiology. The generally disappointing responses of secondary dystonia to 
deep brain stimulation24,  may indicate that different causes of dystonia are associated 
with differential circuit involvement. In CRPS, 
C and Aδ-sensory nerve fibres play a role in neurogenic inflammation and are connected 
with spinal circuits that mediate nociceptive withdrawal reflexes (NWRs). One of the 
primary mediators of neurogenic inflammation, Substance P (SP), may also activate SP 
receptors on lamina I neurons in the dorsal horn of the spinal cord, and induce long-
term potentiation (LTP), a form of neuronal plasticity.25 Both SP sensitized NWRs in 
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animal models and dystonia in CRPS patients respond to the GABAB agonist baclofen, 
which enhances spinal GABA-ergic inhibition.26,27 Hence, loss of spinal GABAergic 
inhibition likely is an important mechanism in this type of dystonia. As SSEPs primarily 
depend on conduction of proprioceptive input, we can not exclude a role of abnormal 
processing of small fibre input in CPRS-related dystonia. Possibly, preferential 
stimulation of small fibres by means of laser evoked potentials28 or by stimulation 
with intra- epidermal needle electrodes29 provides a better mode to establish abnormal 
cortical sensory processing.  
Median nerve SSEP amplitudes appeared to be larger than ulnar nerve SSEP amplitudes, 
a finding that was reported by others30 and may be explained by that fact that the ulnar 
nerve, innervating fewer fingers than the median nerve, simply contains fewer sensory 
fibres. An alternative explanation resides in stimulus intensity: this was set on the basis 
of a motor response, and thresholds for sensory and motor responses might differ 
between the two nerves, perhaps because of different localisation of sensory and motor 
fibres in the nerves. 
In conclusion our and previous findings may suggest that proprioceptive sensory 
processing in CRPS is unimpaired and that inhibition at a cortical level is restricted to 
the motor cortex.  In view of the concept of dystonia as a circuit disorder, the finding 
of motor cortex disinhibition raises an interesting chicken and egg issue, which at this 
stage cannot be solved. However, in view of the peripheral initiation of the disorder, 
we favour a spinal origin of dystonia in CRPS-I with secondary changes at supraspinal 
sites of the circuit. 
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Background: The pathogenesis of dystonia in Complex Regional Pain Syndrome 
(CRPS) is unclear. In primary dystonia, functional magnetic resonance imaging 
(fMRI) has revealed changes in cerebral networks during execution of movement.  
Objectives: To determine cerebral network function in CRPS patients with dystonic 
postures.
Design: Assessment of cerebral processing related to both execution and imagining of 
hand movements with fMRI in patients and controls.  
Subjects: 8 CRPS patients with dystonic postures of the right upper extremity and 17 
age matched healthy controls. 
Results: Compared with controls, imaginary movement of the affected hand in patients 
showed reduced activation ipsilaterally in the premotor and adjacent prefrontal cortex, 
and in a cluster comprising frontal operculum, the anterior part of the insular cortex 
and the superior temporal gyrus. Contralaterally, reduced activation was seen in the 
inferior parietal and adjacent primary sensory cortex. There were no differences between 
patients and controls when they executed movements, nor when they imagined moving 
their unaffected hand. 
Conclusions: The altered cerebral activation pattern in patients with CRPS linked 
dystonia most likely reflects an interface between pain-associated circuitry and higher 
order motor control, which points at a specific mechanistic pathophysiology of this 
type of dystonia. 
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Introduction
Complex Regional Pain Syndrome type 1 (CRPS), also called Reflex Sympathetic Dys-
trophy (RSD), is a syndrome predominantly characterised by a variety of sensory, au-
tonomic and trophic features1,2. Symptoms include pain, oedema, hyperhydrosis and 
impaired function. Growing evidence indicates that CRPS may also include some form 
of movement disorder, like tremor and dystonia3-5. 
Dystonia is characterised by involuntary sustained muscle contractions, causing twist-
ing and repetitive movements or abnormal postures3,6. Functional brain imaging with 
PET and fMRI has provided valuable new insights in the role of altered activation 
of basal ganglia-cortical networks during execution of movement in focal and gener-
alized dystonia. Underactivation of the primary motor cortex and overactivation of 
the somatosensory cortex, prefrontal -, premotor - and parietal cortical regions have 
been reported. Other studies showed an overactivation of the primary motor cortex 
and underactivation of the premotor cortex7-9. These inconsistencies may result from a 
combination of differences in scanning procedures, tasks and a varying degree of dysto-
nia during motor execution. However, a distinct pathophysiology underlying different 
forms of dystonia may equally be an option8. 
The pathophysiology of CRPS itself remains a controversial issue10. Some features of 
CRPS favour a spinal aetiology5, other indicate a cerebral reorganization in both the 
sensory and motor domain11,12. A recent fMRI study in CRPS, focussing on mechani-
cal hyperalgesia, reported alterations in nociceptive, cognitive and motor processing13. 
Hitherto, no functional imaging study in dystonia of CRPS during movement execu-
tion has been performed. 
In overt dystonic movement, altered sensory feedback (in particular noxious input) 
during painful movements is a potential confounder in functional brain imaging, 
which can be reduced by motor imagery, i.e. mental rehearsal of a motor act without 
overt movement. Previous work suggests that the volume of brain activation differs be-
tween execution and motor imagery, but the distribution of cerebral activity tends to 
be partly similar14,15. Motor imagery is used in sport to improve performance. A positive 
effect of motor imagery in the rehabilitation of CRPS patients has been established16,17. 
In this study we aimed to explore the distribution of cerebral activations in CRPS pa-
tients with tonic dystonia during both motor execution and imagining of movement, 
of affected as well as unaffected limbs. Based on the clinical resemblance with other 
forms of dystonia, we hypothesised to find a functional alteration in regions supporting 
a primary motor function, and in circuitry associated with higher-order motor control, 





Eight patients (seven female, mean age 46.4, SD 6.0 years) with CRPS related dysto-
nia from the Leiden University Medical Center and seventeen healthy volunteers (15 
female, age 42.9, SD 9.2 years), matched for age, were studied. All patients fulfilled 
the officially accepted diagnostic criteria for CRPS of the IASP18. Revisions of these 
diagnostic criteria are under consideration19. Furthermore, the presence of tonic dys-
tonia in at least the right upper extremity was obligatory. The presence of dystonia in 
the CRPS-affected limb was based on the presence of prolonged muscle contractions 
resulting in abnormal postures or movements of the limb. In upper limb dystonia such 
involuntary muscle contractions resulted in typical flexion postures of the hand and fin-
gers. In all patients a tonic stretch reflex was present. Passive stretching of the affected 
digits induced increased flexor activity. The dystonic limb was also always the CRPS af-
fected limb. In five patients the right leg was also affected, in one the left leg and in one 
both legs (Table 1). Patients in which the left arm was affected by CRPS were excluded. 
Right handedness was obligatory and was assessed according to the Dutch Handedness 
Questionnaire20. The ability to perform mental imagery was assessed by the Vividness 
of Movement Imagery Questionnaire (VMIQ)21. Further assessments included a neu-
rological examination. The T1 weighted MRI scan did not show pathology. Informed 
written consent was obtained and the study was approved by the Medical Ethical Com-
mittees of the Groningen and Leiden University Medical Centers. 
Tasks
Subjects performed four tasks: execution and imagination of flexion/extension move-
ments of the separate right and left wrist. The movements were performed in a vertical 
plane and paced at 0.5 Hz by a visual stimulus: in response to each stimulus one self-
paced extension-flexion cycle was made. The forearms were positioned in pronation 
on pillows. All tasks were preceded by a rest condition. All conditions had a duration 
of 30 seconds. Three runs were performed lasting 12 minutes each. In each run, 12 
response blocks were scheduled. For each subject, tasks were presented in a random, 
but balanced order. Subjects were monitored and videotaped during scanning. Special 
attention was paid to voluntary and involuntary movements of wrists. Prior to the ex-
periment, subjects practised the tasks outside the MRI scanner. They were instructed to 
imagine moving their wrist freely. Their limbs were not within their field of view. After 
data acquisition all patients reported pain during the movement execution task.  None 
of the patients reported pain during the imagined movements.  Pain was not formally 
quantified by standardized questionnaires. 
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Functional imaging
Subjects were scanned using a 3 Tesla Philips MRI scanner (Best, the Netherlands). The 
following pulse sequence parameters were used: single shot EPI; 46 slices; 3.5 mm slice 
thickness; no gap; 224 x 224 mm field of view; 64 x 64 scan matrix; transverse slice ori-
entation; repetition time 3000 ms; echo time 35 ms; flip angle 90º. Three runs of 240 
brain volumes each were acquired, i.e. 10 volumes per 30 seconds condition block. In 
addition, a T1-weighted whole brain anatomical image was acquired (resolution 1x1x1 
mm). 
Statistical analysis
Spatial pre-processing and statistical analysis (random effects) was carried out using 
Statistical Parametric Mapping (version SPM2)22. The functional images were re-
aligned, normalised and subsequently smoothed with an isotropic Gaussian filter using 
an 8 mm Full Width-Half Maximum Gaussian kernal. Head movements were more 
frequently seen in the patient group. This reflects the difficulties the patients had in 
performing the tasks. Optionally, the estimated head-motion parameters were used as 
covariates as described by Friston et al.23. Only minor differences were encountered 
in this comparison, indicating the presence of task-related head movements. However, 
areas affected by motion did not show overlap with areas activated during the tasks, 
demonstrating that the group result was not caused by head motion. Note, for the re-
ported results motion correction has been applied.  In the first analysis,  the movement 
and imagining conditions of each hand were compared with rest for each single subject 
(first level analysis). For within-group analysis, for the patient and control group re-
spectively, these contrasts were tested using a one sample T-test (second level analysis). 
For the larger control group (17 subjects), a high threshold at voxel level was used (P 
< 0.05 Family-wise Error (FWE); extent threshold ≥ 5 voxels). This avoided overlap of 
activations which would have blurred regional identification when thresholded at P < 
0.001 (uncorrected). For patients (8 subjects) a threshold at P < 0.001 (uncorrected) 
was used. This was done as to look for the spatial distribution of a circuitry with general 
resemblance to that observed in controls. For a between-group analysis (i.e. patients 
compared to controls) a two-sample T-test was used (P < 0.001 (uncorrected)). Re-
sulting clusters for both tests were considered significant at P < 0.05 (cluster-level cor-




Findings on the VMIQ questionnaire (patients 110 ± 52, control subjects 83 ± 34; 
two-sample T-test, 2-tailed P=0.133) revealed no significant differences.  
In both controls and patients, activated areas during imagining showed a symmetrical 
distribution and activation of the sensorimotor cortex was not observed. Activation 
in the patient group appeared to be less robust than in the controls for the four dif-
ferent tasks (Figure 1, Table 2). By visual inspection, it already was apparent that the 
patients’ activation networks were most affected during imagining of motor perfor-
mance with the affected hand. But direct comparison of the figures only allows obser-
vation of a trend, partly because of  differences in population size (17 controls versus 
8 patients). The statistical significance of differences between the two groups can only 
be established by formal between-group analysis. Such statistically significant differ-
ences between patients and controls were only obtained during imagining right hand 
movements. No statistically significant between-group differences were obtained for 
the three other tasks. 
During imagining of right hand movements three regions were significantly less acti-
vated in patients compared with controls. No increases were seen in the patients dur-
ing this task. These foci of reduced activation were distributed ipsilateral over both 
the middle frontal gyrus, comprising the prefrontal cortex and premotor cortex (P 
corrected-cluster-level 0.030, cluster size 186 voxels), and the anterior part of the in-
sular cortex adjoining the superior temporal gyrus and the inferior frontal gyrus (P 
corrected-cluster-level 0.010, cluster size 242 voxels). In the hemisphere contralateral 
to the imaginary moving hand, the postcentral gyrus and inferior parietal cortex were 
less activated in the patient group (P corrected-cluster-level 0.030, cluster size 186 vox-
els), (Figure 2, Table 3).  
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. Areas of activation in controls (n=17) and patients (n=8)
Four different tasks compared with rest condition, projected on a template rendered brain 
image. 
P uncorrected < 0.01, extent threshold ≥ 5 voxels.






























































    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    










    
    
    
    
    
    
    
    


















































































































































































































































































































































































































Figure 2. Areas with reduced activation in patients compared with controls during imagining of 
movement of the right hand. 
Areas projected on glass brain and transversal slices of a mean template image. P < 0.05 (volume 
corrected, cluster-level). (1) Ipsilateral middle frontal gyrus and premotor cortex, (2) ipsilateral 
anterior part of insular cortex, superior temporal gyrus and inferior frontal gyrus, (3) contralat-
eral inferior parietal cortex and postcentral gyrus.
Discussion
Both execution and imagining of the motor task in our healthy volunteers results in 
activation of previously described cerebral circuitry14,15,24. In CRPS patients, however, 
the motor imagining paradigm revealed a conspicuously reduced activation of cortical 
networks that subserve imagining of movement of the affected limb, in comparison 
with controls. Only two other imaging studies have reported an imagining paradigm 
in dystonia patients. In a preliminary PET study idiopathic torsion dystonia patients 
showed a similar activation pattern as controls25. In a recent fMRI study on post-
stroke dystonia, mental representations of movement of the affected hand resulted in 
overactivity of the ipsilateral inferior parietal cortex, insula, bilateral prefrontal cortex 
and other cortical areas26. Part of these regions are also involved in our CRPS patients, 
although we found underactivity. This difference may be due to differences in the 
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Imagining of Movement
All patients recalled the ability  to perform the imagining task with their affected limb. 
Moreover, the ability of patients for imagining  movement in general did not signifi-
cantly differ from the controls, as we inferred from the VMQI questionnaire. This dem-
onstrated the ability of the patients to perform a movement imagery task, although we 
have no behavioural characteristics to answer the question to what extent imagining 
movement of the affected hand was correct. In CRPS (without dystonia), prolonged 
time for imagining moving the affected body part, when compared to the not-affected 
body part, has previously been explained by a distorted cortical correlate of the body 
scheme27,28. Such a distorted body image has also been inferred from referred sensa-
tions29, mislocalization of tactile stimulation 30 and the experience of an increased size 
of the affected limb31. 
The aforementioned behavioural findings are consistent with the idea that cortical re-
organization plays an important role in CRPS 11,12. We think it likely that changes in 
body scheme, associated with changes in cortical representation, play an important role 
in our results. By using sensory stimuli, cerebral reorganization in CRPS has also been 
demonstrated to occur in the nociceptive (or sensory) domain as well as  in cognitive 
and motor domains13,33,32. A recently published  case-report even mentioned  a tempo-
rally increase in pain and swelling of the affected hand in a CRPS-patient after imag-
ined movements34. Although this was not mentioned by our patients and the report 
was limited to one patient, it implies that symptoms of CRPS may be mediated by 
cortical mechanisms associated with (imagined) movement of the affected body part.  
In order to comprehend the specific distribution of the regional decreases in our move-
ment execution and movement imagining study, it is important to consider how the 
functions of these regions may provide a logical combination in the context of pain and 
disturbed motor control. The premotor cortex is related to planning and organization 
of movement35. Both impaired activation and enhanced activation in the premotor cor-
tex during a motor task in different forms of dystonia has been reported (for an over-
view see8). The inferior parietal cortex is an association area, which receives information 
of different sensory modalities and thus holds a strategic position in processing space 
perception, body scheme and so in linking sensation to motor control36. The posterior 
part of the sensory cortex which constituted the anterior border of the parietal activa-
tion in our group is particularly involved in the proprioceptic sensation related to limb 
movement37,38.
The posterior insula is known as a secondary motor area. For the anterior part of the in-
sula, however, a relation with motor control is less obvious39. The latter has a dominant 
role in autonomic regulation. The paralimbic cortex in the anterior superior temporal 
sulcus, along with anterior insula and orbitofrontal cortex, have been proposed to pro-
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vide an interface between limbic cortex in the medial temporal lobes and frontopari-
etal association cortices36. The anterior part of the insula and superior temporal sulcus 
are situated between the posterior cortex and frontal cortices, thus linking multimodal 
perception of stimuli and executive processes40. The anterior insula is involved in path-
ways that are critical for mental processing of pain related experiences in patients with 
an amputated hand during imagining of painful finger movements41 and in a pin-prick 
hyperalgesia study in CRPS patients13. 
In view of the long disease duration (mean 11 years) of our patients, long-lasting pain 
may have induced changes on efficient motor control, reflected by a decreased activa-
tion in circuitry providing limbic access to higher-order motor control. 
Execution of Movement 
Motor execution of the affected side in patients showed only non significant differ-
ences between patients and controls. At first sight, this may look strange. On the other 
hand, the between–group comparison may not have reached statistical significance as 
a consequence of higher intersubject variability in the activated areas during execution. 
Such variability may be caused by differences in effort to move.  Our most plausible ex-
planation is the altered sensory feedback in the patients, as they experience pain when 
performing the movement task. This sensory feedback may result in activation of corti-
cal areas, scaling down the areas activated in relation with the execution of movement. 
However, the fact that we did not find a consistently increased activation in pain-as-
sociated circuitry makes us reluctant to provide a definitive explanation in this matter. 
Findings on motor execution in our patients with dystonia of CRPS, are different from 
those found in other causes of dystonia, although studies on dystonia, in general, have 
reported contradictory findings. This can often be attributed to methodological differ-
ences, but a different pathophysiology for different forms of dystonia may also be an 
option. In the case of CRPS, a different pathophysiology of dystonia is likely.
In conclusion, patients with CRPS and dystonia displayed areas with decreased activa-
tion during imagining tasks that are involved in planning of movement, multimodal 
sensorimotor integration, autonomic function and pain. Pain may profoundly alter the 
cerebral organization of movement by functional interaction between these regions.
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Dystonia in Complex Regional Pain Syndrome (CRPS) responds poorly to treatment. 
Intrathecal baclofen (ITB) may improve this type of dystonia, but information on its 
efficacy and safety is limited.  A single-blind, placebo-run-in, dose-escalation study 
was carried out in 42 CRPS-patients to evaluate whether dystonia responds to ITB. 
Thirty-six of the 38 patients who met the responder criteria received a pump for 
continuous ITB administration and were followed for 12 months to assess long-term 
efficacy and safety (open-label study). Primary outcome measures were global dystonia 
severity (both studies) and dystonia-related functional limitations (open-label study). 
The dose-escalation study showed a dose-effect of baclofen on dystonia severity in 31 
patients in doses up to 450 µg/day. One patient did not respond to treatment in the 
dose-escalation study and three patients dropped out. Thirty-six patients entered the 
open-label study. Intention-to-treat analysis revealed a substantial improvement in 
patient and assessor-rated dystonia scores, pain, disability and quality of life (Qol) at 
12 months. The response in the dose-escalation study did not predict the response to 
ITB in the open-label study. Eighty-nine adverse events occurred in 26 patients and 
were related to baclofen (n=19), pump/catheter system defects (n=52), or could not 
be specified (n=18). The pump was explanted in 6 patients during the follow-up phase. 
Dystonia, pain, disability and Qol all improved on ITB and remained efficacious over 
a period of one year. However, ITB is associated with a high complication rate in this 
patient group and methods to improve patient selection and catheter-pump integrity 
are warranted.
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Introduction 
Complex Regional Pain Syndrome (CRPS) is a poorly understood disorder that 
predominantly affects women and usually is preceded by an injury or surgery1,2. Early 
clinical features of CRPS include persistent pain, swelling, increased sweating, and 
changes in skin color and temperature and may reflect an aberrant inflammatory 
response to trauma2,3. Various studies have reported the involvement of perturbed 
functions of both C and A delta fibers of sensory nerves (neurogenic inflammation) 
and also a perturbed function of the local immune system in the skin4-7. Several other 
studies have reported axonal degeneration in small distal nerve fibers of patients with 
CRPS8-10. Aberrant processing of spinal and supraspinal sensorimotor neural networks 
are held responsible for the development of chronic pain, allodynia, hyperalgesia, 
and movement disorders11,12. Approximately 20% of patients with CRPS develop 
dystonia2,13,14, which is defined as abnormal involuntary muscle contractions that 
cause twisting or repetitive movements or sustained postures15. Dystonia in CRPS is 
predominantly characterized by fixed flexion postures, frequently has a delayed onset 
and may spread to other extremities14,16,17. Dystonia in CRPS is generally refractory 
to treatment18 and therefore adds considerably to the disease burden, leaving some 
patients severely disabled.
Knowledge of the mechanism that underlies dystonia in CRPS is a prerequisite for the 
development of a treatment. In 2000, we reported on the beneficial effects of continuous 
administration of intrathecal baclofen (ITB) in six CRPS patients with multifocal or 
generalized dystonia19. Baclofen stimulates the presynaptic gamma-aminobutyric-
acid B (GABAb) receptor, which inhibits sensory input to spinal neurons
20, but may 
also act post-synaptically21. The aim of the current study was 1) to further elucidate 
the efficacy of ITB in a dose-escalation study of a large group of patients with CRPS-
related dystonia and 2) to evaluate whether ITB is effective and safe in this population 
over a 12-month period.    
Methods
Patients
All patients who visited our clinic with a diagnosis of CRPS and dystonia in at least 
one extremity and who fulfilled the CRPS criteria of the International Association 
for the Study of Pain (IASP)3 were considered for inclusion in the study. The IASP 
criteria include a combination of 1) the presence of an initiating noxious event or a 
cause of immobilization, 2) continuing pain, allodynia or hyperalgesia with which 
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the pain is disproportionate to any inciting event, 3) evidence at some time of edema, 
changes in skin blood flow or abnormal sudomotor activity in the region of the pain 
and 4) absence of a condition that would otherwise account for the degree of pain 
and dysfunction. Criteria 2-4 are necessary for a diagnosis of CRPS3. We increased the 
homogeneity of the population by only including CRPS patients in whom a noxious 
event triggered the onset of the syndrome in the first affected extremity. Patients were 
only eligible if they experienced no benefit of oral baclofen up to a minimum daily dose of 
60 mg or if this treatment caused dose-limiting side effects. Exclusion criteria were other 
causes of dystonia (birth injury, head trauma, neuroleptic treatments), other medical 
or psychiatric concomitant disorders that could affect the surgical risk or completion 
of the trial, pregnancy and spinal deformities that could interfere with implantation of 
the pump/catheter system. Physicians throughout the Netherlands referred patients to 
our department. Patient consent was obtained in accordance with the Declaration of 
Helsinki and the local Ethics Committee approved the study.
Dose-escalation study
A single-blind, placebo-run-in, dose-escalation study with continuous infusion of 
baclofen was conducted. This design was chosen for the following reasons. Firstly, 
our increasing experience of ITB in CRPS patients with dystonia indicates that bolus 
injections may result in effects lasting several days. These prolonged effects suggest that 
the previously used cross-over design19 with baclofen and placebo on alternate days is 
inappropriate. We therefore chose to administer placebo before baclofen. Patients were 
blind as to which days they received placebo. Secondly, bolus injections with ITB are 
less effective than continuous infusions with ITB22. 
Baclofen or placebo was administered via a percutaneous catheter that was introduced 
into the subarachnoid space (L3-4) and advanced to the lower thoracic region. The 
other end of the catheter was tunneled subcutaneously to the flank and connected to an 
external micro-infusion pump. Two days of placebo infusion were followed by the start 
of ITB infusion on the third day at a rate of 200 µg per day, which was increased daily 
according to a fixed schedule (200-250-300-375-450-525-600-700-800 µg) until the 
responder criteria (see below) were reached. If a baclofen-related side effect occurred, the 
dose was decreased or maintained, depending on the severity of the side effect. 
Open-label study 
A programmable pump (SynchroMed Infusion system, Medtronic INC, Minneapolis, 
MN) for ITB administration was implanted subcutaneously in the lower abdominal 
wall in patients who met the responder criteria. The catheter was introduced in the sub-
arachnoid space (L2-L3) under X-ray guidance with placement of the distal tip of the 
catheter in the midthoracic region. The catheter was placed in the same position in all 
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patients, irrespective of upper or lower extremity involvement of dystonia. The catheter 
was then tunneled subcutaneously and connected to the pump. 
ITB was started at a rate of 150 µg per day and increased in 10-20% steps until 1) 
patients experienced a satisfactory reduction of dystonia, 2) a maximum daily dose of 
1300 µg was reached, or 3) dose-limiting side effects occurred. Pump-catheter system 
integrity was verified postoperatively in all patients and again in patients who showed no 
effect when a minimum daily dose of 1000 µg was reached or who deteriorated after an 
initial positive response.
Outcome
Patients completed Global Dystonia Severity (GDS) and Dystonia-related Functional 
Limitations (DFL) ratings at hourly intervals at home for five consecutive days and also for 
the duration of the dose-escalation study. GDS was assessed using a numeric rating scale 
(NRS) ranging from 0 (absent) to 10 (most severe). DFLs involved four items (transfers, 
general mobility, left/right arm functions) with four response options, ranging from 0 (no 
limitations) to 3 (severe limitations). 
Patients participating in the open-label study were evaluated at baseline and 3, 6, 9, 
and 12 months after surgery. Primary outcome measures included the GDS and DFL 
scores. All other outcome measures were considered secondary. Dystonia severity was 
rated using the Burke-Fahn-Marsden (BFM) Dystonia Rating Scale 23, which is the sum 
of the scores of the individual body regions. Pain severity was evaluated using a numeric 
rating scale, ranging from 0 (no pain) to 10 (worst possible pain). The Rivermead 
Mobility Index (RMI) was used to assess mobility and includes 15 questions addressing 
a wide range of activities, from turning over in bed to running. The items are scored 
dichotomously (0-1) and summated, with a higher score reflecting better mobility (0-
15) 24. Activities of daily living were scored using the Barthel index (range 0-20) 25, 
while the Rankin Scale was used to determine global disability (0: no symptoms to 4: 
severe disability) 26. Health-related quality-of-life was assessed with the EuroQol-5D 
27. The EuroQol-5D includes five items with three response options, from which a health 
state value (EQ-Tariff ) is calculated, which ranges from 0 (death) to 1 (perfect health), 
although negative values for health states considered worse than death are possible. It 
also includes a visual analog scale for general health (ranging from 0; worst imaginable to 
100; best imaginable). Higher scores in the RMI, the Barthel Index and the EuroQol-
5D correspond to better mobility, ADL and quality of life, respectively. Higher scores 
in all other measures indicate symptoms with a higher degree of severity or poorer 
function. 
Safety was evaluated by recording the frequency and severity of adverse events, which 




Dose-escalation study. The scores of six hourly intervals from the home evaluation 
(11:00-16:00) were summed (range 0-60) for each of the five days. The selection of 
these six time points was based on the fact that these were the hours that patients were 
active and able to record their evaluations. Sleeping, bathing and other activities often 
caused a larger number of missing values in the earlier and later parts of the day. The 
mean of these 5 days was used as the baseline score. A mean sum score was similarly cal-
culated for the two placebo days and each baclofen day. Missing values in the diary were 
replaced with the value of the previous hour if this concerned two scores or less per day. 
A day was excluded from analysis if three or more values were missing. The placebo and 
baclofen responses were expressed as the percentage change from baseline (i.e, home 
evaluation). The GDS score was used as the primary outcome. The responder criteria 
were set at a ≥ 25% difference between the GDSbaclofen and GDSplacebo responses on two 
consecutive baclofen days. 
Open-label study. The primary outcome measures were the changes in the GDS and 
DFL from baseline to 12 months. Missing data in the primary outcome measures 
were handled in the same way as in the dose-escalation study. Secondary outcome was 
defined as changes from baseline on all other scales. Data from any particular patient’s 
scale were excluded from statistical analyses if 25% or more of the data were missing 
from the scale. The results were analyzed both on an “intention-to-treat” and on an 
“on-treatment” basis. Score differences between baseline and 12 months were compared 
using the paired-samples t-test or Wilcoxon-signed-rank test. The relationship between 
the results from the various scales was assessed using a Spearman’s rho test. A logistic 
regression analysis was performed to evaluate which patient characteristics or screening 
parameters predicted responsiveness to treatment in the open-label study, where a ≥ 25% 
reduction in patient-reported dystonia was considered a positive response. Statistical 
analyses were performed using SPSS (version 14.0). A 95% confidence interval (CI) 
excluding 0 indicated a significant difference at an alpha level of 0.05 (two-sided). No 
adjustments were made for multiple testing.




Fifty-seven CRPS patients were assessed for eligibility between January 2002 and January 
2007, of which 42 patients (40 women) with a mean disease duration of 10.3 (standard 
deviation 6.1) years participated in the study (tables 1 and 2). Nineteen percent of study 
patients had CRPS in two extremities, another 19% in three extremities and 62% had 
symptoms in four extremities. Three percent of patients suffered from dystonia in one 
extremity while two, three and four extremities were affected by dystonia in 31, 21 and 
45 percent of patients, respectively. Demographic and dystonia characteristics of the 
15 excluded patients did not differ significantly from the included patients (figure 1). 
Three patients dropped-out due to intolerable side effects (n=1), CSF leakage (n=1) and 
because the study was considered too demanding (n=1). The number of missing data 
from the primary outcome never exceeded 2 scores per day. Thirty-seven patients followed 
the fixed-dose schedule; side effects required adjustment of the schedule for 5 patients. 
Blinding in the dose-escalation study was generally successful until patients perceived 
an improvement in their dystonia, after which blinding could not be maintained 
successfully. The mean GDSplacebo response was 7% (95% CI: 3 to 12). One patient did 
not respond to ITB. A dose-effect of baclofen on dystonia severity was observed in 
doses up to 450 µg. Thirty-one patients reached the responder criteria at this dose (figure 
2). A total of 38 patients showed a ≥ 25% difference between the baclofen and placebo 
responses on two subsequent baclofen days.   The mean difference between placebo and 
baclofen response was 38% (95% CI: 34 to 43) in favor of baclofen for responders on 
the first response day and 41% (95% CI: 36 to 46) on the second day. The responder 
criteria were reached at a mean baclofen dose of 415 µg/day (SD 139, range 200-800). The 
total DFLplacebo response score showed a worsening of 2% (95% CI: -3 to 7%). The mean 
difference between DFLplacebo and DFLbaclofen response was 25% in favor of baclofen (95% 
CI: 17 to 33) on the first response day and 25% (95% CI: 17 to 31) on the second day.
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Table 1. Demographic and clinical characteristics of patients (n=42)
Characteristic Value
Age - mean (SD), years 35.7 (12.8)
Sex - male / female, no. 2 / 40 
Disease duration - mean (SD), years 10.3 (6.1)
Trauma preceding first affected extremity - no. (%)
     Soft tissue injury
     Fracture 
     Surgery
  23 (55)
  11 (26)
   8  (19)
Extremities affected by CRPS – no. (%)
    2 
    3
    4
 
   8 (19)
   8 (19)
 26 (62)
Extremities affected by dystonia – no. (%)
     1
     2
     3 
     4
 
   1  (3)
 13 (31)
   9 (21)
 19 (45)
Dystonia in upper and lower extremities - no. (%)
      Only upper 
      Only lower 
      Upper and lower 
  3  (7)
  1  (2)
38 (91)
Open-label study  
Thirty-six of the 38 patients who met the responder criteria participated in the open-
label study.  Two patients declined to proceed to implantation, due to catheter-induced 
back pain and persistent partial improvement of dystonia after the dose-escalation study. 
Missing data never exceeded the predefined criteria. All dystonia scores had improved 
significantly between baseline and 12 months (table 3). GDS improved by a mean of 
2.9 (SD 3.0) points (40%). The BFM-score showed a similar improvement of 18.8 
(27.1) points (38%). BFM subscores for the upper extremities improved by 45%, while 
dystonia in the lower extremities improved by 33%. GDS and BFM scores decreased 
during the first six months and remained stable thereafter (Fig 3A and B). Pain severity 
measured by the NRS decreased from 7.7 to 5.7 (26%) and there was a correlation 
between the reduction of pain and the improvement in the GDS score (Spearman’s rho
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Table 2. Signs and symptoms of CRPS in affected extremities 
Variable Affected extremity
1st (n=42) 2nd (n=42) 3rd (n=34) 4th (n=26)
Pain 
  present/ absent/ unknown,  no. 42 / 0 / 0 42 / 0 / 0 34 / 0 / 0 26 / 0 / 0
Hypoalgesia
  present/ absent/ unknown, no. 38 / 4 / 0 32 / 9 / 1 26 / 8 / 0 19 / 5 / 2
Hyperalgesia/allodynia
  present/ absent/ unknown, no. 28 / 14 /   0 22 / 20 / 0 17 / 17 / 0 11 / 15 / 0
Edema
  present/ absent/ unknown, no. 39 / 3 / 0 29 / 13/  0 17 / 17 / 0 12 / 14 / 0
Temperature changes
  present/ absent/ unknown, no. 40 / 2 / 0 36 / 4 / 2 25 / 8 / 1 18 / 6 / 2
Color changes
  present/ absent/ unknown, no. 40 / 1 /  1 38 / 3 / 1 24 / 10 / 0 19 / 6 / 1
Hyper/hypohidrosis
  present/ absent/ unknown, no. 31 / 10 / 1 25 / 15 / 2 19 / 14 / 1 13 / 11 / 2
Hair and nail growth changes
  present/ absent/ unknown, no. 35 / 6 / 1 32 / 8 / 2 23 / 8 / 3  15 / 9/ 2
Variables were deemed to be present if a symptom, a sign or both were reported or observed. 
0.50). The DFL total, mobility, transfers, and left/right arm function scores improved 
by 31, 19, 38, 35 and 33%, respectively. The Rivermead mobility index improved by 
44%. Out of six patients who were completely confined to bed, four changed to using 
a wheelchair (two of which were able to walk short distances with or without walking 
aids) and one patient became fully ambulatory. One explanted patient remained 
confined to bed. Three of four patients who were partially bed-bound changed to full-
time wheelchair use. Of the 14 patients who were wheelchair-bound, 10 remained 
unchanged, two still needed a wheelchair but were able to walk short distances, 
and two became fully ambulatory. All four patients with part-time wheelchair use 
remained unchanged. Of five patients who needed walking aids, four improved to 
walking without aids. One of three ambulatory patients became part-time wheelchair-
dependent due to worsening of CRPS symptoms. The other two patients remained 
ambulatory. The Barthel index improved by 26%. Distribution of the Rankin Scale 
improved; 26 patients had moderate to severe disability at baseline, compared to 15 
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patients during follow-up. The EuroQol-index improved from 0.21 to 0.45 while the 
health state improved from 42 to 54. The pump was explanted in six patients before 
the endpoint was reached (figure 1, mean duration of ITB administration = 6 months, 
range 2-11). Results of the intention-to-treat analysis (n=36) did not differ from the 
on-treatment analysis (n=30). Apart from a slight improvement in GDS score, none 
of the outcome measures in the off-treatment group changed significantly. Seventy 
percent of patients on treatment improved by ≥ 25% on the primary outcome, whereas 
47% of the patients improved by ≥ 50%, and 20% improved by ≥ 75%. 
Figure 1. Enrollment of patients in dose-escalation and open-label studies.
 
36 entered open-label study 2 withdrawn 
    1 catheter-induced back pain 
    1 partial improvement/declined 
30 reached endpoint 6 explanted  
   2 pump pocket infections 
   2 local pain at pump site 
   2 severe ITB side effects   
15 Excluded  
    5 declined to participate  
    2 pregnant 
    4 unstable psychiatric disease 
    2 interfering somatic co-morbidity 
    1 deceased 
    1 lumbar osteosynthesis 
 
1 negative response 38 positive responses 3 discontinued 
  1 intolerable ITB side effects 
  1 leakage 
  1 screening too burdensome 
 
57 Assessed for eligibility  
36 included in intention-to-treat analysis 
30 included in on-treatment analysis 
42 entered dose-escalation study  
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Figure 2. Dose-escalation study: baclofen dose at which the responder criteria were reached.
Kaplan-Meier curve of 42 patients showing the baclofen dose at which patients reached the 
responder criteria. ◊ denotes three patients that dropped out because of intolerable side effects, 
CSF leakage and the fact that the study was too burdensome. * denotes one patient who did not 
respond to ITB.
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Figure 3. Dystonia severity during open-label study. 
Mean (SD) scores of Global Dystonia Severity (GDS, panel A) and the Burke-Fahn-Marsden 
scale (BFM scale, panel B) before and after 3, 6, 9, 12 months of ITB infusion in the on-treatment 
group (n=30). * denotes a significant difference compared to baseline values (p<0.001).
None of the variables tested in the logistic regression analysis (including patient 
characteristics and screening characteristics, such as time to response and dose at which 
the patient met the responder criteria in the screening phase) predicted the response 
to ITB in the open-label study. The median ITB dose in the follow-up study increased 





































































Nineteen ITB-related adverse events were reported in 14 patients (table 4). Most 
frequent ITB-related adverse events were nausea, vomiting, headache, and short-term 
urinary retention at the start of the treatment. Three patients developed baclofen 
intoxication with somnolence, nausea and vomiting, which required temporary 
discontinuation of baclofen. Persistent baclofen-related headache and vomiting, which 
cleared after lowering ITB dose to a minimum rate, led to pump explantation in one 
patient. Three patients had psychiatric adverse events (two with psychosis and one with 
depression), which were probably caused by ITB, as symptoms cleared after lowering or 
stopping ITB. This led to explantation in one of these patients.  
Device-related complications were common: 43 catheter-related complications oc-
curred in 33 patients, with post-dural puncture headache (n = 31) as the most frequent 
complication. 
Five patients, who initially responded to ITB, experienced a gradual worsening of dys-
tonia over a period of 1-2 weeks. Catheter dysfunction was found in these patients and 
dystonia improved after a variable delay of days to months after catheter revision.
Nine pump-related adverse events occurred in eight patients. Two patients experienced 
refractory pain at the site of the pump pocket, which led to explantation in one of these 
patients. The pump was explanted in three of four patients who developed a pocket 
infection. The pump was not re-implanted in two of these patients due to a question-
able effect of ITB. The third patient improved to her former level after re-implantation. 
Discussion 
Dystonia is characterized by impaired inhibition of sensorimotor circuitry at multiple 
levels of the central nervous system28-30. Findings on dystonia in CRPS are in line with 
this and showed a loss of spinal and cortical inhibition28,31,32. The dose-escalation study 
showed that ITB reduces dystonia in patients with CRPS. The fact that baclofen is infused 
around the spinal cord where it is known to stimulate presynaptic GABAb and possibly 
postsynaptic receptors20,21, may indicate that loss of spinal GABAergic inhibition is an 
important mechanism in this type of dystonia. However, since baclofen may diffuse 
more rostrally, we cannot rule out that part of the effect is mediated at a supraspinal level. 
The open-label study showed marked improvement of patient and assessor-rated dystonia 
after one year. The largest improvement in dystonia was seen after three months, with 
a smaller further improvement after 6 months after which dystonia remained stable 
(Figure 2). A similar response pattern was observed in deep brain stimulation (DBS) 
in patients with primary generalized dystonia33 and contrasts with the more rapid 
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Table 4. Adverse events in open-label study. 
Adverse events Type of event N
ITB-related (N=19)  Urinary retention
 Somnolence
 Psychiatric1















Device–related, catheter (N=43)  Post-dural puncture headache
 Dislodgment
 Subcutaneous fluid collection/CSF leak
 Occlusion/kink






Device–related, pump (N=9)  Pump pocket infection
 Pain at pump site
 Migration of pump





Other (N=18) Worsening CRPS symptoms
Psychiatric3
Excessive weight loss
Gastro-intestinal problems (unrelated to 
ITB)








1 psychosis: n=2, depression and anxiety disorders: n=1
2 diplopia, dizziness, anorgasmia
3 confusional state: n=2, reactive depression: n=1, reactive psychosis: n=1
4 anemia, elevated liver enzymes, electrolyte changes  
 
response to DBS of other movement disorders, possibly indicating a typical response 
characteristic of dystonia. A direct antinociceptive effect of baclofen cannot be ruled 
out since pain reduction was only partly explained by a decrease in dystonia severity20. 
The median baclofen dose of 615 µg/d after one year of follow-up was similar to doses 
used in other types of dystonia22,34, but higher than those reported for spasticity (mean 
290 µg/d)35,36, possibly due to differences in the pathophysiology of both disorders. 
We found improvement in arm function (DFL, 35/33%), transfers (DFL, 38%), and 
mobility (DFL 19%, Rivermead Mobility Index 44%) on the disability level. 
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The largest changes in mobility were observed in patients confined to bed. The 
improvements in the impairment and disability levels paralleled those in the quality-of-
life. The efficacy of ITB in CRPS-related dystonia is emphasized by the observation that, 
contrary to the on-treatment group, the off-treatment group failed to change significantly 
in all measures but the GDS. However, the small change in GDS was not paralleled by a 
change in the BFM dystonia rating scale.  
One may postulate that the benefits reported by the patients on ITB reflect placebo 
effects, but we consider this unlikely for the following reasons. Firstly, all patients 
had long-term, progressive dystonia despite numerous interventions, including 
rehabilitation programs and invasive procedures (e.g. spinal cord stimulation). 
Secondly, only a small placebo response (7%) was found in the dose-escalation study, 
which was similar in magnitude to our earlier study19. Thirdly, catheter dysfunction led to 
obvious worsening of dystonia in initial responders when these patients were unaware 
of the immediate cause. This worsening of dystonia also highlights that ITB acts on a 
symptomatic level. 
All patients had met the 25% responder criteria in the dose-escalation study, but only 
70% of the on-treatment patients experienced a ≥ 25% reduction in dystonia, which 
was not anticipated. Malfunctioning of the pump-catheter system or a subtherapeutic 
dose of ITB could not explain this failure to respond. Pump-catheter system integrity 
was verified postoperatively in all patients and again in non-responders when a minimal 
dose of 1000 microgram per day was reached. The cause of the discrepancy between 
both our studies therefore remains uncertain. A possible explanation is the difference in 
ITB flow rates between both studies since the flow rate during the dose-escalation study 
was almost six times higher than the rate in the open-label study. Flow-rate dependent 
effects of intrathecal administration may influence the drug’s distribution along the 
spinal canal 37 and are currently being evaluated in a new study. We encountered a 
high percentage of adverse events during the follow-up period, which were related to 
the surgical procedure, drug delivery system and to baclofen. Particularly, post-dural 
puncture headache (PDPH) occurred more frequently (86%) than commonly reported 
for pump implantation in other disorders (up to 42%,38). A previous study reported high 
frequency of CSF leakage in patients with dystonia22. CSF leakage related to PDPH 
was evident in three of our implanted patients, but we cannot rule out CSF leakage 
at a subclinical level in those patients lacking clear signs of CSF leakage. Migration of 
the pump leading to failure of drug delivery occurred in two patients with a body mass 
index of over 30. ITB likely caused psychosis in two patients and depression in one, 
since lowering the dose resulted in symptoms clearing. The higher number of device-
related adverse events compared to ITB-treated patients with spasticity, can possibly be 
explained by the greater mobility in patients with CRPS-related dystonia.     
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Although the female to male ratio of CRPS is 3-4 in most studies, our patient group 
included a very high percentage (95%) of female patients. This finding is in line with 
other studies in patients with CRPS-related dystonia where the percentage of females 
is much higher (84-86%)14,17,39. To date, no satisfactory explanation has been provided 
for this female predominance.
There is an ongoing controversy over whether dystonia related to peripheral trauma 
with or without CRPS is caused by organic or psychogenic factors. Seventy-four percent 
of patients in our study also participated in a case-control study, in which their 
psychological characteristics were compared with those of patients with affective and 
conversion disorders40. In line with other case-control studies16,39, this study found no 
evidence to support a distinct psychological profile in patients with CRPS-related 
dystonia. 
In conclusion, this placebo-controlled dose-escalation study showed that ITB reduces 
dystonia in CRPS and lends further support to the role of GABAergic mechanisms in 
this cause of dystonia. ITB also improved disability and Qol and remained efficacious 
over a period of one year. However, ITB is associated with a high complication rate and 
therefore methods to improve patient selection and catheter-pump integrity are warranted 
to enhance its therapeutic potential. 
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This thesis describes the results of studies on movement disorders in patients with 
Complex Regional Pain Syndrome (CRPS). First we explored the clinical characteristics 
and disease course of CRPS and movement disorders (MDs), in particular dystonia, in 
patients with multiple affected extremities. Next we evaluated the pathophysiological 
mechanism underlying dystonia of CRPS by neurophysiologic investigations and 
functional brain imaging. Finally we assessed the safety and efficacy of intrathecal 
baclofen treatment for dystonia of CRPS. 
Chapter 1 is the introduction to this thesis. It shortly describes the naming of the 
syndrome and its clinical characteristics which are defined by pain and various 
combinations of sensory disturbances, autonomic features, and sudomotor and trophic 
changes. Furthermore, patients with CRPS may suffer from movement disorders, 
of which dystonia is the most prevalent. Dystonia of CRPS can affect multiple 
extremities, is often resistant to treatment and seems to have a poor prognosis. Reliable 
information on the nature, chronology and clinical determinants of dystonia in CRPS 
patients is lacking but could provide better insight in the underlying pathophysiological 
mechanism. Currently, CRPS is regarded as a multifactorial disease involving complex 
interactions between the immune system and (peripheral and central) nervous system. 
Several current disease concepts underpinning CRPS are discussed. As for CRPS-
related dystonia, few studies report on possible underlying mechanisms and some 
neurophysiological studies have found evidence of impaired inhibition in the spinal 
cord and motor cortex, which is supported by the result of a small study that showed a 
beneficial effect of intrathecal baclofen administration. 
  
In Chapter 2 we studied patterns of spread in CRPS and the patient characteristics 
associated with this phenomenon in patients with CRPS in multiple extremities. One 
hundred-eighty-five CRPS patients were retrospectively evaluated. Eighty-nine patients 
exhibited CRPS in multiple extremities. The pattern of spread was studied in the 72 
patients in whom CRPS started in one extremity and extended to the next, showing 
contralateral spread in 49%, ipsilateral spread in 30% and diagonal spread in 14%. A 
trauma preceded the onset in the second extremity in 37, 44 and 91%, respectively. 
Patterns of spread differed significantly between patients with spontaneous spread 
and patients who showed spread after a separate trauma. Compared to patients with 
CRPS in one extremity, patients with CRPS in multiple extremities were on average 7 
years younger and more often had movement disorders. The hazard of spread of CRPS 
increased with the number of extremities affected. It can be concluded that, in patients 
with CRPS in multiple extremities, spread of symptoms generally follows a contralateral 
or ipsilateral pattern that commonly occurs spontaneously, whereas diagonal spread is 
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rare and generally preceded by trauma. Spread is associated with a younger age at onset 
and the presence of movement disorders. We argue that processes in the spinal cord as 
well as supraspinal changes are responsible for spontaneous spread in CRPS.
Chapter 3 describes findings of a retrospective study in which we evaluated the clinical 
and temporal characteristics of MDs in patients with CRPS. Cox’s proportional hazards 
model was used to evaluate factors influencing the onset of MDs. One-hundred-and 
eighty-five patients suffered CRPS in one or more extremities. MDs occurred in 121 
patients, with dystonia (91%) being the most prevalent. Sixty-two percent of these 
patients displayed dystonia in multiple extremities. Patients with dystonia were on 
average eleven years younger and more often had CRPS in multiple extremities. The 
interval between the onset of CRPS and dystonia in the first affected extremity varied 
from less than one week in 26% of the patients to more than one year in 27%. The 
hazard of developing dystonia in subsequent extremities increased with the number 
of extremities affected by dystonia. From these results we conclude that dystonia in 
CRPS shows highly variable onset latency and is associated with younger age at onset 
and increased risk of developing dystonia in other extremities. The delayed onset and 
progression of dystonia in CRPS may indicate the involvement of a different underlying 
mechanism, possibly associated with maladaptive neuroplasticity. 
The objective of the study in Chapter 4 was to evaluate psychological features in severely 
affected patients with CRPS related dystonia. Personality traits, psychopathology, 
dissociative experiences, the number of traumatic experiences, and quality of life 
were studied in 46 patients. Findings were compared to two historical psychiatric 
control groups (54 patients with conversion disorder (CD) and 50 patients with 
affective disorders (AD)) and to normative population data. The CRPS patients 
showed elevated scores on the measures for somatoform dissociation, traumatic 
experiences, general psychopathology and lower scores on quality of life compared 
to general population data, but had significantly lower total scores on the measures 
for personality traits, recent life events and general psychopathology compared to the 
CD and AD patients. The general level of psychopathology was elevated in the CRPS 
patients in an extent similar to chronic pain patients but this level was significantly 
lower than both psychiatric control groups. Rates of early traumatic experiences were 
comparable to the CD and AD patients, and the level of somatoform dissociation was 
comparable to the CD patients but was elevated in comparison to the AD patients. 
Early traumatic experiences were reported in 87% of the CRPS patients and were 
found to be moderately related to somatoform dissociative experiences, indicating that 
early traumatic experiences might be a predisposing, though not necessary factor for 
Chapter 9
142
the development of CRPS related dystonia. Although the psychological profile of the 
patients with CRPS related dystonia shows some elevations, there does not seem to be 
a unique disturbed psychological profile on a group level.  
In Chapter 5 we evaluated the occurrence and characteristics of hyperacusis in patients 
with CRPS related dystonia. More severely affected patients may experience hyperacusis, 
which may reflect central involvement. The presence of hyperacusis, speech reception 
thresholds (SRT), pure-tone thresholds (PTT) and uncomfortable loudness (UCL) 
were evaluated in 40 patients with CRPS-related dystonia. PTT and SRT were normal 
for all patients. Fifteen patients (38%) reported hyperacusis and this was associated 
with allodynia/hyperalgesia and with the presence of more affected extremities. 
UCLs of patients with hyperacusis were significantly lower than UCLs of patients 
without hyperacusis. These results show that hyperacusis is common among severely 
affected patients with CRPS related dystonia and may reflect the spreading of central 
sensitization to auditory circuitry. 
Chapter 6 involves a study on somatosensory processing in dystonia in CRPS 
patients. We studied somatosensory evoked potentials (SSEPs) in 33 patients with 
CRPS and dystonia and 19 healthy controls. N9, N14, N20 and N35 amplitudes 
were recorded after paired stimulation of median and ulnar nerves (‘spatial’) and after 
stimulation of both nerves with single stimuli and with interstimulus intervals of 20 
and 40 ms (‘temporal’ stimulation). Finally, both methods were integrated resulting 
in spatiotemporal stimulation. Statistical testing was performed using linear mixed 
model analysis of variance. SSEP amplitudes were significantly suppressed after spatial 
and temporal stimulation. No difference was observed between patients and healthy 
controls. Spatiotemporal stimulation did not show an additional suppressive effect in 
any group. In conclusion our and previous findings may suggest that proprioceptive 
sensory processing in CRPS is unimpaired and that inhibition at a cortical level is 
restricted to the motor cortex.  In view of the concept of dystonia as a circuit disorder, 
the finding of motor cortex disinhibition raises an interesting chicken and egg issue, 
which at this stage cannot be solved. However, in view of the peripheral initiation of 
the disorder, we favour a spinal origin of dystonia in CRPS with secondary changes at 
supraspinal sites of the circuit. 
Chapter 7 describes the findings of functional magnetic resonance imaging (fMRI) 
study. The aim of this study was to determine cerebral network function in CRPS 
patients with dystonic postures. Cerebral processing related to both execution and 
imagining of hand movements in patients and controls was assessed with fMRI. Eight 
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CRPS patients with dystonic postures of the right upper extremity and 17 age-matched 
healthy controls were studied. Compared with controls, imaginary movement of the 
affected hand in patients showed reduced activation ipsilaterally in the premotor and 
adjacent prefrontal cortex, and in a cluster comprising frontal operculum, the anterior 
part of the insular cortex and the superior temporal gyrus. Contralaterally, reduced 
activation was seen in the inferior parietal and adjacent primary sensory cortex. There 
were no differences between patients and controls when they executed movements, nor 
when they imagined moving their unaffected hand. In conclusion, patients with CRPS 
and dystonia displayed areas with decreased activation during imagining tasks that are 
involved in planning of movement, multimodal sensorimotor integration, autonomic 
function and pain. Pain may profoundly alter the cerebral organization of movement 
by functional interaction between these regions.
Chapter 8 describes a study on the efficacy and safety of intrathecal baclofen (ITB) 
in CRPS related dystonia.  A single-blind, placebo-run-in, dose-escalation study was 
carried out in 42 CRPS-patients to evaluate whether dystonia responds to ITB. Thirty-
six of the 38 patients who met the responder criteria received a pump for continuous 
ITB administration and were followed for 12 months to assess long-term efficacy and 
safety (open-label study). Primary outcome measures were global dystonia severity 
(both studies) and dystonia-related functional limitations (open-label study). The 
dose-escalation study showed a dose-effect of baclofen on dystonia severity in 31 
patients in doses up to 450 µg/day. One patient did not respond to treatment in the 
dose-escalation study and three patients dropped out. Thirty-six patients entered the 
open-label study. Intention-to-treat analysis revealed a substantial improvement in 
patient and assessor-rated dystonia scores, pain, disability and quality of life (Qol) at 
12 months. The response in the dose-escalation study did not predict the response to 
ITB in the open-label study. Eighty-nine adverse events occurred in 26 patients and 
were related to baclofen (n=19), pump/catheter system defects (n=52), or could 
not be specified (n=18). The pump was explanted in 6 patients during the follow-
up phase. Dystonia, pain, disability and Qol all improved on ITB and the treatment 
remained efficacious over a period of one year. However, ITB is associated with a high 
complication rate in this patient group and methods to improve patient selection and 




In the last two decades knowledge on movement disorders of CRPS is slowly increasing. 
The awareness that CRPS patients may suffer MDs has resulted in a proposal of an 
expert consensus panel to add this clinical category to the new criteria set1. A better 
delineation of clinical, pathophysiological and therapeutic aspects of MDs in CRPS may 
potentially contribute to better management strategies for this disabling component of 
the syndrome and these three topics will be discussed in the following sections.
Clinical characteristics
The first aim of this study was to improve our knowledge on clinical characteristics 
and the disease course of multiple CRPS and MDs of CRPS. We studied a group of 
patients with a severe phenotype with disabling features. We realize that this subgroup 
of patients does not represent the “average” CRPS patient, but the large number 
of these patients seen at our department over the last years, underscores that this 
development is not rare. Patients with a more severe CRPS phenotype with dystonia 
and/or multiple affected extremities were significantly younger at the onset of CRPS 
symptoms compared to patients with a milder phenotype. This finding may suggest 
a genetic susceptibility, as has been shown for other diseases2. CRPS may occur in a 
familial form and these patients develop the disease at younger age and have a more 
severe phenotype than sporadic cases3, which also suggests an increased susceptibility 
to develop the disease4,5. Another hint for a genetic component came from a study that 
found an increased for siblings of CRPS patients with an age at onset younger than 506. 
Finally, a genetic predisposition is apparent from genetic associations that were found 
with different human leukocyte antigen (HLA) factors7-10.  
Fifty-six percent of the patients in our study developed dystonia more than one month 
after onset of CRPS, 27% beyond a year and three patients developed dystonia even 
more than 5 years following CRPS. The clinical characteristics of patients with onset of 
dystonia before or after one year were similar, likely suggesting a common mechanism 
of dystonia in these patients. The delayed onset of dystonia encountered in many CRPS 
patients may suggest that mechanisms underlying the acute phase of CRPS and dystonia 
differ. In line with another study, we found that if dystonia developed in a later stage than 
the non-motor symptoms of CRPS, the occurrence of a new trauma before the onset 
of dystonia was rare11. Whether dystonia that is related to peripheral trauma is caused 
by organic or psychogenic factors is an ongoing controversy. However, in accordance 
with other studies in CRPS patients12-14 and in chronic CRPS patients with dystonia,15 
our study does not support the presence of a unique disturbed psychological profile. 
Compared with the general Dutch population, the general level of psychopathology 
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was elevated in the CRPS patients in an extent similar to chronic pain patients,16 but 
this level was significantly lower than in psychiatric control groups of patients with 
affective disorders and conversion disorders. Early traumatic experiences are more 
prevalent in patients with CRPS-I-related dystonia as compared to students and the 
general population and may be a possible, although not necessary predisposing factor 
for CRPS-I-related dystonia. As expected, the study group reported poorer general 
health and quality of life as compared to the general population.
It should be stressed that, in analogy to the care of other chronic pain patients, effective 
management of CRPS requires that psychosocial and behavioral aspects are addressed 
as part of an integrated multidisciplinary treatment approach17. Comorbid psychiatric 
disorders or major ongoing life stressors should be identified and treated to improve 
successful treatment. 
Pathophysiology
The results of our studies on clinical and neurophysiologic aspects of patients with 
multiple CRPS and MDs in CRPS provided data that suggest disturbances at multiple 
levels of the CNS.
Convincing evidence points to the initiating role of the immune system and peripheral 
nervous system in CRPS, both contributing to aberrant inflammation18,19. However, 
the occurrence of spread of symptoms and the occurrence of MDs cannot exclusively be 
explained by peripheral disturbances. The results of the research presented in this thesis 
provide arguments for changes at both spinal and supraspinal level.
Arguments for alterations on spinal level:
•	 Spontaneous spread of CRPS symptoms occurs most frequently according to 
a contralateral pattern which can be explained by spinal processing of incoming 
sensory information20,21 and may occur through commissural spinal interneurons 
and likely also involves spinal glia cells and pro-inflammatory cytokines22,23.
•	 In many CRPS patients, we encountered a delayed onset of dystonia. Once 
dystonia is present, the hazard of dystonia in subsequent extremities increased 
with the number of extremities already affected by dystonia. Likewise, the presence 
of CRPS in multiple extremities increases the hazard of spread of symptoms to 
subsequent extremities without the requirement of a new trauma. Both the 
delayed onset and an accellerated disease course are characteristics of maladaptive 
neuronal plasticity and have been documented for clinical manifestations of other 
diseases24-27.  In this respect, maladaptive plasticity at a spinal level may manifest as 
disinhibition of spinally nociceptive withdrawal reflexes (NWRs, see hereafter). 
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However, the findings may also be explained by supraspinal alterations. 
•	 Our placebo-controlled dose-escalation study showed that ITB reduces dystonia in 
CRPS and lends further support to the role of spinal GABAergic mechanisms; C 
and Aδ sensory fibres play a role in neurogenic inflammation and are connected 
with spinal circuits that mediate nociceptive withdrawal reflexes (NWRs). One 
of the primary mediators of neurogenic inflammation, Substance P (SP), may also 
activate SP receptors on lamina I neurons in the dorsal horn of the spinal cord, 
and induce long-term potentiation (LTP), a form of neuronal plasticity. Animal 
models of neurogenic inflammation have shown that SP enhances NWRs.28 
Flexor muscles play a prominent role in NWRs and, interestingly, there also 
is a conspicuous involvement of flexor postures in CRPS-related dystonia.29,30 
Neurophysiologic studies have shown a decreased presynaptic GABA-ergic 
inhibition in CRPS patients with dystonia.31 Both SP sensitized NWRs in animal 
models and dystonia in CRPS patients respond to the intrathecal administration 
of GABAB agonist baclofen, which enhances spinal GABA-ergic inhibition.
32 In 
view of the sequence of events in CRPS, these findings may suggest disinhibition 
of spinal mediated NWRs as a primary causal mechanism of dystonia in CRPS, 
reflecting maladaptive plasticity.
Arguments for alterations on supraspinal level: 
•	 Hyperacusis is common among severely affected patients with CRPS related 
dystonia and may reflect the spreading of central sensitization to auditory circuitry 
in the thalamus.
•	 Functional brain imaging with fMRI of patients with CRPS and dystonia displayed 
cortical areas with decreased activation during imagining tasks that are involved in 
planning of movement, multimodal sensorimotor integration, autonomic function 
and pain. 
•	 Some researchers provided arguments for disinhibition at the level of the motor 
cortex in CRPS patients33,34. The findings of the SSEP study indicate that cortical 
sensory processing of proprioceptive input is normal in patients with CPRS and 
dystonia. If cortical inhibition plays a role it is probably restricted to the motor 
cortex. 
Taken together, the results of our studies on movement disorders and spread in CRPS 
provide evidence for changes in the CNS at both the spinal and supraspinal level. 
Maladaptive neural plasticity likely is an important mechanism underpinning the MDs 
that may occur in CRPS. Neural plasticity is a property of the CNS that is characterized 
by remodelling of neuronal contacts and circuits in the CNS in an attempt to adapt to 
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the altered condition35. Neural plasticity can be beneficial and is necessary for normal 
development of the CNS and learning. On the other hand abnormal plasticity may 
cause disorders like neuropathic pain, tinnitus, and levodopa induced dyskinesias25,27,35. 
In neuropathic pain, maladaptive plasticity may manifest as ectopic generation of action 
potentials, facilitation and disinhibition of synaptic transmission, loss of synaptic 
connectivity, formation of new synaptic circuits, and altered neuroimmune interactions. 
Genetic polymorphisms, gender, and age all influence the risk of developing chronic 
pain36. For both chronic pain and dystonia in CRPS, it can be postulated that peripheral 
neurogenic inflammation may induce maladaptive neural plasticity in the spinal cord 
(e.g. central sensitisation) which subsequently may spread to more rostral (that is 
supraspinal) structures. Referred sensations, changes in the size and organization of the 
somatosensory map, and changes in motor cortex representation are strongly suggestive 
of cortical involvement in CRPS37. A recent fMRI study on pediatric CRPS patients 
reports on Blood-Oxygen-Level-Dependent (BOLD) responses during fulminating 
CRPS and again following their clinical recovery38. The authors found significant 
changes in CNS circuitry that persisted despite resolution of pain. Hence, which 
level of the CNS is the primary site where pathological alterations originate, remains 
unsolved. 
The presence of disturbances at multiple levels of the central nervous system in dystonia 
of CRPS parallels recent hypotheses on the underlying mechanisms suggested for other 
types of dystonia39-42. For focal dystonia several researchers have provided evidence for 
abnormal cortical plasticity in susceptible individuals43.
Therapy
Our study on intrathecal baclofen administration in patients with CRPS and dystonia 
showed marked improvement of dystonia and pain scores after one year. Improvements 
in the impairment and disability levels paralleled those of quality-of-life. The 
worsening of dystonia after catheter or pump dysfunction highlights that ITB acts on 
a symptomatic level. Complications of ITB can be severe and include infections, drain 
dysfunctions and psychiatric symptoms that can result in explantation of the pump-
catheter system. Therefore, the therapy should be limited to patients who are resistant 
to conventional therapies and should be conducted by physicians with considerable 
experience in implantation and care of intrathecal devices. However, patient selection 
remains difficult as we were unable to identify variables that predicted a poor response 




Prospective longitudinal epidemiological studies are needed to describe the natural 
course of CRPS and identify risk factors that can predict which patients will display 
spread to other extremities or develop MDs. Genetic studies will possibly further 
unravel which individuals are predisposed to CRPS and MDs in particular. One of 
the other challenges for future research is to solve the chicken and egg issue on the 
sequence of pathophysiological mechanisms at different levels of the nervous system; 
the order and dynamics of the alterations at the peripheral, spinal and supraspinal 
level requires further elucidation. In this respect, longitudinal neurophysiologic and 
CSF biomarker studies may contribute to the development of tailored diagnostic and 
treatment strategies, which may prevent the spread of symptoms to other extremities 
and the occurrence of MDs. In the meantime, intrathecal baclofen administration is a 
promising treatment for MDs in CRPS, although it should be applied very selectively 
in view of the requirement of surgery and high complication rate. Additionally, the 
efficacy of ITB may be improved, for example by studying the effect of different 
infusion rates, the refinement of catheters and pump devices and a better identification 
of patients that will likely show a good response to therapy. Because of the nature of 
CRPS, however, non-invasive treatment strategies aiming to modulate aberrant neural 
plasticity are preferred. Both for focal forms of dystonia and CRPS, sensorimotor 
training programmes that target maladaptive cortical changes, for example mirror 
therapy and transcranial magnetic stimulation, have reported beneficial effects44,45. 
Peripheral trauma induced movement disorders (PTMDs) may present another focus 
of future research. Of all reported cases of PTMDs in literature fifty percent have 
CRPS (own data, submitted). PTMDs have been a controversial topic in the field 
of movement disorders for a long time. A relation between peripheral trauma and 
MDs has gained acceptance over time and a set diagnostic criteria were proposed by 
Cardoso and Jankovic in 1995. However, so far the apparent lack of consensus on the 
pathogenesis of PTMDs has remained unresolved. Some authors suggest that PTMDs 
are the result of maladaptive plasticity of the central nervous system46,47 but this is not 
supported by everyone48.  Studies on the role of peripheral trauma in CRPS induced 
MDs may contribute to a better understanding of involved mechanisms of disease. 
Collectively, future studies on the mechanisms underpinning neural plasticity and 
studies on modulation of aberrant neural plasticity may lead to better management 
strategies of dystonia in CRPS and thus contribute to a better quality of life and 
prognosis of these patients.
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Dit proefschrift beschrijft de resultaten van aan aantal studies naar bewegingsstoornissen 
bij patiënten met Complex Regionaal Pijn Syndroom (CRPS). Ten eerste onderzochten 
we de klinische karakteristieken en het ziektebeloop van bewegingsstoornissen bij 
CRPS (in het bijzonder dystonie) bij patiënten met meerdere aangedane extremiteiten. 
Vervolgens bestudeerden we de pathofysiologie van de aandoening door middel van 
neurofysiologisch onderzoek en functionele beeldvorming van de hersenen. Tenslotte 
evalueerden we de veiligheid en effectiviteit van behandeling met intrathecaal baclofen 
bij CRPS-gerelateerde dystonie.
Hoofdstuk 1 is de introductie van dit proefschrift. Hierin worden kort de naamgeving 
van het syndroom en de symptomatologie beschreven. De symptomen bestaan uit 
pijn en verschillende combinaties van sensibele stoornissen, autonome kenmerken 
en sudomotore en trofische veranderingen. Daarnaast kunnen patiënten met CRPS 
bewegingsstoornissen ontwikkelen waarbij dystonie het meeste voorkomt. CRPS-
gerelateerde dystonie kan zich voordoen in meerdere extremiteiten, is vaak moeilijk 
te behandelen en lijkt een slechte prognose te hebben. Er is gebrek aan betrouwbare 
informatie over de aard, het beloop en de klinische karakteristieken van dystonie 
bij CRPS patiënten. Deze informatie zou een beter inzicht kunnen verschaffen in 
onderliggende pathofysiologische mechanismen. Momenteel wordt CRPS gezien als 
een multifactoriële aandoening waarbij complexe interacties tussen het immuunsysteem 
en het (perifere en centrale) zenuwstelsel een rol spelen. Meerdere ziekteconcepten 
worden in dit hoofdstuk besproken. Er zijn slechts een paar studies gepubliceerd die 
de mogelijke mechanismen die aan CRPS-gerelateerde dystonie ten grondslag liggen 
als onderwerp hebben. Uit neurofysiologisch onderzoek zijn er aanwijzingen voor een 
gebrek aan inhibitie in het ruggenmerg en de motore cortex, wat verder ondersteund 
wordt door de resultaten van een kleine studie die een gunstig effect liet zien van een 
behandeling met intrathecaal baclofen, een middel dat inhibitie bevordert.
In hoofdstuk 2 werden spreidingspatronen en de hiermee samenhangende 
klinische karakteristieken bestudeerd bij patiënten met CRPS in meerdere 
extremiteiten. Honderdvijfentachtig CRPS patiënten werden retrospectief 
geëvalueerd. Negenentachtig patiënten vertoonden CRPS in meerdere extremiteiten. 
Spreidingspatronen werden bestudeerd bij 72 patiënten bij wie CRPS begon in één 
extremiteit en uitbreidde naar een volgende. Hierbij werd contralaterale spreiding 
gevonden in 49%, ipsilaterale spreiding in 30% en diagonale spreiding in 14% van de 
patiënten. Er was sprake van een voorafgaand trauma bij respectievelijk 37, 44 en 91%. 
Spreidingspatronen verschilden significant tussen patiënten met spontane spreiding en 
patiënten met spreiding na een voorafgaand trauma. In vergelijking met patiënten met 
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één aangedane extremiteit, waren patiënten met meerdere aangedane extremiteiten 
gemiddeld zeven jaar jonger en hadden tevens vaker bewegingsstoornissen. De ‘hazard’ 
op spreiding van CRPS nam toe met het aantal aangedane extremiteiten. Concluderend 
kan gesteld worden dat bij patiënten met CRPS in meerdere extremiteiten, spreiding 
van symptomen veelal spontaan verloopt volgens een contralateraal of ipsilateraal 
patroon, en dat diagonale spreiding zeldzaam is en meestal vooraf wordt gegaan door 
een trauma. Spreiding van symptomen hangt samen met een jongere leeftijd bij ontstaan 
van CRPS en met de aanwezigheid van bewegingsstoornissen. Zowel processen in 
het ruggenmerg als supraspinale veranderingen zijn mogelijk verantwoordelijk voor 
spontane spreiding van CRPS.
Hoofdstuk 3 beschrijft de resultaten van een retrospectieve studie waarbij we 
de klinische en temporele karakteristieken van bewegingsstoornissen bij CRPS 
onderzochten. Een Cox proportional hazards model werd gebruikt om factoren die het 
ontstaan van bewegingsstoornissen beïnvloedden te evalueren. Honderdvijfentachtig 
patiënten hadden CRPS in één of meerdere extremiteiten. Honderdéénentwintig van 
deze patiënten hadden bewegingsstoornissen waarbij dystonie het meeste voorkwam 
(91%). Tweeënzestig procent van deze patiënten vertoonde dystonie in meerdere 
extremiteiten. Patiënten met dystonie waren gemiddeld elf jaar jonger dan patiënten 
zonder dystonie en hadden ook vaker CRPS in meerdere extremiteiten. Het interval 
tussen het ontstaan van CRPS en dystonie in de eerste aangedane extremiteit varieerde 
van minder dan een week in 26% van de patiënten tot meer dan één jaar in 27%. De 
hazard op het ontwikkelen van dystonie in andere extremiteiten nam toe met het 
aantal extremiteiten dat al dystonie had ontwikkeld. Uit deze resultaten kan worden 
geconcludeerd dat dystonie bij CRPS een zeer variabele latentietijd kent, geassocieerd 
is met een jongere leeftijd bij ontstaan van CRPS en tevens een verhoogd risico geeft 
op het ontwikkelen van dystonie in andere extremiteiten. Het bestaan van een interval 
tussen ontstaan van de eerste CRPS symptomen en het ontstaan van dystonie en het 
progressieve beloop kan wijzen op de betrokkenheid van een ander onderliggend 
mechanisme welke mogelijk geassocieerd is met maladaptieve neuroplasticiteit.
Het doel van de studie beschreven in hoofdstuk 4 was het evalueren van psychologische 
kenmerken bij ernstig aangedane patiënten met CRPS-gerelateerde dystonie. Bij 
46 patiënten werden persoonlijkheidskenmerken, psychopathologie, dissociatieve 
ervaringen, het aantal traumatische ervaringen en kwaliteit van leven bestudeerd. De 
bevindingen bij deze groep werden vergeleken met twee historische controlegroepen 
(54 patiënten met een conversiestoornis en 50 patiënten met een affectieve stoornis) en 
met normatieve populatie data. Bij CRPS patiënten was er sprake van verhoogde scores 
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op de metingen voor somatoforme dissociatie, traumatische ervaringen, algemene 
psychopathologie, en lagere scores voor kwaliteit van leven vergeleken met data 
voor de algemene populatie. In vergelijking met patiënten met een conversiestoornis 
of een affectieve stoornis lieten CRPS patiënten significant lagere scores zien op de 
metingen voor persoonlijkheidskenmerken, recente levensgebeurtenissen en algemene 
psychopathologie. Het algemene niveau van psychopathologie bij CRPS patiënten 
was evenveel verhoogd als dat van patiënten met chronische pijn, maar het niveau 
was significant lager dan dat van beide psychiatrische controlegroepen. Het aantal 
vroege traumatische ervaringen was vergelijkbaar met dat van conversiepatiënten 
maar verhoogd in vergelijking met patiënten met een affectieve stoornis. Vroege 
traumatische ervaringen werden gerapporteerd bij 87% van de CRPS patiënten en 
lieten een matige correlatie met somatoforme dissociatieve ervaringen zien. Dit zou 
erop kunnen wijzen op dat vroege traumatische ervaringen een predisponerende, maar 
niet noodzakelijke factor zijn voor het ontwikkelen van CRPS-gerelateerde dystonie. 
Hoewel het psychologisch profiel van patiënten met CRPS-gerelateerde dystonie enkele 
afwijkingen laat zien, is een uniek afwijkend psychologisch profiel op groepsniveau niet 
aantoonbaar. 
In hoofdstuk 5 werden het voorkomen en de karakteristieken van hyperacusis bij 
patiënten met CRPS-gerelateerde dystonie onderzocht. Ernstig aangedane patiënten 
zouden mogelijk vaker hyperacusis hebben, hetgeen centrale betrokkenheid kan 
suggereren. Het voorkomen van hyperacusis en het niveau van spraakwaarneemdrempels 
(SRT), pure toon drempels (PTT) en onaangename luidheid (UCL) werden 
geëvalueerd bij 40 patiënten met CRPS-gerelateerde dystonie. PTT en SRT waren 
bij alle patiënten normaal. Vijftien patiënten (38%) rapporteerden hyperacusis en dit 
was geassocieerd met allodynie/hyperalgesie en met de aanwezigheid van meerdere 
aangedane extremiteiten. UCLs van patiënten met hyperacusis waren significant lager 
dan UCLs van patiënten zonder hyperacusis. De resultaten laten zien dat hyperacusis 
frequent voorkomt bij ernstig aandane patiënten met CRPS-gerelateerde dystonie, wat 
kan wijzen op de uitbreiding van centrale sensitisatie naar auditieve circuits. 
In hoofdstuk 6 wordt een studie naar somatosensore verwerking van perifeer 
toegediende stimuli bij CRPS patiënten met dystonie beschreven. Bij 33 patiënten met 
CRPS en dystonie en 19 gezonde controles werden “somatosensory evoked potentials” 
(SSEPs) bestudeerd. N9, N14, N20 en N35 amplitudes werden geregistreerd na 
gepaarde stimulatie van de n. medianus en n. ulnaris (“spatiëel”), en na stimulatie van 
beide zenuwen met enkelvoudige stimuli en inter-stimulus intervallen van 20 en 40 ms 
(“temporele” stimulatie). Tenslotte werden beide methoden geïntegreerd, wat resulteerde 
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in “spatiotemporele” stimulatie. De statistische analyse werd uitgevoerd met behulp van 
een “linear mixed model” variantie analyse. SSEP amplitudes waren significant lager 
na spatiële en temporele stimulatie. Er was geen verschil tussen patiënten en gezonde 
controles. Bij spatiotemporele stimulatie werd in beide groepen geen additioneel 
onderdrukkend effect gezien. Concluderend kunnen deze bevindingen erop wijzen dat 
proprioceptieve sensore verwerking bij CRPS-gerelateerde dystonie ongestoord is en 
dat inhibitie mogelijk beperkt is tot de motore cortex. Met het oog op het concept van 
dystonie als een stoornis van neurale circuits, is het de vraag of een bevinding als motore 
disinhibitie moet worden gezien als de “”kip” of het “ei”. Gezien de perifere initiatie van 
de aandoening lijkt een spinale origine van CRPS-gerelateerde dystonie met secundaire 
veranderingen op het supraspinale niveaus het meest waarschijnlijk. 
Hoofdstuk 7 beschrijft de bevindingen van ‘functionele magnetic resonance imaging’ 
(fMRI). Het doel van deze studie was het bepalen van de cerebrale-netwerk-functie bij 
CRPS patiënten met dystonie. Bij patiënten en controles werd de cerebrale verwerking 
van zowel het uitvoeren als visualiseren van handbewegingen met fMRI gemeten. Acht 
CRPS patiënten met dystonie van de rechter bovenste extremiteit en 17 gezonde, op 
leeftijd gematchte controles werden onderzocht. Vergeleken met controles werd bij 
patiënten bij het visualiseren van bewegingen van de aangedane hand aan de ipsilaterale 
zijde verminderde activatie gezien in de premotore en de aangrenzende prefrontale 
cortex, als ook in een cluster bestaande uit het frontale operculum, het anterieure deel van 
de insula en de gyrus temporalis superior. Aan de contralaterale zijde werd verminderde 
activatie gezien in de inferiore pariëtale en aangrenzende primaire sensore cortex. Bij 
het uitvoeren noch het visualiseren van bewegingen van de niet-aangedane hand was er 
verschil tussen patiënten en controles. Er kan geconcludeerd worden dat patiënten met 
CRPS-gerelateerde dystonie bij visualisatietaken verminderde activatie laten zien in 
gebieden die betrokken zijn bij het plannen van beweging, multimodale sensomotore 
integratie, autonome functie en pijn. Mogelijk resulteert pijn in veranderingen in de 
cerebrale organisatie van beweging door functionele interactie tussen deze gebieden. 
In hoofdstuk 8 wordt een studie naar de effectiviteit en veiligheid van behandeling met 
intrathecaal baclofen (ITB) bij CRPS-gerelateerde dystonie beschreven. Om de respons 
van dystonie op ITB te onderzoeken werd een enkelblinde, placebo-run-in, dosis-
escalatie studie uitgevoerd bij 42 CRPS patiënten. Zesendertig van de 38 patiënten 
die aan de responscriteria voldeden, kregen een pomp voor continue toediening van 
ITB en zij werden gedurende 12 maanden gevolgd om de langetermijneffectiviteit en 
-veiligheid vast te stellen (open-label studie). Primaire uitkomstmaten waren de globale 
dystoniescore (beide studies) en de score voor dystonie-gerelateerde functionele 
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beperkingen (open-label studie). Bij doseringen tot 450 µg per dag liet de dosis-
escalatie studie bij 31 patiënten een dosis-effect van baclofen op de dystoniescore zien. 
Eén patiënt reageerde niet op behandeling in de dosis-escalatie studie en drie patiënten 
vielen uit. Zesendertig patiënten stroomden door naar de open-label studie. Intention-
to-treat analyse van de data van 12 maanden liet een substantiële verbetering zien van 
dystoniescore, pijn, beperkingen en kwaliteit van leven. De respons in de dosis-escalatie 
studie bleek de respons op ITB in de open-label studie niet te kunnen voorspellen. 
Bij 26 patiënten traden in totaal negenentachtig bijwerkingen op die gerelateerd 
waren aan baclofen (n=19) of aan defecten van het pomp/kathetersysteem (n=52). 
De overige bijwerkingen (n=18) konden niet worden duidelijk worden toegewezen. 
Bij zes patiënten werd de pomp in de follow-up fase geëxplanteerd. Samenvattend 
kan men stellen dat ITB behandeling resulteert in verbetering van dystonie, pijn, 
beperkingen en kwaliteit van leven en dat deze interventie effectief blijft gedurende 
een follow-upperiode van één jaar. Behandeling met ITB gaat echter gepaard met veel 
complicaties en het is belangrijk om de patiëntenselectie en de functie van het pomp/
kathetersysteem te verbeteren. 
Conclusies
In de laatste twee decennia is de kennis over bewegingsstoornissen bij CRPS langzaamaan 
toegenomen. De realisatie dat CRPS patiënten ook bewegingsstoornissen kunnen 
ontwikkelen heeft geresulteerd in een voorstel van een ‘expert consensus panel’ om deze 
klinische categorie aan de nieuwe criteria set toe te voegen1. Een goede beschrijving van 
klinische, pathofysiologische en therapeutische aspecten van bewegingsstoornissen bij 
CRPS kan mogelijk bijdragen aan betere behandelstrategieën voor deze invaliderende 
symptomen van het syndroom, en deze drie onderwerpen zullen worden bediscussieerd 
in het nu volgende deel van het proefschrift. 
Klinische karakteristieken
Het eerste doel van deze studie was het uitbreiden van onze kennis over de klinische 
karakteristieken en het ziektebeloop van aan CRPS gerelateerde bewegingsstoornissen 
en van die welke samengaan met het voorkomen van deze aandoening in meerdere 
extremiteiten. Wij onderzochten dus patiënten met een ernstig fenotype met 
invaliderende kenmerken. We realiseren ons dat deze subgroep van patiënten niet de 
“gemiddelde” CRPS patiënt representeert, maar het grote aantal van deze patiënten 
die in de loop der jaren op onze afdeling zijn gezien toont aan dat een dergelijk 
fenotype niet zeldzaam is. Patiënten met een ernstig CRPS fenotype met dystonie 
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en/of meerdere aangedane extremiteiten waren significant jonger bij het ontstaan van 
de CRPS symptomen in vergelijking met patiënten met een milder fenotype. Deze 
bevinding suggereert een genetische susceptibiliteit zoals ook bij andere aandoeningen 
is aangetoond2. CRPS blijkt daarnaast voor te kunnen komen in families en zulke 
patiënten ontwikkelen de ziekte op een jongere leeftijd en hebben een ernstiger fenotype 
dan sporadische gevallen3, wat tevens kan wijzen op een verhoogde vatbaarheid om de 
ziekte te krijgen4,5. Een andere studie liet een verhoogd risico zien voor broers en zussen 
van CRPS patiënten die de ziekte voor het vijftigste jaar ontwikkelden, en ook dit wijst 
op een mogelijke genetische component6. Tenslotte is een genetische predispositie 
waarschijnlijk gezien de associaties die werden gevonden met verschillende “human 
leukocyte antigen” (HLA) factoren7-10. 
Zesenvijftig procent van de patiënten in onze studie ontwikkelden dystonie meer 
dan een maand na het begin van CRPS, terwijl 27% dit na één jaar en drie patiënten 
dit zelfs na meer dan vijf jaar na het begin van de ziekte ontwikkelden. De klinische 
kenmerken van patiënten die binnen een jaar na het begin van CRPS dystonie 
ontwikkelden verschilden niet van die welke dit na meer dan een jaar ontwikkelden 
en dit suggereert een gemeenschappelijk achterliggend mechanisme bij deze patiënten. 
Het latere ontstaan van dystonie dat bij veel patiënten werd gezien, suggereert dat 
onderliggende mechanismen van de acute fase van CRPS verschillen van die van 
dystonie. In overeenstemming met een andere studie vonden we dat als dystonie 
later ontstaat dan de niet-motorische symptomen van CRPS, het optreden van een 
nieuw trauma voorafgaand aan het ontstaan van dystonie zeldzaam is11. De vraag of 
dystone symptomen die aan een perifeer trauma gerelateerd zijn een organische of 
psychogene oorzaak hebben is een voortdurend onderwerp van discussie. Echter, 
in overeenstemming met andere studies bij CRPS patiënten12-14 en bij chronische 
CRPS patiënten met dystonie,15 liet onze studie geen aanwijzingen zien voor de 
aanwezigheid van een  uniek afwijkend psychologisch profiel. Ten opzichte van de 
algemene Nederlandse populatie liet het algemene niveau van psychopathologie bij 
CRPS patiënten een verhoging zien die vergelijkbaar is met die van patiënten met 
chronische pijn;16 dit niveau was echter significant lager dan die van psychiatrische 
controlegroepen van  patiënten met affectieve stoornissen of conversiestoornissen. 
Vroege traumatische ervaringen komen bij patiënten met CRPS-gerelateerde dystonie 
vaker voor dan bij studenten en de algemene populatie, en kunnen een mogelijke, hoewel 
niet noodzakelijke predisponerende factor voor CRPS-gerelateerde dystonie vormen. 
Zoals verwacht, rapporteerde de patiëntengroep een slechtere algemene gezondheid en 
lagere kwaliteit van leven dan de algemene populatie. 
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Het is belangrijk te benadrukken dat om een effectieve behandeling van CRPS te 
bewerkstelligen er aandacht dient te zijn voor psychosociale en gedragsmatige aspecten 
als onderdeel van de geïntegreerde multidisciplinaire benadering,17 net zoals dat geldt 
voor andere groepen patiënten met chronische pijn, Co-existente psychiatrische 
stoornissen en belangrijke voortdurende stressoren moeten worden geïdentificeerd en 
behandeld om het succes van therapie te verbeteren. 
Pathofysiologie
De resultaten van onze studies naar klinische en neurofysiologische aspecten van 
patiënten met CRPS in meerdere extremiteiten en patiënten met bewegingsstoornissen 
bij CRPS laten aanwijzingen zien voor afwijkingen op meerdere niveaus van het 
centrale zenuwstelsel (CZS).
Er bestaat overtuigend bewijs voor een initiërende rol van het immuunsysteem en het 
perifere zenuwstelsel bij CRPS, waarbij er sprake is van abnormale inflammatie18,19. Het 
uitbreiden van symptomen en het optreden van bewegingsstoornissen kan echter niet 
alleen worden verklaard door stoornissen op een perifeer niveau. De resultaten van de 
onderzoeken in dit proefschrift geven argumenten voor veranderingen op zowel spinaal 
als supraspinaal niveau.  
Argumenten voor veranderingen op spinaal niveau:
•	 Spontane uitbreiding van CRPS-symptomen treedt vaak op volgens een 
contralateraal patroon, wat verklaard kan worden door afwijkende spinale 
verwerking van binnenkomende sensore informatie20,21. Hierbij zouden 
commissurale spinale interneuronen een rol kunnen spelen, en mogelijk zijn hierbij 
ook spinale gliacellen en pro-inflammatoire cytokinen betrokken22,23.
•	 Veel CRPS patiënten ontwikkelden de dystonie later dan de andere symptomen. 
Zodra dystonie eenmaal aanwezig was, nam de hazard op dystonie in andere 
extremiteiten toe met het aantal extremiteiten dat reeds door dystonie was 
aangedaan. Op vergelijkbare wijze nam met de aanwezigheid van CRPS in 
meerdere extremiteiten de hazard op spreiding van symptomen naar volgende 
extremiteiten toe, zonder dat hiervoor een nieuwe trauma voor nodig was. Zowel 
het latere begin van dystonie als de versnelling van het ziektebeloop zijn kenmerken 
van maladaptieve neuronale plasticiteit en dit is ook een bekend fenomeen bij 
klinische manifestaties van enkele andere ziekten24-27. Dit overwegende, zou 
maladaptieve plasticiteit op spinaal niveau zich kunnen uiten in disinhibitie van 
spinale nociceptieve terugtrekreflexen (zie hierna). De bevindingen zouden echter 
ook kunnen worden verklaard door supraspinale veranderingen.
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•	 Onze placebo-gecontroleerde dosis-escalatiestudie liet zien dat dystonie bij CRPS 
afneemt door behandeling met ITB.  Dit ondersteunt de rol van spinale GABA-
erge mechanismen bij deze aandoening; C en Aδ sensibele vezels spelen een rol bij 
neurogene inflammatie en zijn verbonden met spinale circuits die nociceptieve 
terugtrekreflexen moduleren. Een van de primaire mediatoren van neurogene 
inflammatie, Substance P (SP), kan ook SP receptoren activeren op neuronen 
in lamina I van de achterhoorn van het ruggenmerg en zodoende long-term 
potentiation (LTP) induceren, een vorm van neuronale plasticiteit. Diermodellen 
van neurogene inflammatie hebben laten zien dat SP terugtrekreflexen verstrekt28. 
Buigspieren spelen een prominente rol bij terugtrekreflexen en het is opvallend 
dat er bij CRPS-gerelateerde dystonie een prominente betrokkenheid is van 
flexiehoudingen29,30. Neurofysiologische studies bij CRPS patiënten met dystonie 
hebben een verminderde presynaptische GABA-erge inhibitie laten zien31. 
Zowel de SP gesensitiseerde nociceptieve terugtrekreflexen in diermodellen 
als de dystonie bij CRPS- patiënten reageren op intrathecale toediening van de 
GABAB-agonist baclofen, welke spinale GABA-erge inhibitie verhoogt.
32 Onze 
bevindingen zouden kunnen wijzen op een disinhibitie van spinaal gemediëerde 
terugtrekreflexen als primair causaal mechanisme bij CRPS-gerelateerde dystonie 
als uiting van maladaptieve plasticiteit.
Argumenten voor veranderingen op supraspinaal niveau: 
•	 Hyperacusis komt frequent voor bij patiënten met een ernstige vorm van CRPS-
gerelateerde dystonie en is mogelijk een uiting van het uitbreiden van centrale 
sensitisatie naar auditieve circuits in de thalamus.
•	 Bij functionele beeldvorming van de hersenen met fMRI bij patiënten met 
CRPS en dystonie werd verminderde activatie tijdens visualisatietaken gezien in 
corticale gebieden die betrokken zijn bij het plannen van beweging, multimodale 
sensomotore integratie, autonome functie en pijn. 
•	 Verschillende onderzoekers geven argumenten voor disinhibitie op het niveau van 
de motorische cortex bij CRPS-patienten33,34. De resultaten van de SSEP studie 
laten zien dat corticale sensore verwerking van proprioceptieve input normaal is 
bij patiënten met CPRS en dystonie. Als corticale inhibitie een rol spelt, zal dat 
waarschijnlijk beperkt zijn tot de motore cortex. 
Samengevat wijzen de resultaten van onze studies naar bewegingsstoornissen en 
spreiding bij CRPS op veranderingen in het CZS op zowel spinaal als supraspinaal 
niveau. Maladaptieve neurale plasticiteit is waarschijnlijk een belangrijk mechanisme 
dat ten grondslag ligt aan de bewegingsstoornissen. Neurale plasticiteit is een 
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eigenschap van het CZS die wordt gekarakteriseerd door het remodelleren van 
neuronale contacten in een poging om zich aan te passen aan een gewijzigde situatie35. 
Neurale plasticiteit kan gunstige effecten hebben en is nodig voor een normale 
ontwikkeling van het centrale zenuwstelsel en leren. Aan de andere kant kan abnormale 
plasticiteit aandoeningen veroorzaken zoals neuropathische pijn, tinnitus, en levodopa-
geïnduceerde dyskinesiën25,27,35. Bij neuropathische pijn kan maladaptieve plasticiteit 
zich manifesteren door ectopische generatie van actiepotentialen, facilitatie en 
disinhibitie van synaptische transmissie, verlies van synaptische verbindingen, formatie 
van nieuwe synaptische circuits en gewijzigde neuroimmunologische interacties. 
Genetische polymorfismen, geslacht en leeftijd beïnvloeden allen de ontwikkeling van 
chronische pijn36. Bij de CRPS-symptomen chronische pijn en dystonie zou perifere 
neurogene inflammatie  maladaptieve neurale plasticiteit in het ruggenmerg kunnen 
induceren (b.v. centrale sensitisatie) wat zich vervolgens kan uitbreiden naar meer 
rostraal (dus supraspinaal) gelegen structuren. 
“Referred sensations”, veranderingen in grootte en de organisatie van de somatosensore 
kaart, en veranderingen in representatie van de motorische cortex suggereren corticale 
betrokkenheid in CRPS37. Een recente fMRI studie bij kinderen met  CRPS rapporteert 
over Blood-Oxygen-Level-Dependent (BOLD) responses tijdens fulminante CRPS en 
na klinisch herstel38. De auteurs vonden significante veranderingen in circuits van het 
CZS die ondanks het verdwijnen van de pijn persisteerden. De vraag op welk niveau 
van het CZS pathologische veranderingen primair hun oorsprong hebben, blijft dus 
onopgehelderd.
De aanwezigheid van verstoringen op meerdere niveaus van het CZS bij CRPS-
gerelateerde dystonie komt overeen met recente hypothesen betreffende onderliggende 
mechanismen voor andere vormen van dystonie39-42. Bij focale dystonie hebben 
verschillende onderzoekers bewijs gevonden voor corticale plasticiteit in vatbare 
personen43.
Therapie
Onze studie naar behandeling van patiënten met CRPS-gerelateerde dystonie met ITB 
liet een duidelijke verbetering zien van dystonie en pijnscores na één jaar. Verbeteringen 
op het niveau van stoornissen en beperkingen kwamen overeen met verbeteringen in 
kwaliteit van leven. De toename van dystonie na katheter- of pompdysfunctie laat zien 
dat ITB slechts op symptomatisch niveau werkt. Behandeling met ITB kon ernstige 
complicaties geven, welke onder andere bestonden uit infecties, draindysfuncties en 
psychiatrische symptomen die konden resulteren in explantatie van het pomp-katheter 
systeem. Deze therapie zou daarom alleen toegepast moeten worden bij patiënten die 
geen baat hebben bij conventionele therapieën en dient te worden uitgevoerd door 
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artsen met ruime ervaring met implanteren en instellen van intrathecale pompen. 
De patiëntenselectie blijft echter moeilijk aangezien we geen variabelen konden 
identificeren die een slechte respons of verhoogde kans op complicaties kunnen 
voorspellen. 
Toekomstplannen
Prospectieve longitudinale epidemiologische studies zijn nodig om het natuurlijk beloop 
van CRPS te beschrijven en risicofactoren te identificeren die kunnen voorspellen bij 
welke patiënten de ziekte zal uitbreiden naar andere extremiteiten en welke patiënten 
bewegingsstoornissen zullen ontwikkelen. Genetisch onderzoek zal mogelijk 
aantonen welke personen gepredisponeerd zijn voor CRPS en bewegingsstoornissen 
in het bijzonder. Een van de andere toekomstige uitdagingen is het oplossen van 
het kip-of-ei vraagstuk betreffende de diverse pathofysiologische mechanismen op 
verschillende niveaus van het CZS; de volgorde en dynamiek van de veranderingen 
op perifeer, spinaal en supraspinaal niveau vereist nadere opheldering. Hier kunnen 
longitudinale neurofysiologische studies en biomarkerstudies in liquor bijdragen aan 
de ontwikkeling van geïndividualiseerde diagnostische en therapeutische strategieën, 
welke de uitbreiding van symptomen naar andere extremiteiten of de ontwikkeling 
van bewegingsstoornissen zouden kunnen voorkomen. Daarbij is ITB-behandeling 
een veelbelovende therapie voor bewegingsstoornissen bij CRPS, hoewel het selectief 
moet worden toegepast aangezien het een operatie vereist en vaak complicaties geeft. 
Daarnaast kan de effectiviteit van ITB verbeterd worden, bijvoorbeeld door onderzoek 
naar het effect van verschillende infusiesnelheden, de verfijning van katheters en 
pompsystemen en een betere identificatie van patiënten die waarschijnlijk goed 
zullen reageren op de therapie. Vanwege de achtergrond van CRPS verdienen niet-
invasieve behandelstrategieën toegespitst op het moduleren van neurale plasticiteit 
de voorkeur. Zowel bij focale vormen van dystonie als bij CRPS zijn er ten aanzien 
van sensomotore trainingsprogramma’s die gericht zijn op maladaptieve corticale 
veranderingen (bijvoorbeeld spiegeltherapie en transcraniële magnetische stimulatie) 
gunstige effecten gerapporteerd44,45. 
Perifeer-geïnduceerde bewegingsstoornissen (Peripheral Trauma induced Movement 
Disorders, PTMDs) kunnen een andere focus van toekomstig onderzoek vormen. 
Van alle bekende gevallen van PTMDs in de literatuur heeft vijftig procent CRPS 
(eigen data, ingediend ter publicatie). PTMDs zijn sinds lange tijd een controversieel 
onderwerp in de wereld van bewegingsstoornissen. De relatie tussen perifeer trauma 
en bewegingsstoornissen heeft in de loop der tijd aan acceptatie gewonnen en in 1995 
werd door Cardoso en Jankovic een voorstel gedaan voor diagnostische criteria. Er 
is echter nog steeds een duidelijk gebrek aan consensus betreffende de pathogenese 
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van PTMDs. Sommige auteurs opperen dat PTMDs veroorzaakt worden door 
maladaptieve plasticiteit in het CZS46,47 maar dit wordt niet door iedereen gesteund48. 
Studies naar de rol van perifeer trauma bij CRPS-geïnduceerde bewegingsstoornissen 
kunnen bijdragen aan een beter begrip van betrokken ziektemechanismen. 
Samengevat kunnen toekomstige studies naar onderliggende mechanismen van neurale 
plasticiteit en studies naar modulatie van gestoorde neurale plasticiteit mogelijk leiden 
tot verbeterde behandelstrategieën bij CRPS-gerelateerde dystonie en op deze manier 
bijdragen aan een betere kwaliteit van leven en prognose van deze patiënten. 
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